data_2flj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2flj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.694 0.759 . . . . 0.0 112.724 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.57 4.95 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.197 1.561 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.84 68.7 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.82 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.661 1.23 . . . . 0.0 108.541 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.43 112.47 24.9 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.728 -1.578 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.7 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.77 174.0 15.16 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.43 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.25 -39.13 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.39 1.09 . . . . 0.0 108.06 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.36 8.1 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.68 -42.59 97.43 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.98 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.327 11.1 pt -90.95 14.15 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.064 -1.854 . . . . 0.0 111.672 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.98 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.406 11.3 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.75 67.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.201 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 60.4 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.6 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.951 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.28 158.05 32.63 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.08 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 111.298 -2.683 . . . . 0.0 106.664 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -117.22 158.55 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.629 1.206 . . . . 0.0 111.193 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.31 6.69 48.34 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.3 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.95 134.6 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.22 158.38 38.28 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.87 1.319 . . . . 0.0 110.592 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -137.45 167.96 20.6 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 18.7 ttmm -163.73 138.58 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.1 126.61 51.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.332 1.063 . . . . 0.0 110.181 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.4 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.32 9.41 Favored 'General case' 0 CA--C 1.449 -2.909 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.817 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.61 146.24 22.07 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.119 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.5 mt -55.72 131.71 47.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.39 56.27 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.44 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.735 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.071 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.666 3.6 mm? -52.34 -44.24 65.07 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 114.023 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.66 0.24 39.55 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.543 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.6 154.37 40.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.94 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.659 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.54 17.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.33 12.72 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.58 54.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.882 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.25 123.11 48.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.741 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.45 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.858 -1.776 . . . . 0.0 114.238 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -130.93 75.33 78.78 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.13 128.25 29.1 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.94 31.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.63 157.26 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.52 162.34 41.13 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.4 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.7 122.85 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.617 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.69 102.81 7.78 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.666 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.82 124.87 29.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.93 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.49 48.2 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.288 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 1.9 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.62 63.2 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.675 0.75 . . . . 0.0 112.668 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.54 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.97 68.55 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.561 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -107.74 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.82 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.63 138.15 49.84 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.722 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -48.6 125.21 9.49 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 123.025 1.393 . . . . 0.0 112.56 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.32 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.677 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.81 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.23 -39.1 82.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.431 1.11 . . . . 0.0 108.131 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.77 -40.76 93.74 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.19 -45.15 89.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.013 1.863 . . . . 0.0 109.364 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.619 0.0 OUTLIER -60.21 -41.38 92.89 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.9 179.386 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.65 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.96 82.09 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.5 pt -90.95 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 23.6 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 122.993 1.329 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.217 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 -34.68 75.22 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.654 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -63.87 -49.15 73.87 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.396 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.13 70.68 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.47 0.653 . . . . 0.0 111.288 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.25 61.84 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.8 -10.28 58.18 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.68 -10.75 47.36 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.3 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.56 14.82 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.0 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.07 117.2 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.025 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.23 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.84 -112.56 4.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.54 146.22 34.42 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.815 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.21 167.0 17.46 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.3 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.76 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.681 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.7 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.35 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.753 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.64 146.26 22.06 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.122 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.17 43.01 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.67 131.69 47.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.89 136.5 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.98 169.18 18.21 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.17 127.37 37.62 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.742 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.08 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.704 3.5 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.17 26.09 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 117.911 1.924 . . . . 0.0 117.911 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.23 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.601 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.08 22.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.6 34.9 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.54 154.45 40.57 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.721 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.669 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.94 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.5 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.89 126.62 52.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 123.917 1.817 . . . . 0.0 111.896 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.97 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.533 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.74 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.931 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.62 122.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 122.038 0.923 . . . . 0.0 109.962 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.59 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.5 t -127.6 119.0 24.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -102.96 121.12 53.74 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.508 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.86 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.373 0.606 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.8 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.22 10.78 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.03 -14.63 24.14 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.883 0.873 . . . . 0.0 112.123 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.87 124.88 29.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.48 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.4 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.82 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.903 0.859 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.327 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.55 4.92 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -3.0 68.51 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.657 1.228 . . . . 0.0 108.592 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.8 p -127.39 138.68 53.06 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.138 0.899 . . . . 0.0 110.22 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.521 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.591 0.0 OUTLIER -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.9 pt -90.9 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.144 -1.822 . . . . 0.0 111.634 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.426 38.4 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.12 70.73 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.25 61.74 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.35 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.95 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 158.06 33.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.321 2.681 . . . . 0.0 116.216 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -117.28 158.59 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.709 1.255 . . . . 0.0 111.172 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.57 4.3 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.67 48.39 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.79 19.01 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -141.45 124.59 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.41 52.18 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 20.1 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 m -116.88 153.93 31.67 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.996 0.903 . . . . 0.0 109.037 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.66 131.64 47.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.649 3.2 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.76 0.31 39.69 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.434 1.709 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.12 143.43 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.83 171.51 14.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.04 128.63 53.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.6 t -109.81 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.25 16.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.96 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.96 31.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.1 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.96 121.17 53.8 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.91 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.688 -0.632 . . . . 0.0 109.738 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.45 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.384 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.11 130.39 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.85 119.24 61.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.344 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.11 133.68 52.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.743 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.67 -32.54 63.33 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.61 0.719 . . . . 0.0 112.658 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.05 57.96 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.19 -2.9 68.34 Favored Glycine 0 C--O 1.195 -2.318 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.76 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.698 1.249 . . . . 0.0 108.597 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.77 135.42 49.21 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.844 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -48.59 125.21 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.591 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.35 -43.17 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.676 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.91 15.3 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -165.58 155.86 13.16 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.635 1.209 . . . . 0.0 111.782 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.77 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -78.11 -35.45 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.527 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.21 -39.11 82.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.78 -40.8 93.93 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -64.23 -45.11 89.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 124.0 1.857 . . . . 0.0 109.316 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.4 ptm -60.15 -41.46 92.83 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.953 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.293 14.0 pt -90.92 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.32 55.91 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.384 3.714 . . . . 0.0 122.384 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.407 21.9 t -71.46 131.61 34.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 CA-C-N 120.001 1.9 . . . . 0.0 110.316 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.96 30.25 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.92 -33.47 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.72 -10.33 58.21 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.828 0.851 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.86 47.27 Favored 'General case' 0 N--CA 1.419 -2.021 0 C-N-CA 117.478 -1.689 . . . . 0.0 109.365 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.71 80.48 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.004 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.25 158.01 32.71 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.208 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.98 126.24 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.63 1.205 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.87 143.44 50.73 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.919 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.13 117.19 41.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.055 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.19 110.17 0.51 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.87 -112.55 4.29 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.39 6.72 48.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.2 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.086 -2.246 . . . . 0.0 113.834 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.22 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.94 138.77 18.92 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.3 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.3 38.51 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.862 1.315 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.63 16.38 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.164 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.39 52.15 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.71 76.27 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.85 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.446 -1.302 . . . . 0.0 114.386 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.51 50.84 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.337 1.065 . . . . 0.0 110.164 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 m -116.91 153.94 31.69 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.986 0.898 . . . . 0.0 109.046 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.31 9.29 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.91 65.6 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.786 1.075 . . . . 0.0 115.786 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.88 136.48 56.2 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.474 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.24 127.38 37.7 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.713 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.97 143.53 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.2 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.654 3.4 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.69 0.24 39.66 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.06 26.38 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.949 1.94 . . . . 0.0 117.949 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.22 156.9 17.16 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.85 171.95 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.26 117.58 34.83 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -124.58 154.42 40.67 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.453 1.72 . . . . 0.0 111.754 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.85 171.44 14.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.6 150.42 22.27 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.01 1.324 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.17 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -120.02 128.7 53.77 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.8 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -117.82 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.59 54.64 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.918 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.533 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.42 17.69 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.939 -1.725 . . . . 0.0 114.219 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.3 p-10 -64.53 -25.96 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.97 75.34 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.384 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.6 m -138.89 149.66 45.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.14 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.856 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.6 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.064 0.935 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.58 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.009 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -124.76 113.86 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.42 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.75 42.5 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.55 119.0 25.04 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 mt -103.0 121.12 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.526 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -110.85 123.3 49.83 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.767 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.3 tp -124.66 102.84 7.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.09 -14.56 24.13 Favored 'General case' 0 CA--C 1.47 -2.129 0 C-N-CA 123.883 0.873 . . . . 0.0 112.126 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.9 124.81 29.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.83 1.331 . . . . 0.0 111.931 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.7 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.27 61.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.14 133.69 52.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.715 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.33 132.57 48.23 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.005 0.816 . . . . 0.0 112.229 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.228 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.69 63.17 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.35 -10.59 4.96 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.95 57.9 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.736 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 -3.0 68.57 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.609 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.31 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.275 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.742 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.82 13.11 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 124.686 1.241 . . . . 0.0 111.766 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.03 -35.53 49.67 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.405 1.5 ptm -60.24 -41.36 92.98 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.32 11.9 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.411 21.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.029 1.349 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.18 62.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.46 -28.97 65.64 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.931 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.4 pt -117.28 158.54 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.58 14.92 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.872 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.49 38.23 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.85 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.845 0.716 . . . . 0.0 111.924 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.89 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.24 34.31 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.09 -2.244 . . . . 0.0 113.757 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.64 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.45 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.0 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.76 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.33 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.1 127.35 37.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.58 37.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.09 -1.631 . . . . 0.0 106.963 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.614 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.76 0.34 39.57 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.87 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.11 117.53 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.53 154.48 40.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.423 1.702 . . . . 0.0 111.732 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.49 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.61 150.47 22.22 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 125.035 1.334 . . . . 0.0 111.181 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.65 -22.45 18.01 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.211 2.735 . . . . 0.0 119.211 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.56 73.22 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -10.38 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.28 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.7 t -127.54 118.95 24.94 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.3 48.31 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 111.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.6 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.773 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.072 0.857 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.61 -32.56 63.22 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.669 0.747 . . . . 0.0 112.706 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.73 135.42 49.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.64 138.18 49.81 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 123.005 1.383 . . . . 0.0 112.584 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.1 28.78 9.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.19 -39.13 82.56 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.8 -40.75 93.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -64.19 -45.15 89.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.013 1.863 . . . . 0.0 109.35 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 10.3 ttm -60.14 -41.48 92.78 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.916 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.99 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.355 9.3 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.401 3.72 . . . . 0.0 122.401 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.465 14.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.95 -33.44 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.24 -34.66 75.15 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 63.9 mtm-85 -63.81 -49.22 73.74 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.15 70.57 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.464 0.649 . . . . 0.0 111.258 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.41 -28.98 65.54 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.361 0.978 . . . . 0.0 113.864 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.79 -10.32 58.17 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.426 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.7 152.58 18.33 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.8 80.32 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.33 158.07 32.8 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.365 2.71 . . . . 0.0 116.153 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.609 1.195 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.55 14.81 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.055 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.8 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.78 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.68 138.66 6.18 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.433 -1.307 . . . . 0.0 114.426 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.98 139.21 42.95 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.663 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.7 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.61 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.36 128.47 56.3 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.85 136.48 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.2 18.17 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.482 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.16 127.36 37.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.763 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -127.05 143.49 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.2 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.19 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.606 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.7 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.669 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.84 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.09 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.51 -22.54 18.23 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.04 128.64 53.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -117.85 126.61 52.73 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.59 54.59 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.878 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.42 17.72 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.916 -1.74 . . . . 0.0 114.268 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.349 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -138.85 149.62 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.58 122.39 69.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.038 0.923 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.26 135.6 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.01 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.78 113.86 18.49 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.6 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.96 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.7 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.0 121.09 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.489 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.0 m -110.85 123.25 49.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.625 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.767 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.67 102.82 7.78 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.87 124.86 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.885 1.366 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.43 127.43 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.433 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -133.09 130.4 39.26 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.81 119.28 61.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.349 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.988 0.805 . . . . 0.0 112.255 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.66 63.02 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.55 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.5 28.62 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.996 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.623 1.211 . . . . 0.0 108.561 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.59 125.22 9.5 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.93 1.347 . . . . 0.0 112.62 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.703 1.252 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.85 9.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.16 -35.45 48.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.25 -39.08 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.0 108.106 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.8 -40.74 93.78 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 9.2 ttm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.67 97.45 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.0 82.13 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.351 9.6 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.448 13.2 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.018 1.344 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.91 -33.53 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.215 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.68 75.34 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.654 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.47 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.403 0.62 . . . . 0.0 111.281 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.27 61.75 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.01 65.35 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.79 -10.29 58.19 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.6 -10.79 47.48 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.356 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.8 mt -95.64 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.79 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.975 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.894 0.746 . . . . 0.0 111.976 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.023 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.87 138.79 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.345 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.97 134.63 55.19 Favored 'General case' 0 C--O 1.279 2.648 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.28 158.34 38.43 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.553 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.7 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 18.9 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.7 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.32 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.782 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.98 139.17 43.0 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.38 37.59 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.07 143.48 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.107 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.18 120.62 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.924 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.685 3.9 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.69 0.24 39.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.26 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.08 22.32 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.45 40.61 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.93 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.53 54.55 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.907 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.22 123.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -89.96 -166.76 1.67 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.78 62.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.902 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.076 0.941 . . . . 0.0 109.942 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.89 31.06 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.64 157.27 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.522 1.63 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.19 10.68 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.84 124.79 29.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.977 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.39 127.47 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.419 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.8 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.26 146.78 52.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.84 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.305 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.68 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.55 4.96 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.99 57.89 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.704 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.691 1.246 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.1 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.35 -43.11 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.689 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.83 173.96 15.19 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.509 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.56 155.85 13.19 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 124.703 1.252 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -78.06 -35.49 49.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.71 -40.8 93.61 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.393 1.2 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 9.4 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.99 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.429 24.3 t -71.47 131.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 CA-C-N 120.01 1.905 . . . . 0.0 110.291 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.32 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.019 1.344 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.24 62.0 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.03 65.47 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.413 1.007 . . . . 0.0 113.939 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.28 158.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.65 146.59 14.96 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.902 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.53 38.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.9 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.863 0.727 . . . . 0.0 111.907 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.89 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.21 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.62 48.53 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.57 146.24 34.33 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.081 -2.248 . . . . 0.0 113.757 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.3 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 84.5 tttt -163.73 138.6 6.1 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 118.463 -1.295 . . . . 0.0 114.371 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.51 50.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.323 1.059 . . . . 0.0 110.225 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.29 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.57 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.089 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.0 139.21 42.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.734 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -1.88 65.63 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.3 128.46 56.28 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.91 136.47 56.16 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.12 18.31 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.515 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.15 127.39 37.61 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.745 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.25 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.17 120.61 37.84 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.945 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.671 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.79 0.39 39.45 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.22 26.17 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.3 156.84 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.609 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.03 22.24 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.9 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.19 117.56 34.82 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.4 m -124.52 154.45 40.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.439 1.712 . . . . 0.0 111.736 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.44 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.47 22.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.998 1.319 . . . . 0.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.67 -22.44 17.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.85 16.49 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.79 126.61 52.74 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.56 127.57 54.63 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.916 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.6 -25.96 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.57 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -10.41 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.289 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.57 118.99 24.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.02 121.19 53.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.504 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.3 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.09 133.74 52.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.737 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.53 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.089 0.868 . . . . 0.0 112.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.6 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.58 63.29 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.615 0.722 . . . . 0.0 112.62 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.6 5.07 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.43 28.83 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -107.76 135.4 49.25 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.839 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -48.65 125.21 9.56 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.576 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.29 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.0 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.617 1.198 . . . . 0.0 111.74 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.08 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.24 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.83 9.3 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.539 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.25 -39.08 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.348 1.07 . . . . 0.0 108.123 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.8 -40.74 93.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -64.2 -45.15 89.58 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 124.03 1.871 . . . . 0.0 109.335 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.4 ptm -60.19 -41.4 92.85 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.885 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.64 -42.68 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.02 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.89 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.713 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.29 55.94 Favored Glycine 0 C--O 1.213 -1.16 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.425 23.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.9 30.4 Favored Glycine 0 CA--C 1.49 -1.493 0 CA-C-O 123.003 1.335 . . . . 0.0 114.299 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.65 75.27 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.22 61.94 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -28.94 65.52 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.82 -10.29 58.16 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.355 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.65 152.61 18.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.69 80.43 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.615 -2.084 . . . . 0.0 111.004 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.34 158.06 32.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.403 2.735 . . . . 0.0 116.157 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 CA-C-O 122.675 1.226 . . . . 0.0 111.182 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.16 138.5 38.11 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.797 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.857 0.723 . . . . 0.0 111.976 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.09 117.15 41.15 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.05 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.6 4.31 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.74 48.2 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.25 34.32 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.751 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.21 167.04 17.4 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.99 138.77 18.88 Favored 'General case' 0 C--N 1.263 -3.153 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.3 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -137.52 167.88 20.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.77 76.38 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.703 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 84.4 tttt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.64 146.17 21.97 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.18 42.97 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.6 40.91 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.66 131.69 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.47 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.98 169.14 18.28 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.512 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.713 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.04 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.085 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.61 37.81 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.945 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.616 3.6 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.71 0.29 39.53 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.48 40.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.732 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.5 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.42 22.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.13 89.08 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.54 177.93 50.46 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.55 -22.52 18.16 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.0 128.62 53.71 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.8 118.69 57.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -117.84 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.914 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.883 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.02 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.791 -1.564 . . . . 0.0 108.492 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.45 17.72 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.991 -1.693 . . . . 0.0 114.239 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.53 -25.92 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.384 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.88 149.63 45.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.75 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.88 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.8 mt -115.65 122.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.053 0.93 . . . . 0.0 109.966 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.012 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.54 73.2 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.74 42.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.2 t -127.56 118.95 24.93 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.3 mt -102.95 121.09 53.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.497 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.79 123.23 49.67 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.69 -0.631 . . . . 0.0 109.804 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.75 122.79 68.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.66 102.79 7.77 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.22 10.8 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.04 -14.67 24.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.906 0.882 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.77 29.35 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.785 1.303 . . . . 0.0 111.983 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.45 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.42 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.48 148.8 49.63 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.327 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.25 132.54 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.283 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.57 56.23 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.196 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.64 63.12 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.671 0.748 . . . . 0.0 112.699 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.56 4.99 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 142.99 58.01 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.704 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.84 69.11 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.84 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.664 1.232 . . . . 0.0 108.524 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.46 24.88 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.602 1.668 . . . . 0.0 110.303 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.661 -1.609 . . . . 0.0 106.784 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.33 -43.15 3.56 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.7 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.8 173.96 15.2 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.46 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.85 13.03 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.633 1.208 . . . . 0.0 111.728 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.11 28.8 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -78.09 -35.49 49.3 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.15 82.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.77 93.64 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.051 1.881 . . . . 0.0 109.391 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.5 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.96 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.315 12.4 pt -90.93 14.18 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -2.007 0 C-N-CA 117.09 -1.844 . . . . 0.0 111.688 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.417 21.9 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.57 74.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.83 47.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -95.61 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.39 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.982 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.223 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -119.99 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.317 -2.674 . . . . 0.0 106.703 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 pt -117.25 158.59 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.702 1.251 . . . . 0.0 111.207 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.404 0.621 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.56 4.3 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.66 48.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.89 138.86 19.05 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.283 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.03 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.68 16.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.39 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -137.5 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.662 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 53.3 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.05 126.54 51.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.297 1.046 . . . . 0.0 110.205 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.29 9.33 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.782 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.6 40.93 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.96 132.98 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.63 131.68 47.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.43 56.28 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.86 136.45 56.17 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.45 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -127.07 143.56 51.25 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.05 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.617 3.5 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.75 0.26 39.88 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.21 25.97 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.909 1.924 . . . . 0.0 117.909 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.543 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.96 110.06 22.3 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.87 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.18 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -124.6 154.41 40.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.72 28.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.695 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -137.98 143.49 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.22 89.15 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.94 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.194 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.63 -22.51 17.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.38 12.73 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.59 127.58 54.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.942 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.25 123.14 48.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.741 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.06 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.502 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.45 17.63 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.51 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -130.91 75.4 78.69 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.63 122.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.086 0.946 . . . . 0.0 109.905 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.5 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.015 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.87 31.02 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.54 157.23 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.57 73.25 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.58 1.657 . . . . 0.0 109.411 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.88 116.39 48.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.676 1.227 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 121.13 53.77 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.89 -1.131 . . . . 0.0 111.504 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.71 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.644 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.69 33.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.794 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.45 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.42 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.79 49.67 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.269 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.692 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.26 132.46 48.19 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 123.969 0.793 . . . . 0.0 112.245 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.36 1.552 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 143.05 57.94 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.181 1.55 . . . . 0.0 109.687 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.23 -2.95 68.35 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.78 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.609 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.75 135.42 49.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.784 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.265 1.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.0 tp -48.64 125.22 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.8 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.82 173.94 15.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.43 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.763 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.1 -35.49 49.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.53 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.72 93.47 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -64.23 -45.15 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.53 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.409 1.4 ptm -60.19 -41.45 92.97 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.935 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.61 97.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.01 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.33 11.2 pt -90.92 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.1 -1.84 . . . . 0.0 111.684 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.419 31.1 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.98 30.33 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.47 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.21 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.33 -34.54 74.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.645 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.83 -49.26 73.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.18 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.04 65.5 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.939 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.7 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -95.65 152.66 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.26 158.05 32.58 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.324 2.683 . . . . 0.0 116.263 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 111.358 -2.656 . . . . 0.0 106.733 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.284 12.2 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.62 1.2 . . . . 0.0 111.155 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.27 138.52 38.19 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.91 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.877 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.493 0.663 . . . . 0.0 111.102 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.3 6.65 48.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.58 146.27 34.3 Favored 'General case' 0 N--CA 1.403 -2.807 0 C-N-CA 116.036 -2.266 . . . . 0.0 113.79 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.75 18.93 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.327 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.95 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.7 76.27 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.84 -6.76 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 55.0 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.11 126.55 51.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.283 1.04 . . . . 0.0 110.216 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.17 157.29 9.32 Favored 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.841 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.57 146.24 22.13 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.086 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.65 40.94 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.63 131.63 46.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.86 65.86 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.18 127.37 37.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -126.97 143.52 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.12 120.59 37.77 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.115 -1.615 . . . . 0.0 106.905 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.5 p -78.01 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.631 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.648 3.4 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.13 26.24 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.25 156.9 17.17 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.62 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.87 171.92 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.21 117.61 34.92 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -124.58 154.39 40.72 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.464 1.727 . . . . 0.0 111.764 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.307 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.83 171.45 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.57 150.46 22.22 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.103 1.361 . . . . 0.0 111.169 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.13 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.94 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.194 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 -22.43 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.79 16.38 12.68 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -119.97 128.69 53.81 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.83 118.56 57.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.252 16.6 t-160 -117.76 126.58 52.71 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.816 1.77 . . . . 0.0 111.988 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.91 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -109.29 123.08 48.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.754 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.4 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.2 p-10 -64.54 -26.01 68.23 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -130.93 75.36 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 m -138.89 149.64 45.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.3 135.56 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.008 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -124.77 113.94 18.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.23 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.65 -10.43 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.256 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.5 t -127.57 118.98 24.96 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-O 122.557 1.17 . . . . 0.0 111.181 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.97 121.2 53.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.96 -1.088 . . . . 0.0 111.508 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.3 mt -113.69 122.79 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.67 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.75 33.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.735 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.6 148.8 49.73 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.77 52.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.805 0.812 . . . . 0.0 111.408 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.08 130.45 39.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.917 -1.492 . . . . 0.0 114.291 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.722 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.29 132.54 48.19 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.046 0.841 . . . . 0.0 112.268 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.714 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.256 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.647 0.736 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.9 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.75 140.34 15.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.545 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.644 1.688 . . . . 0.0 110.282 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.74 135.45 49.13 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.784 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.68 138.15 49.91 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.31 -43.23 3.55 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.678 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.95 15.24 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.8 9.41 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -78.13 -35.49 49.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.539 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.12 82.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.79 -40.78 93.9 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -64.21 -45.13 89.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.0 1.857 . . . . 0.0 109.349 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.15 -41.48 92.85 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.916 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.59 97.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.3 pt -90.92 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.982 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.28 55.94 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.379 3.712 . . . . 0.0 122.379 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.416 23.2 t -71.49 131.63 34.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.289 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.69 67.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.82 47.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.61 152.65 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.951 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.22 158.04 32.45 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.199 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.687 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -117.27 158.59 17.83 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 O-C-N 124.62 1.2 . . . . 0.0 111.191 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.51 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.43 6.73 48.21 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.57 55.22 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.4 p -128.22 158.34 38.37 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.7 t -141.5 124.64 16.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.91 139.43 52.13 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -137.54 167.9 20.73 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 53.8 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.15 126.51 50.89 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.269 1.033 . . . . 0.0 110.176 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.69 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.9 65.7 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.49 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.2 127.42 37.67 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.703 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.687 3.5 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.69 0.21 39.79 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.06 26.27 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.926 1.93 . . . . 0.0 117.926 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -101.17 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.237 -1.385 . . . . 0.0 110.606 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.18 117.55 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.42 40.68 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.75 28.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.659 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.98 143.48 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.87 171.47 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 54.9 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.61 54.65 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.918 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -109.31 123.14 48.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.708 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.07 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.533 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.42 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.941 -1.724 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.49 -25.97 68.23 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.93 149.62 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.59 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.33 135.53 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 117.893 -1.523 . . . . 0.0 108.964 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.78 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.27 16.79 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.53 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.34 48.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.1 m -110.88 123.3 49.85 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 mt -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.53 119.73 33.79 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -124.62 102.84 7.81 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.88 124.81 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.77 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.691 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.27 132.55 48.15 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.984 0.802 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.8 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.62 -32.58 63.24 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.687 0.756 . . . . 0.0 112.698 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.99 57.93 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.735 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.73 140.37 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.563 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.682 1.706 . . . . 0.0 110.255 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.72 135.39 49.23 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.664 -1.607 . . . . 0.0 106.804 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.65 138.15 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.32 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 173.97 15.22 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.505 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -165.63 155.82 13.0 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.78 9.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.1 -35.55 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.15 -39.11 82.74 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.82 -40.75 93.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -64.17 -45.17 89.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 123.987 1.851 . . . . 0.0 109.354 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 8.3 ttm -60.12 -41.46 92.66 Favored 'General case' 0 N--CA 1.41 -2.433 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.95 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.04 82.1 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.299 13.2 pt -90.91 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.974 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.707 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.27 55.99 Favored Glycine 0 C--O 1.214 -1.124 0 N-CA-C 122.411 3.724 . . . . 0.0 122.411 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.434 12.2 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.72 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.08 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.2 mtm-85 -63.8 -49.26 73.58 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.07 65.61 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.346 0.97 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.4 mt -83.73 -10.27 58.25 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.771 0.828 . . . . 0.0 109.433 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt -95.64 152.6 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.71 80.4 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.95 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.23 158.03 32.51 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.333 2.689 . . . . 0.0 116.238 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.748 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.7 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.628 1.204 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.56 14.9 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.92 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.25 138.52 38.16 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.761 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.9 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.945 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.17 117.23 41.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.961 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.91 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.66 48.41 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.2 158.31 38.46 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.803 1.287 . . . . 0.0 110.627 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.5 t -141.49 124.68 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.87 139.44 52.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.7 p -137.51 167.86 20.79 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.24 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.88 -6.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 50.1 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.936 1.397 . . . . 0.0 111.055 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.2 m -107.92 139.22 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.745 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.34 160.62 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.99 133.05 56.29 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.61 131.67 46.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -1.9 65.93 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 115.708 1.043 . . . . 0.0 115.708 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.82 136.45 56.2 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.17 18.22 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.735 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.16 120.63 37.86 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.888 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -77.97 168.43 19.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.637 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.625 4.1 mm? -52.45 -44.2 65.37 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.153 -1.839 . . . . 0.0 113.963 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.4 m -117.92 171.91 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.9 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.61 154.44 40.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.659 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.03 143.4 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.7 p -145.81 171.5 14.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.62 150.43 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.087 1.355 . . . . 0.0 111.189 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.6 177.89 50.4 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 115.635 -3.174 . . . . 0.0 105.183 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.57 -22.47 18.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.265 2.756 . . . . 0.0 119.265 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.81 16.42 12.67 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.03 128.68 53.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -117.85 126.56 52.62 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 123.81 1.767 . . . . 0.0 111.947 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.91 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.31 123.13 48.78 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.719 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.706 -1.598 . . . . 0.0 108.549 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.38 17.71 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.9 -1.75 . . . . 0.0 114.235 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.36 11.3 p-10 -64.59 -25.95 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.93 149.64 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.77 62.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.2 mt -115.62 122.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.59 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 108.988 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -124.8 113.9 18.54 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.94 31.15 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.69 157.21 16.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.33 41.13 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -32.47 73.16 Favored 'General case' 0 N--CA 1.41 -2.443 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.47 19.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 115.503 -2.479 . . . . 0.0 117.274 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.76 42.61 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.73 122.84 68.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.625 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.68 33.65 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.8 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.61 102.79 7.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.14 10.53 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.666 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.12 -14.6 24.05 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.871 0.868 . . . . 0.0 112.085 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.83 29.42 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.832 1.332 . . . . 0.0 111.906 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.8 t -120.43 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.436 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.57 148.77 49.71 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.76 52.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -133.08 130.46 39.37 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.291 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.13 133.66 52.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.721 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.25 132.54 48.13 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.984 0.802 . . . . 0.0 112.283 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.54 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.371 1.558 . . . . 0.0 110.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.52 28.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.77 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.541 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.51 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.56 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.01 15.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.64 155.83 12.99 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.598 1.187 . . . . 0.0 111.759 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.2 -39.18 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.72 -40.76 93.52 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.349 8.4 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.93 81.85 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.99 14.13 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.149 -1.821 . . . . 0.0 111.66 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.95 23.26 56.01 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.442 12.5 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -73.0 -33.44 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.235 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.89 -49.15 73.81 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.48 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.205 -1.668 0 CA-C-O 122.427 1.015 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.75 47.49 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.67 152.62 18.29 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.25 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.279 14.5 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.666 1.229 . . . . 0.0 111.208 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.56 14.88 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.859 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.758 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.506 0.669 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.29 6.65 48.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.61 55.19 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.37 38.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.876 1.322 . . . . 0.0 110.565 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.6 tttt -163.73 138.62 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.34 9.44 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.788 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 132.97 56.35 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.63 131.72 47.13 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.648 1.69 . . . . 0.0 110.499 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.18 127.4 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.764 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.05 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.508 1.623 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.105 -1.622 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.1 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -101.19 156.87 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.574 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.86 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.659 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.65 -22.46 17.99 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.153 2.713 . . . . 0.0 119.153 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.82 16.33 12.66 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.1 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.46 17.67 Favored Glycine 0 CA--C 1.491 -1.445 0 O-C-N 119.902 -1.749 . . . . 0.0 114.207 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.5 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.908 1.128 . . . . 0.0 111.429 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.8 149.65 45.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.21 119.7 62.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.891 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.55 122.36 69.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -124.74 113.87 18.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.52 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.9 123.23 49.73 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.436 0.636 . . . . 0.0 109.733 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.65 122.81 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.644 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.17 10.58 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.84 29.41 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.885 1.366 . . . . 0.0 111.915 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.4 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.27 132.54 48.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.973 0.796 . . . . 0.0 112.255 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.52 56.18 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.38 2.47 28.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.04 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.95 68.5 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.701 1.251 . . . . 0.0 108.565 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.52 24.95 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.59 125.27 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.621 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.41 138.73 53.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.079 0.862 . . . . 0.0 110.198 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -78.1 -35.47 49.26 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.18 -39.11 82.62 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.35 1.071 . . . . 0.0 108.111 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.7 ttm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.329 11.0 pt -90.87 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.438 11.7 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.69 67.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.5 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.269 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.223 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.16 -46.2 61.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.04 65.72 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.85 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.34 158.55 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.636 1.21 . . . . 0.0 111.158 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.27 138.48 38.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.94 -163.84 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.493 0.663 . . . . 0.0 111.124 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.62 48.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.51 146.21 34.49 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.115 -2.234 . . . . 0.0 113.808 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.5 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.0 p -137.47 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.62 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.7 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.01 143.52 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.705 4.0 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.77 28.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.06 143.4 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.8 171.51 14.68 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.87 52.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.06 128.72 53.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.524 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 12.0 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.92 75.32 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.15 128.23 29.01 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.913 1.13 . . . . 0.0 111.368 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.4 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.82 113.93 18.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.47 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.57 118.95 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.898 -1.127 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.78 122.82 68.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.575 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.72 33.78 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.758 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -133.1 130.39 39.21 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.254 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.33 -10.56 4.89 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -2.96 68.7 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.636 1.218 . . . . 0.0 108.561 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.0 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.104 0.878 . . . . 0.0 110.24 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.472 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.9 ttm -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.345 9.9 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.441 12.0 t -71.44 131.61 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.295 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.87 30.45 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.472 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.11 70.76 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.22 61.82 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.37 158.06 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.177 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.22 158.59 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.19 138.51 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.68 48.35 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.62 16.41 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.37 52.19 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -116.91 153.95 31.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.016 0.913 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.686 4.1 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.72 0.26 39.72 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.606 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.476 1.735 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.08 143.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.859 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.64 127.53 54.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.907 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.22 123.01 48.55 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 124.629 1.206 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.92 -166.7 1.65 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.783 -1.567 . . . . 0.0 108.531 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.859 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.52 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.648 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.4 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.84 119.28 61.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.314 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.956 -1.929 . . . . 0.0 111.743 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.59 63.3 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.68 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.4 2.45 28.71 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.073 -0.651 . . . . 0.0 112.042 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.72 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.59 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.44 112.47 24.9 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 123.597 1.665 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.844 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.57 138.17 49.74 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.524 0.678 . . . . 0.0 109.659 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.56 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -159.73 174.0 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.46 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.62 155.84 13.05 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.633 1.208 . . . . 0.0 111.709 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.77 9.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.25 -39.13 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.381 1.086 . . . . 0.0 108.077 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.77 -40.73 93.63 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -64.17 -45.12 89.82 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 124.009 1.862 . . . . 0.0 109.406 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.359 8.3 ttm -60.18 -41.46 92.95 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.901 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.6 -42.65 97.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.318 11.5 pt -90.95 14.13 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.66 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.25 56.05 Favored Glycine 0 C--O 1.214 -1.108 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.409 10.8 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.95 30.16 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-O 123.037 1.354 . . . . 0.0 114.287 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.79 67.01 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.57 75.01 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 60.5 mtm-85 -63.89 -49.16 73.78 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.76 -10.29 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.6 mt -95.65 152.63 18.28 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.74 80.35 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.981 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.3 158.0 33.01 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.21 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.98 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.755 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.2 158.55 17.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.693 1.245 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.818 0.698 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.464 0.65 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.95 -112.65 4.33 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.69 48.33 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.64 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.23 158.33 38.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.849 1.309 . . . . 0.0 110.578 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.52 124.68 16.39 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.109 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.45 52.15 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.6 p -137.5 167.87 20.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.5 tttt -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.0 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.12 157.37 9.48 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.764 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.66 146.24 22.01 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.9 1.375 . . . . 0.0 111.055 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -108.01 139.18 43.04 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.664 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.59 40.93 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.99 132.97 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.6 131.74 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.91 65.36 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.99 169.16 18.24 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.735 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.63 37.91 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.125 -1.609 . . . . 0.0 106.87 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.96 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.679 3.7 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -81.72 0.33 39.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.85 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.0 144.78 28.77 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.72 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.37 22.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.17 89.16 2.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.103 -3.199 . . . . 0.0 105.103 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.5 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.8 16.33 12.67 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.82 52.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -119.96 128.65 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.58 -162.45 17.71 Favored Glycine 0 CA--C 1.49 -1.505 0 O-C-N 119.9 -1.75 . . . . 0.0 114.223 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 12.0 p-10 -64.54 -25.99 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.14 128.19 28.86 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.841 1.1 . . . . 0.0 111.416 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.6 45.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.77 62.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.88 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.62 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.964 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.76 113.87 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.63 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.587 1.661 . . . . 0.0 109.447 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.88 123.27 49.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.369 0.605 . . . . 0.0 109.774 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.68 122.81 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.644 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.1 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.548 -2.263 . . . . 0.0 109.666 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.61 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.906 0.882 . . . . 0.0 112.112 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.83 124.82 29.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 124.83 1.331 . . . . 0.0 111.906 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.2 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.4 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.7 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.79 52.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -133.12 130.44 39.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.88 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.311 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.54 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.283 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.79 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.199 -179.869 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.6 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.59 63.18 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.39 2.51 28.78 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.033 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.4 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.38 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.663 1.232 . . . . 0.0 108.58 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.224 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -48.64 125.27 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.686 1.241 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.42 138.71 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.147 0.904 . . . . 0.0 110.181 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -78.07 -35.46 49.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.26 -39.05 82.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.357 1.075 . . . . 0.0 108.122 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.389 1.6 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.264 13.1 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.365 17.7 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.89 -33.54 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.233 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.696 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -63.85 -49.19 73.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.419 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.14 70.65 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.23 61.95 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.02 65.55 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.91 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.73 -10.29 58.24 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.73 47.58 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 117.426 -1.71 . . . . 0.0 109.395 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.187 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.289 13.8 pt -117.34 158.56 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.146 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.57 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.23 138.52 38.14 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.75 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.894 0.746 . . . . 0.0 111.948 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 m -97.08 117.15 41.14 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.053 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.45 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.163 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.8 p -137.47 167.98 20.56 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.655 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 84.2 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.062 0.934 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.16 43.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.717 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.29 160.56 40.88 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.64 46.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -127.03 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.117 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.11 120.61 37.79 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.954 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.4 p -78.0 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.388 1.09 . . . . 0.0 111.59 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.532 3.7 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.21 25.97 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -124.57 154.45 40.63 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.743 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.02 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.656 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.12 143.41 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.51 14.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.18 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.629 -3.177 . . . . 0.0 105.174 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.03 128.72 53.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.57 54.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.876 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.363 11.3 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.4 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.8 mt -115.61 122.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.55 162.32 41.17 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.4 20.02 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.513 -2.475 . . . . 0.0 117.247 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -127.54 118.93 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 121.635 -0.665 . . . . 0.0 109.747 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.77 122.83 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.565 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.2 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tt -80.82 124.78 29.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.865 1.353 . . . . 0.0 112.008 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.41 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.52 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.79 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -133.1 130.38 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.357 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -110.1 133.64 53.0 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.65 -32.57 63.31 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.65 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.98 57.93 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.767 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.97 68.46 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.5 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.197 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.267 1.989 0 CA-C-O 121.431 0.634 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.22 9.58 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.74 173.99 15.2 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.05 -35.54 49.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.18 -39.11 82.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.342 10.8 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.38 55.88 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.452 3.741 . . . . 0.0 122.452 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.991 1.895 . . . . 0.0 110.298 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.92 -33.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.704 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.15 62.11 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.01 65.78 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.342 0.968 . . . . 0.0 113.846 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.71 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.379 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.3 158.56 17.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.654 1.216 . . . . 0.0 111.119 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.67 146.54 14.89 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.936 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.23 138.48 38.2 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.761 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.09 117.16 41.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.053 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -137.52 167.87 20.78 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.72 76.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.77 -6.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.7 tttt -163.67 138.65 6.19 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.408 -1.317 . . . . 0.0 114.366 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.9 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.33 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.34 160.58 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.06 56.29 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.67 46.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.82 65.75 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.01 169.13 18.3 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.457 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.733 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.02 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.475 1.607 . . . . 0.0 115.085 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.65 37.86 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.936 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -78.03 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.603 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.659 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.14 26.22 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.954 1.941 . . . . 0.0 117.954 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.626 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.42 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.8 171.54 14.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.63 150.47 22.23 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.014 1.326 . . . . 0.0 111.181 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.85 118.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.62 54.61 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.771 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.914 -1.741 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.341 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.94 75.27 78.86 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.22 28.95 Favored 'Trans proline' 0 C--N 1.284 -2.829 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.73 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.053 0.93 . . . . 0.0 109.994 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.63 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 109.013 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.32 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.49 73.15 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 -10.39 19.99 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 115.532 -2.467 . . . . 0.0 117.247 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -152.99 158.73 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -127.52 118.93 24.92 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.89 123.27 49.81 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.591 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.76 33.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.741 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.7 102.74 7.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.511 -2.281 . . . . 0.0 109.687 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.78 29.39 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.42 127.51 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.379 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.75 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.09 130.44 39.3 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.349 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.018 0.824 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.254 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.7 p . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.652 0.739 . . . . 0.0 112.724 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.43 -10.49 4.96 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.179 1.549 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.8 140.41 15.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.623 1.211 . . . . 0.0 108.529 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.73 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.779 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.18 9.5 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.971 1.367 . . . . 0.0 112.63 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.095 0.872 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.77 9.48 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.1 -35.47 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.28 -39.03 82.25 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.396 1.094 . . . . 0.0 108.098 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.82 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.72 -42.56 97.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.99 82.17 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.34 10.8 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.091 -1.844 . . . . 0.0 111.702 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.33 55.88 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.1 t -71.5 131.64 34.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.264 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.96 30.36 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.79 66.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.91 -33.5 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.201 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.65 75.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.24 73.67 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.13 70.69 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.22 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.29 -29.08 65.38 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.429 1.016 . . . . 0.0 113.918 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.74 -10.32 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.786 0.834 . . . . 0.0 109.426 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.79 47.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.38 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.63 152.54 18.35 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.76 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.652 -2.067 . . . . 0.0 110.951 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.177 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.99 126.22 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.247 -2.706 . . . . 0.0 106.687 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.27 158.6 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.18 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.88 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.2 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.016 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.95 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.445 0.64 . . . . 0.0 111.119 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.52 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.69 48.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -128.25 167.05 17.43 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.273 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.03 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.38 38.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.855 1.312 . . . . 0.0 110.58 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.7 p -137.45 167.97 20.58 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.662 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.85 -6.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 85.0 tttt -163.74 138.57 6.08 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.431 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.304 1.049 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -116.96 153.89 31.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.15 157.29 9.35 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.782 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.58 146.2 22.09 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.119 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.94 139.24 42.86 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.714 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.65 131.68 47.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.9 65.64 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.9 136.48 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.19 127.44 37.67 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.714 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -127.07 143.54 51.25 Favored 'General case' 0 CA--C 1.588 2.406 0 CA-C-O 123.418 1.58 . . . . 0.0 115.07 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.19 -1.569 . . . . 0.0 106.866 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -77.99 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-O 122.354 1.073 . . . . 0.0 111.654 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.661 3.6 mm? -52.34 -44.21 65.05 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.233 -1.803 . . . . 0.0 114.023 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.7 0.21 39.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.22 25.91 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.29 156.87 17.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.539 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.09 22.33 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.9 m -124.59 154.4 40.74 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.718 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.82 28.72 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.659 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.0 mt -138.07 143.45 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.88 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.194 -3.162 . . . . 0.0 105.194 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.58 -22.55 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.42 12.71 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.76 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.1 mt -119.97 128.67 53.79 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.78 118.61 57.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.53 52.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.978 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.55 127.55 54.62 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.947 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.27 123.1 48.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 124.669 1.231 . . . . 0.0 108.735 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.67 1.64 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.518 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.44 17.73 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.91 -1.744 . . . . 0.0 114.254 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.95 75.4 78.66 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.17 128.3 29.32 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.913 1.13 . . . . 0.0 111.386 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.92 149.62 45.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.6 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.56 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.013 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.74 113.85 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.87 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.64 157.25 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.37 41.09 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.48 20.01 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.314 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.74 42.59 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.53 119.0 25.05 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.88 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.599 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.6 119.69 33.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.732 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.21 10.76 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.679 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.79 124.82 29.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.887 1.367 . . . . 0.0 111.992 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.47 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.395 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.51 148.78 49.66 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.75 52.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.02 130.45 39.45 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.922 -1.49 . . . . 0.0 114.269 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.691 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.992 0.807 . . . . 0.0 112.288 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.51 -32.64 63.07 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.729 0.776 . . . . 0.0 112.699 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.37 -10.55 4.94 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.5 28.63 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.076 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 142.98 57.99 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.711 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.33 15.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.39 112.47 24.92 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.28 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.51 138.16 49.69 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.733 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.26 9.64 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.701 1.251 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.42 138.73 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.246 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.007 1.861 . . . . 0.0 109.391 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.3 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.304 13.4 pt -90.94 14.17 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.672 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.415 23.5 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.88 30.38 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.052 1.362 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.84 66.6 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -177.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.89 -33.47 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.295 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.688 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.2 61.92 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.03 65.46 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.38 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.982 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.55 14.86 Favored 'General case' 0 N--CA 1.394 -3.257 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.847 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.758 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.61 4.31 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.22 167.0 17.47 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.85 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.32 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.27 158.36 38.37 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.69 16.43 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.104 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.37 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.2 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 85.0 tttt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.08 126.59 51.12 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.314 1.054 . . . . 0.0 110.197 177.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.4 m -116.96 153.93 31.76 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.6 146.29 22.13 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.109 178.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.19 42.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.29 160.53 40.85 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.91 132.98 56.35 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.61 131.7 46.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.36 128.38 56.28 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.644 1.688 . . . . 0.0 110.517 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.78 136.44 56.22 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.735 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -127.03 143.51 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.108 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.677 3.6 mm? -52.32 -44.27 65.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.024 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -81.71 0.28 39.59 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.34 12.71 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -109.22 123.11 48.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.741 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.41 17.7 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.873 -1.767 . . . . 0.0 114.272 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.357 11.3 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -138.8 149.62 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.8 113.88 18.51 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.95 115.94 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.54 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.8 42.62 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.61 118.98 24.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.94 123.23 49.74 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.681 -0.637 . . . . 0.0 109.722 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.65 122.85 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.617 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.13 10.48 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.8 124.83 29.39 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.85 49.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.19 146.83 52.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.17 130.43 39.15 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.289 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.49 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.01 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.257 1.598 . . . . 0.0 109.719 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-N 118.701 1.251 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp -48.66 125.25 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.31 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.728 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -78.07 -35.53 49.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.11 82.58 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.404 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.07 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.346 10.1 pt -90.89 14.08 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.117 -1.833 . . . . 0.0 111.691 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.418 23.8 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.89 30.37 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.073 1.374 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.72 -47.68 67.16 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -177.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.52 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.21 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.65 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.18 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.03 65.52 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.868 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.77 -10.27 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.66 18.26 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.3 158.55 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-O 122.616 1.198 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.25 138.52 38.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.75 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.93 143.46 50.74 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.894 0.746 . . . . 0.0 111.923 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.019 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.95 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.881 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.23 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.77 18.95 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.343 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.96 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 50.8 tttm -163.74 138.6 6.1 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.403 -1.319 . . . . 0.0 114.395 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.55 51.0 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -116.92 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.31 9.24 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.801 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.17 42.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.61 40.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.37 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.05 143.48 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.663 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.963 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.59 34.88 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.48 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.55 150.46 22.21 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.108 1.363 . . . . 0.0 111.203 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.95 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.46 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.224 2.74 . . . . 0.0 119.224 -178.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.83 16.41 12.65 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -120.0 128.63 53.73 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.77 118.6 57.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.26 123.07 48.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.777 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.93 75.31 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.19 128.21 29.0 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.85 149.68 45.17 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.902 178.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.2 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -124.81 113.94 18.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -177.73 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.59 118.94 24.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.577 1.18 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.73 122.77 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.594 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.8 33.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.728 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -133.1 130.39 39.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.349 -178.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.71 133.5 56.16 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.732 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.254 -179.925 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.52 -32.6 63.06 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.674 0.75 . . . . 0.0 112.724 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.79 140.36 15.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.548 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.38 112.51 24.98 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.72 135.36 49.28 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.57 138.14 49.78 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.63 125.18 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.979 1.371 . . . . 0.0 112.569 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.38 138.66 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.15 28.79 9.45 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 178.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.23 -39.07 82.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.431 1.11 . . . . 0.0 108.147 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.81 -40.72 93.8 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.68 97.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.6 -47.82 66.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.95 -33.44 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.64 75.11 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.696 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.15 70.6 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.225 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.2 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.8 -10.32 58.15 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.34 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.28 158.06 32.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.415 2.743 . . . . 0.0 116.172 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.54 14.86 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.875 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.25 138.49 38.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.788 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.055 179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.96 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.273 178.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.37 38.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -141.49 124.69 16.42 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.92 139.36 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -137.51 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.72 76.29 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.689 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 46.0 tttm -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.3 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.31 9.35 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.685 -1.206 . . . . 0.0 109.763 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.717 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.32 160.53 40.82 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -55.65 131.73 47.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.65 -1.9 65.33 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.41 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.657 1.694 . . . . 0.0 110.497 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.5 56.25 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -136.98 169.18 18.22 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.41 37.65 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.744 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.09 143.49 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.074 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.866 177.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -78.0 168.32 20.08 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.59 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.27 -44.33 64.88 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.992 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.12 26.12 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.24 156.86 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.57 178.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -124.57 154.41 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.95 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.669 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.9 50.38 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.84 16.36 12.64 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.79 52.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -119.97 128.66 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.85 126.52 52.55 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.949 -177.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.57 127.56 54.62 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.907 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -109.31 123.07 48.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.702 179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.61 45.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.902 178.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.58 122.37 69.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.076 0.941 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.22 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.4 20.05 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.5 m -110.85 123.19 49.62 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.709 -0.619 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.73 33.77 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.732 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.53 -117.21 10.72 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 117.528 -2.272 . . . . 0.0 109.676 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.76 124.78 29.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.885 1.366 . . . . 0.0 111.992 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.44 127.41 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.4 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.47 148.84 49.61 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.2 146.78 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -133.08 130.44 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.91 119.32 61.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.267 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.6 4.99 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.4 2.5 28.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.071 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 142.98 58.01 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.736 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.46 24.87 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.245 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.684 1.24 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.109 0.881 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -64.18 -45.14 89.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.051 1.881 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.402 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.9 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.694 -179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.8 66.83 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.02 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.0 65.6 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.91 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.035 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.25 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.286 -2.688 . . . . 0.0 106.703 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.19 138.54 38.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.846 0.716 . . . . 0.0 111.964 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.22 167.04 17.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.76 18.93 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.347 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -141.44 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.163 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.87 139.41 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 51.0 tttm -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.55 51.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.318 1.056 . . . . 0.0 110.224 177.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.3 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.61 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.119 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.16 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.99 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.119 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.665 3.6 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -81.74 0.28 39.73 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.5 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.2 123.09 48.66 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.798 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.41 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.67 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.8 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.81 113.9 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.94 115.93 31.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.1 t -127.57 118.98 24.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.15 10.54 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.82 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.79 119.28 61.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.327 -178.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.58 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.02 57.96 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.93 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.8 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 118.736 1.268 . . . . 0.0 108.592 178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.592 1.663 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.42 -43.09 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.698 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.83 173.97 15.17 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.479 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.57 155.83 13.14 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.702 1.251 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.37 138.73 53.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.126 0.891 . . . . 0.0 110.198 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.79 9.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -78.09 -35.4 49.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.8 pt -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.684 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.23 56.09 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.413 23.6 t -71.43 131.62 34.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 119.994 1.897 . . . . 0.0 110.291 179.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 161.91 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 122.99 1.328 . . . . 0.0 114.271 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.9 -49.16 73.79 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.426 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.06 70.98 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-O 121.425 0.631 . . . . 0.0 111.281 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.2 62.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.09 65.59 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.035 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.32 158.06 32.84 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.22 138.5 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.828 0.705 . . . . 0.0 111.948 179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.019 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.24 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 178.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.65 48.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.829 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.21 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.048 -2.261 . . . . 0.0 113.808 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.25 166.98 17.55 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.78 19.0 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.347 178.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.43 124.64 16.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.142 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.39 52.18 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.83 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 51.1 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.51 50.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.351 1.072 . . . . 0.0 110.219 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.29 9.22 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.39 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.02 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.098 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.8 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.33 -44.25 65.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.81 0.41 39.46 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.26 26.07 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.29 156.86 17.2 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.614 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.2 117.63 34.96 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.6 154.39 40.74 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.409 1.693 . . . . 0.0 111.764 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.77 28.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.67 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.1 143.42 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.83 171.44 14.79 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.55 150.41 22.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.048 1.339 . . . . 0.0 111.184 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.64 -22.5 17.99 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.86 52.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.02 128.69 53.76 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.58 52.7 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.6 54.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.91 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.71 1.65 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.491 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.4 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.93 68.18 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.85 149.64 45.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.78 113.88 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.92 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -10.47 20.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.582 -2.447 . . . . 0.0 117.314 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.59 119.02 25.02 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.6 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 117.588 -2.244 . . . . 0.0 109.615 -177.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.63 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.69 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.06 133.72 52.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.715 179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.46 48.23 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.991 0.807 . . . . 0.0 112.265 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.319 1.533 . . . . 0.0 110.725 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.694 0.759 . . . . 0.0 112.724 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.57 4.95 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.197 1.561 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.84 68.7 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.82 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.661 1.23 . . . . 0.0 108.541 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.43 112.47 24.9 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.728 -1.578 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.7 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.77 174.0 15.16 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.43 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.25 -39.13 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.39 1.09 . . . . 0.0 108.06 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.36 8.1 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.68 -42.59 97.43 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.98 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.327 11.1 pt -90.95 14.15 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.064 -1.854 . . . . 0.0 111.672 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.98 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.406 11.3 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.75 67.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.201 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 60.4 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.6 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.951 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.28 158.05 32.63 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.08 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 111.298 -2.683 . . . . 0.0 106.664 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -117.22 158.55 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.629 1.206 . . . . 0.0 111.193 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.31 6.69 48.34 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.3 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.95 134.6 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.22 158.38 38.28 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.87 1.319 . . . . 0.0 110.592 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -137.45 167.96 20.6 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 18.7 ttmm -163.73 138.58 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.1 126.61 51.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.332 1.063 . . . . 0.0 110.181 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.4 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.32 9.41 Favored 'General case' 0 CA--C 1.449 -2.909 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.817 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.61 146.24 22.07 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.119 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.5 mt -55.72 131.71 47.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.39 56.27 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.44 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.735 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.071 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.666 3.6 mm? -52.34 -44.24 65.07 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 114.023 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.66 0.24 39.55 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.543 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.6 154.37 40.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.94 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.659 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.54 17.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.33 12.72 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.58 54.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.882 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.25 123.11 48.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.741 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.45 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.858 -1.776 . . . . 0.0 114.238 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -130.93 75.33 78.78 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.13 128.25 29.1 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.94 31.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.63 157.26 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.52 162.34 41.13 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.4 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.7 122.85 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.617 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.69 102.81 7.78 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.666 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.82 124.87 29.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.93 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.49 48.2 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.288 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 1.9 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.62 63.2 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.675 0.75 . . . . 0.0 112.668 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.54 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.97 68.55 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.561 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -107.74 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.82 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.63 138.15 49.84 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.722 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -48.6 125.21 9.49 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 123.025 1.393 . . . . 0.0 112.56 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.32 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.677 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.81 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.23 -39.1 82.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.431 1.11 . . . . 0.0 108.131 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.77 -40.76 93.74 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.19 -45.15 89.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.013 1.863 . . . . 0.0 109.364 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.619 0.0 OUTLIER -60.21 -41.38 92.89 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.9 179.386 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.65 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.96 82.09 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.5 pt -90.95 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 23.6 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 122.993 1.329 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.217 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 -34.68 75.22 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.654 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -63.87 -49.15 73.87 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.396 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.13 70.68 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.47 0.653 . . . . 0.0 111.288 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.25 61.84 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.8 -10.28 58.18 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.68 -10.75 47.36 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.3 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.56 14.82 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.0 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.07 117.2 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.025 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.23 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.84 -112.56 4.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.54 146.22 34.42 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.815 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.21 167.0 17.46 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.3 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.76 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.681 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.7 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.35 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.753 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.64 146.26 22.06 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.122 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.17 43.01 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.67 131.69 47.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.89 136.5 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.98 169.18 18.21 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.17 127.37 37.62 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.742 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.08 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.704 3.5 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.17 26.09 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 117.911 1.924 . . . . 0.0 117.911 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.23 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.601 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.08 22.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.6 34.9 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.54 154.45 40.57 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.721 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.669 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.94 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.5 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.89 126.62 52.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 123.917 1.817 . . . . 0.0 111.896 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.97 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.533 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.74 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.931 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.62 122.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 122.038 0.923 . . . . 0.0 109.962 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.59 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.5 t -127.6 119.0 24.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -102.96 121.12 53.74 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.508 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.86 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.373 0.606 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.8 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.22 10.78 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.03 -14.63 24.14 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.883 0.873 . . . . 0.0 112.123 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.87 124.88 29.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.48 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.4 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.82 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.903 0.859 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.327 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.55 4.92 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -3.0 68.51 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.657 1.228 . . . . 0.0 108.592 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.8 p -127.39 138.68 53.06 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.138 0.899 . . . . 0.0 110.22 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.521 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.591 0.0 OUTLIER -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.9 pt -90.9 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.144 -1.822 . . . . 0.0 111.634 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.426 38.4 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.12 70.73 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.25 61.74 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.35 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.95 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 158.06 33.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.321 2.681 . . . . 0.0 116.216 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -117.28 158.59 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.709 1.255 . . . . 0.0 111.172 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.57 4.3 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.67 48.39 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.79 19.01 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -141.45 124.59 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.41 52.18 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 20.1 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 m -116.88 153.93 31.67 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.996 0.903 . . . . 0.0 109.037 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.66 131.64 47.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.649 3.2 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.76 0.31 39.69 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.434 1.709 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.12 143.43 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.83 171.51 14.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.04 128.63 53.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.6 t -109.81 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.25 16.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.96 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.96 31.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.1 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.96 121.17 53.8 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.91 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.688 -0.632 . . . . 0.0 109.738 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.45 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.384 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.11 130.39 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.85 119.24 61.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.344 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.11 133.68 52.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.743 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.67 -32.54 63.33 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.61 0.719 . . . . 0.0 112.658 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.05 57.96 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.19 -2.9 68.34 Favored Glycine 0 C--O 1.195 -2.318 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.76 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.698 1.249 . . . . 0.0 108.597 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.77 135.42 49.21 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.844 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -48.59 125.21 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.591 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.35 -43.17 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.676 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.91 15.3 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -165.58 155.86 13.16 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.635 1.209 . . . . 0.0 111.782 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.77 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -78.11 -35.45 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.527 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.21 -39.11 82.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.78 -40.8 93.93 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -64.23 -45.11 89.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 124.0 1.857 . . . . 0.0 109.316 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.4 ptm -60.15 -41.46 92.83 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.953 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.293 14.0 pt -90.92 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.32 55.91 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.384 3.714 . . . . 0.0 122.384 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.407 21.9 t -71.46 131.61 34.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 CA-C-N 120.001 1.9 . . . . 0.0 110.316 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.96 30.25 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.92 -33.47 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.72 -10.33 58.21 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.828 0.851 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.86 47.27 Favored 'General case' 0 N--CA 1.419 -2.021 0 C-N-CA 117.478 -1.689 . . . . 0.0 109.365 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.71 80.48 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.004 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.25 158.01 32.71 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.208 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.98 126.24 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.63 1.205 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.87 143.44 50.73 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.919 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.13 117.19 41.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.055 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.19 110.17 0.51 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.87 -112.55 4.29 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.39 6.72 48.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.2 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.086 -2.246 . . . . 0.0 113.834 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.22 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.94 138.77 18.92 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.3 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.3 38.51 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.862 1.315 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.63 16.38 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.164 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.39 52.15 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.71 76.27 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.85 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.446 -1.302 . . . . 0.0 114.386 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.51 50.84 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.337 1.065 . . . . 0.0 110.164 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 m -116.91 153.94 31.69 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.986 0.898 . . . . 0.0 109.046 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.31 9.29 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.91 65.6 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.786 1.075 . . . . 0.0 115.786 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.88 136.48 56.2 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.474 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.24 127.38 37.7 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.713 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.97 143.53 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.2 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.654 3.4 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.69 0.24 39.66 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.06 26.38 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.949 1.94 . . . . 0.0 117.949 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.22 156.9 17.16 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.85 171.95 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.26 117.58 34.83 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -124.58 154.42 40.67 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.453 1.72 . . . . 0.0 111.754 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.85 171.44 14.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.6 150.42 22.27 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.01 1.324 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.17 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -120.02 128.7 53.77 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.8 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -117.82 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.59 54.64 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.918 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.533 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.42 17.69 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.939 -1.725 . . . . 0.0 114.219 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.3 p-10 -64.53 -25.96 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.97 75.34 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.384 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.6 m -138.89 149.66 45.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.14 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.856 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.6 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.064 0.935 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.58 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.009 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -124.76 113.86 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.42 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.75 42.5 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.55 119.0 25.04 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 mt -103.0 121.12 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.526 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -110.85 123.3 49.83 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.767 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.3 tp -124.66 102.84 7.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.09 -14.56 24.13 Favored 'General case' 0 CA--C 1.47 -2.129 0 C-N-CA 123.883 0.873 . . . . 0.0 112.126 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.9 124.81 29.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.83 1.331 . . . . 0.0 111.931 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.7 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.27 61.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.14 133.69 52.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.715 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.33 132.57 48.23 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.005 0.816 . . . . 0.0 112.229 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.228 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.69 63.17 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.35 -10.59 4.96 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.95 57.9 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.736 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 -3.0 68.57 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.609 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.31 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.275 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.742 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.82 13.11 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 124.686 1.241 . . . . 0.0 111.766 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.03 -35.53 49.67 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.405 1.5 ptm -60.24 -41.36 92.98 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.32 11.9 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.411 21.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.029 1.349 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.18 62.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.46 -28.97 65.64 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.931 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.4 pt -117.28 158.54 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.58 14.92 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.872 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.49 38.23 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.85 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.845 0.716 . . . . 0.0 111.924 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.89 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.24 34.31 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.09 -2.244 . . . . 0.0 113.757 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.64 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.45 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.0 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.76 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.33 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.1 127.35 37.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.58 37.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.09 -1.631 . . . . 0.0 106.963 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.614 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.76 0.34 39.57 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.87 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.11 117.53 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.53 154.48 40.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.423 1.702 . . . . 0.0 111.732 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.49 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.61 150.47 22.22 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 125.035 1.334 . . . . 0.0 111.181 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.65 -22.45 18.01 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.211 2.735 . . . . 0.0 119.211 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.56 73.22 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -10.38 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.28 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.7 t -127.54 118.95 24.94 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.3 48.31 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 111.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.6 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.773 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.072 0.857 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.61 -32.56 63.22 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.669 0.747 . . . . 0.0 112.706 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.73 135.42 49.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.64 138.18 49.81 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 123.005 1.383 . . . . 0.0 112.584 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.1 28.78 9.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.19 -39.13 82.56 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.8 -40.75 93.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -64.19 -45.15 89.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.013 1.863 . . . . 0.0 109.35 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 10.3 ttm -60.14 -41.48 92.78 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.916 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.99 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.355 9.3 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.401 3.72 . . . . 0.0 122.401 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.465 14.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.95 -33.44 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.24 -34.66 75.15 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 63.9 mtm-85 -63.81 -49.22 73.74 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.15 70.57 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.464 0.649 . . . . 0.0 111.258 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.41 -28.98 65.54 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.361 0.978 . . . . 0.0 113.864 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.79 -10.32 58.17 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.426 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.7 152.58 18.33 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.8 80.32 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.33 158.07 32.8 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.365 2.71 . . . . 0.0 116.153 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.609 1.195 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.55 14.81 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.055 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.8 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.78 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.68 138.66 6.18 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.433 -1.307 . . . . 0.0 114.426 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.98 139.21 42.95 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.663 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.7 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.61 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.36 128.47 56.3 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.85 136.48 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.2 18.17 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.482 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.16 127.36 37.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.763 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -127.05 143.49 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.2 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.19 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.606 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.7 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.669 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.84 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.09 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.51 -22.54 18.23 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.04 128.64 53.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -117.85 126.61 52.73 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.59 54.59 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.878 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.42 17.72 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.916 -1.74 . . . . 0.0 114.268 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.349 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -138.85 149.62 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.58 122.39 69.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.038 0.923 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.26 135.6 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.01 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.78 113.86 18.49 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.6 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.96 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.7 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.0 121.09 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.489 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.0 m -110.85 123.25 49.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.625 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.767 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.67 102.82 7.78 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.87 124.86 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.885 1.366 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.43 127.43 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.433 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -133.09 130.4 39.26 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.81 119.28 61.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.349 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.988 0.805 . . . . 0.0 112.255 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.66 63.02 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.55 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.5 28.62 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.996 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.623 1.211 . . . . 0.0 108.561 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.59 125.22 9.5 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.93 1.347 . . . . 0.0 112.62 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.703 1.252 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.85 9.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.16 -35.45 48.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.25 -39.08 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.0 108.106 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.8 -40.74 93.78 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 9.2 ttm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.67 97.45 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.0 82.13 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.351 9.6 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.448 13.2 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.018 1.344 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.91 -33.53 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.215 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.68 75.34 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.654 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.47 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.403 0.62 . . . . 0.0 111.281 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.27 61.75 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.01 65.35 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.79 -10.29 58.19 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.6 -10.79 47.48 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.356 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.8 mt -95.64 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.79 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.975 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.894 0.746 . . . . 0.0 111.976 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.023 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.87 138.79 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.345 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.97 134.63 55.19 Favored 'General case' 0 C--O 1.279 2.648 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.28 158.34 38.43 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.553 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.7 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 18.9 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.7 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.32 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.782 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.98 139.17 43.0 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.38 37.59 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.07 143.48 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.107 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.18 120.62 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.924 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.685 3.9 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.69 0.24 39.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.26 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.08 22.32 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.45 40.61 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.93 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.53 54.55 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.907 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.22 123.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -89.96 -166.76 1.67 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.78 62.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.902 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.076 0.941 . . . . 0.0 109.942 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.89 31.06 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.64 157.27 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.522 1.63 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.19 10.68 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.84 124.79 29.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.977 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.39 127.47 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.419 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.8 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.26 146.78 52.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.84 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.305 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.68 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.55 4.96 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.99 57.89 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.704 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.691 1.246 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.1 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.35 -43.11 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.689 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.83 173.96 15.19 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.509 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.56 155.85 13.19 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 124.703 1.252 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -78.06 -35.49 49.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.71 -40.8 93.61 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.393 1.2 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 9.4 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.99 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.429 24.3 t -71.47 131.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 CA-C-N 120.01 1.905 . . . . 0.0 110.291 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.32 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.019 1.344 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.24 62.0 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.03 65.47 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.413 1.007 . . . . 0.0 113.939 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.28 158.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.65 146.59 14.96 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.902 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.53 38.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.9 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.863 0.727 . . . . 0.0 111.907 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.89 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.21 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.62 48.53 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.57 146.24 34.33 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.081 -2.248 . . . . 0.0 113.757 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.3 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 84.5 tttt -163.73 138.6 6.1 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 118.463 -1.295 . . . . 0.0 114.371 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.51 50.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.323 1.059 . . . . 0.0 110.225 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.29 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.57 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.089 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.0 139.21 42.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.734 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -1.88 65.63 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.3 128.46 56.28 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.91 136.47 56.16 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.12 18.31 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.515 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.15 127.39 37.61 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.745 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.25 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.17 120.61 37.84 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.945 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.671 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.79 0.39 39.45 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.22 26.17 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.3 156.84 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.609 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.03 22.24 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.9 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.19 117.56 34.82 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.4 m -124.52 154.45 40.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.439 1.712 . . . . 0.0 111.736 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.44 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.47 22.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.998 1.319 . . . . 0.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.67 -22.44 17.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.85 16.49 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.79 126.61 52.74 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.56 127.57 54.63 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.916 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.6 -25.96 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.57 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -10.41 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.289 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.57 118.99 24.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.02 121.19 53.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.504 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.3 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.09 133.74 52.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.737 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.53 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.089 0.868 . . . . 0.0 112.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.6 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.58 63.29 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.615 0.722 . . . . 0.0 112.62 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.6 5.07 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.43 28.83 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -107.76 135.4 49.25 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.839 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -48.65 125.21 9.56 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.576 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.29 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.0 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.617 1.198 . . . . 0.0 111.74 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.08 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.24 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.83 9.3 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.25 -39.08 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.348 1.07 . . . . 0.0 108.123 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.8 -40.74 93.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -64.2 -45.15 89.58 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 124.03 1.871 . . . . 0.0 109.335 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.4 ptm -60.19 -41.4 92.85 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.885 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.64 -42.68 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.02 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.89 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.713 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.29 55.94 Favored Glycine 0 C--O 1.213 -1.16 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.425 23.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.9 30.4 Favored Glycine 0 CA--C 1.49 -1.493 0 CA-C-O 123.003 1.335 . . . . 0.0 114.299 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.65 75.27 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.22 61.94 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -28.94 65.52 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.82 -10.29 58.16 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.355 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.65 152.61 18.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.69 80.43 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.615 -2.084 . . . . 0.0 111.004 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.34 158.06 32.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.403 2.735 . . . . 0.0 116.157 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 CA-C-O 122.675 1.226 . . . . 0.0 111.182 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.16 138.5 38.11 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.797 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.857 0.723 . . . . 0.0 111.976 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.09 117.15 41.15 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.05 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.6 4.31 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.74 48.2 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.25 34.32 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.751 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.21 167.04 17.4 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.99 138.77 18.88 Favored 'General case' 0 C--N 1.263 -3.153 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.3 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -137.52 167.88 20.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.77 76.38 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.703 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 84.4 tttt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.64 146.17 21.97 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.18 42.97 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.6 40.91 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.66 131.69 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.47 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.98 169.14 18.28 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.512 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.713 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.04 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.085 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.61 37.81 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.945 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.616 3.6 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.71 0.29 39.53 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.48 40.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.732 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.5 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.42 22.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.13 89.08 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.54 177.93 50.46 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.55 -22.52 18.16 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.0 128.62 53.71 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.8 118.69 57.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -117.84 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.914 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.883 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.02 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.791 -1.564 . . . . 0.0 108.492 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.45 17.72 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.991 -1.693 . . . . 0.0 114.239 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.53 -25.92 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.384 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.88 149.63 45.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.75 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.88 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.8 mt -115.65 122.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.053 0.93 . . . . 0.0 109.966 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.012 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.54 73.2 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.74 42.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.2 t -127.56 118.95 24.93 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.3 mt -102.95 121.09 53.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.497 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.79 123.23 49.67 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.69 -0.631 . . . . 0.0 109.804 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.75 122.79 68.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.66 102.79 7.77 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.22 10.8 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.04 -14.67 24.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.906 0.882 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.77 29.35 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.785 1.303 . . . . 0.0 111.983 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.45 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.42 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.48 148.8 49.63 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.327 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.25 132.54 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.283 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.57 56.23 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.196 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.64 63.12 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.671 0.748 . . . . 0.0 112.699 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.56 4.99 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 142.99 58.01 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.704 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.84 69.11 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.84 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.664 1.232 . . . . 0.0 108.524 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.46 24.88 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.602 1.668 . . . . 0.0 110.303 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.661 -1.609 . . . . 0.0 106.784 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.33 -43.15 3.56 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.7 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.8 173.96 15.2 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.46 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.85 13.03 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.633 1.208 . . . . 0.0 111.728 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.11 28.8 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -78.09 -35.49 49.3 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.15 82.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.77 93.64 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.051 1.881 . . . . 0.0 109.391 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.5 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.96 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.315 12.4 pt -90.93 14.18 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -2.007 0 C-N-CA 117.09 -1.844 . . . . 0.0 111.688 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.417 21.9 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.57 74.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.83 47.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -95.61 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.39 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.982 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.223 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -119.99 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.317 -2.674 . . . . 0.0 106.703 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 pt -117.25 158.59 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.702 1.251 . . . . 0.0 111.207 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.404 0.621 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.56 4.3 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.66 48.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.89 138.86 19.05 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.283 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.03 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.68 16.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.39 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -137.5 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.662 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 53.3 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.05 126.54 51.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.297 1.046 . . . . 0.0 110.205 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.29 9.33 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.782 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.6 40.93 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.96 132.98 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.63 131.68 47.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.43 56.28 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.86 136.45 56.17 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.45 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -127.07 143.56 51.25 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.05 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.617 3.5 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.75 0.26 39.88 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.21 25.97 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.909 1.924 . . . . 0.0 117.909 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.543 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.96 110.06 22.3 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.87 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.18 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -124.6 154.41 40.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.72 28.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.695 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -137.98 143.49 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.22 89.15 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.94 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.194 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.63 -22.51 17.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.38 12.73 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.59 127.58 54.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.942 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.25 123.14 48.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.741 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.06 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.502 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.45 17.63 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.51 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -130.91 75.4 78.69 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.63 122.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.086 0.946 . . . . 0.0 109.905 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.5 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.015 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.87 31.02 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.54 157.23 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.57 73.25 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.58 1.657 . . . . 0.0 109.411 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.88 116.39 48.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.676 1.227 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 121.13 53.77 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.89 -1.131 . . . . 0.0 111.504 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 mp -113.71 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.644 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.69 33.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.794 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.45 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.42 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.79 49.67 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.269 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.692 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.26 132.46 48.19 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 123.969 0.793 . . . . 0.0 112.245 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.36 1.552 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 143.05 57.94 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.181 1.55 . . . . 0.0 109.687 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.23 -2.95 68.35 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.78 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.609 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.75 135.42 49.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.784 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.265 1.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.0 tp -48.64 125.22 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.8 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.82 173.94 15.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.43 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.763 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.1 -35.49 49.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.53 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.72 93.47 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -64.23 -45.15 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.53 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.409 1.4 ptm -60.19 -41.45 92.97 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.935 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.61 97.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.01 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.33 11.2 pt -90.92 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.1 -1.84 . . . . 0.0 111.684 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.419 31.1 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.98 30.33 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.47 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.21 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.33 -34.54 74.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.645 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.83 -49.26 73.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.18 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.04 65.5 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.939 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.7 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -95.65 152.66 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.26 158.05 32.58 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.324 2.683 . . . . 0.0 116.263 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 111.358 -2.656 . . . . 0.0 106.733 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.284 12.2 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.62 1.2 . . . . 0.0 111.155 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.27 138.52 38.19 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.91 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.877 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.493 0.663 . . . . 0.0 111.102 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.3 6.65 48.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.58 146.27 34.3 Favored 'General case' 0 N--CA 1.403 -2.807 0 C-N-CA 116.036 -2.266 . . . . 0.0 113.79 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.75 18.93 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.327 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.95 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.7 76.27 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.84 -6.76 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 55.0 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.11 126.55 51.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.283 1.04 . . . . 0.0 110.216 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.17 157.29 9.32 Favored 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.841 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.57 146.24 22.13 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.086 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.65 40.94 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.63 131.63 46.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.86 65.86 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.18 127.37 37.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -126.97 143.52 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.12 120.59 37.77 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.115 -1.615 . . . . 0.0 106.905 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.5 p -78.01 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.631 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.648 3.4 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.13 26.24 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.25 156.9 17.17 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.62 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.87 171.92 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.21 117.61 34.92 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -124.58 154.39 40.72 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.464 1.727 . . . . 0.0 111.764 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.307 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.83 171.45 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.57 150.46 22.22 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.103 1.361 . . . . 0.0 111.169 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.13 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.94 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.194 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 -22.43 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.79 16.38 12.68 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -119.97 128.69 53.81 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.83 118.56 57.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.252 16.6 t-160 -117.76 126.58 52.71 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.816 1.77 . . . . 0.0 111.988 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.91 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -109.29 123.08 48.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.754 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.4 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.2 p-10 -64.54 -26.01 68.23 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -130.93 75.36 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 m -138.89 149.64 45.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.3 135.56 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.008 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -124.77 113.94 18.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.23 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.65 -10.43 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.256 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.5 t -127.57 118.98 24.96 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-O 122.557 1.17 . . . . 0.0 111.181 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.97 121.2 53.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.96 -1.088 . . . . 0.0 111.508 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.3 mt -113.69 122.79 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.67 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.75 33.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.735 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.6 148.8 49.73 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.77 52.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.805 0.812 . . . . 0.0 111.408 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.08 130.45 39.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.917 -1.492 . . . . 0.0 114.291 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.722 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.29 132.54 48.19 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.046 0.841 . . . . 0.0 112.268 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.714 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.256 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.647 0.736 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.9 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.75 140.34 15.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.545 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.644 1.688 . . . . 0.0 110.282 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.74 135.45 49.13 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.784 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.68 138.15 49.91 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.31 -43.23 3.55 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.678 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.95 15.24 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.8 9.41 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -78.13 -35.49 49.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.12 82.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.79 -40.78 93.9 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -64.21 -45.13 89.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.0 1.857 . . . . 0.0 109.349 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.15 -41.48 92.85 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.916 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.59 97.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.3 pt -90.92 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.982 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.28 55.94 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.379 3.712 . . . . 0.0 122.379 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.416 23.2 t -71.49 131.63 34.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.289 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.69 67.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.82 47.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.61 152.65 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.951 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.22 158.04 32.45 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.199 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.687 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -117.27 158.59 17.83 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 O-C-N 124.62 1.2 . . . . 0.0 111.191 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.51 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.43 6.73 48.21 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.57 55.22 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.4 p -128.22 158.34 38.37 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.7 t -141.5 124.64 16.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.91 139.43 52.13 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -137.54 167.9 20.73 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 53.8 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.15 126.51 50.89 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.269 1.033 . . . . 0.0 110.176 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.69 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.9 65.7 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.49 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.2 127.42 37.67 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.703 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.687 3.5 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.69 0.21 39.79 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.06 26.27 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.926 1.93 . . . . 0.0 117.926 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -101.17 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.237 -1.385 . . . . 0.0 110.606 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.18 117.55 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.42 40.68 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.75 28.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.659 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.98 143.48 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.87 171.47 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 54.9 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.61 54.65 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.918 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -109.31 123.14 48.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.708 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.07 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.533 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.42 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.941 -1.724 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.49 -25.97 68.23 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.93 149.62 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.59 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.33 135.53 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 117.893 -1.523 . . . . 0.0 108.964 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.78 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.27 16.79 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.53 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.34 48.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.1 m -110.88 123.3 49.85 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 mt -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.53 119.73 33.79 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -124.62 102.84 7.81 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.88 124.81 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.77 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.691 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.27 132.55 48.15 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.984 0.802 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.8 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.62 -32.58 63.24 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.687 0.756 . . . . 0.0 112.698 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.99 57.93 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.735 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.73 140.37 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.563 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.682 1.706 . . . . 0.0 110.255 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.72 135.39 49.23 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.664 -1.607 . . . . 0.0 106.804 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.65 138.15 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.32 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 173.97 15.22 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.505 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -165.63 155.82 13.0 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.78 9.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.1 -35.55 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.15 -39.11 82.74 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.82 -40.75 93.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -64.17 -45.17 89.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 123.987 1.851 . . . . 0.0 109.354 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 8.3 ttm -60.12 -41.46 92.66 Favored 'General case' 0 N--CA 1.41 -2.433 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.95 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.04 82.1 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.299 13.2 pt -90.91 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.974 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.707 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.27 55.99 Favored Glycine 0 C--O 1.214 -1.124 0 N-CA-C 122.411 3.724 . . . . 0.0 122.411 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.434 12.2 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.72 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.08 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.2 mtm-85 -63.8 -49.26 73.58 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.07 65.61 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.346 0.97 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.4 mt -83.73 -10.27 58.25 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.771 0.828 . . . . 0.0 109.433 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt -95.64 152.6 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.71 80.4 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.95 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.23 158.03 32.51 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.333 2.689 . . . . 0.0 116.238 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.748 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.7 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.628 1.204 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.56 14.9 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.92 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.25 138.52 38.16 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.761 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.9 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.945 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.17 117.23 41.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.961 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.91 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.66 48.41 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.2 158.31 38.46 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.803 1.287 . . . . 0.0 110.627 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.5 t -141.49 124.68 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.87 139.44 52.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.7 p -137.51 167.86 20.79 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.24 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.88 -6.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 50.1 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.936 1.397 . . . . 0.0 111.055 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.2 m -107.92 139.22 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.745 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.34 160.62 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.99 133.05 56.29 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.61 131.67 46.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -1.9 65.93 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 115.708 1.043 . . . . 0.0 115.708 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.82 136.45 56.2 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.17 18.22 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.735 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.16 120.63 37.86 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.888 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -77.97 168.43 19.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.637 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.625 4.1 mm? -52.45 -44.2 65.37 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.153 -1.839 . . . . 0.0 113.963 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.4 m -117.92 171.91 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.9 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.61 154.44 40.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.659 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.03 143.4 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.7 p -145.81 171.5 14.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.62 150.43 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.087 1.355 . . . . 0.0 111.189 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.6 177.89 50.4 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 115.635 -3.174 . . . . 0.0 105.183 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.57 -22.47 18.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.265 2.756 . . . . 0.0 119.265 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.81 16.42 12.67 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.03 128.68 53.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -117.85 126.56 52.62 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 123.81 1.767 . . . . 0.0 111.947 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.91 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.31 123.13 48.78 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.719 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.706 -1.598 . . . . 0.0 108.549 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.38 17.71 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.9 -1.75 . . . . 0.0 114.235 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.36 11.3 p-10 -64.59 -25.95 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.93 149.64 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.77 62.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.2 mt -115.62 122.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.59 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 108.988 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -124.8 113.9 18.54 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.94 31.15 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.69 157.21 16.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.33 41.13 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -32.47 73.16 Favored 'General case' 0 N--CA 1.41 -2.443 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.47 19.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 115.503 -2.479 . . . . 0.0 117.274 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.76 42.61 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.73 122.84 68.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.625 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.68 33.65 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.8 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.61 102.79 7.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.14 10.53 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.666 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.12 -14.6 24.05 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.871 0.868 . . . . 0.0 112.085 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.83 29.42 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.832 1.332 . . . . 0.0 111.906 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.8 t -120.43 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.436 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.57 148.77 49.71 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.76 52.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -133.08 130.46 39.37 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.291 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.13 133.66 52.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.721 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.25 132.54 48.13 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.984 0.802 . . . . 0.0 112.283 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.54 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.371 1.558 . . . . 0.0 110.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 -179.923 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.52 28.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.77 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.541 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.51 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.56 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.01 15.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.64 155.83 12.99 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.598 1.187 . . . . 0.0 111.759 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.2 -39.18 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.72 -40.76 93.52 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.349 8.4 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.93 81.85 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.99 14.13 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.149 -1.821 . . . . 0.0 111.66 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.95 23.26 56.01 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.442 12.5 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -73.0 -33.44 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.235 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.89 -49.15 73.81 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.48 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.205 -1.668 0 CA-C-O 122.427 1.015 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.75 47.49 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.67 152.62 18.29 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.25 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.279 14.5 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.666 1.229 . . . . 0.0 111.208 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.56 14.88 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.859 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.758 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.506 0.669 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.29 6.65 48.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.61 55.19 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.37 38.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.876 1.322 . . . . 0.0 110.565 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.6 tttt -163.73 138.62 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.34 9.44 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.788 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 132.97 56.35 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.63 131.72 47.13 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.648 1.69 . . . . 0.0 110.499 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.18 127.4 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.764 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.05 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.508 1.623 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.105 -1.622 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.1 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -101.19 156.87 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.574 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.86 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.659 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.65 -22.46 17.99 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.153 2.713 . . . . 0.0 119.153 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.82 16.33 12.66 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.1 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.46 17.67 Favored Glycine 0 CA--C 1.491 -1.445 0 O-C-N 119.902 -1.749 . . . . 0.0 114.207 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.5 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.908 1.128 . . . . 0.0 111.429 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.8 149.65 45.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.21 119.7 62.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.891 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.55 122.36 69.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -124.74 113.87 18.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.52 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.9 123.23 49.73 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.436 0.636 . . . . 0.0 109.733 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.65 122.81 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.644 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.17 10.58 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.84 29.41 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.885 1.366 . . . . 0.0 111.915 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.4 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.27 132.54 48.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.973 0.796 . . . . 0.0 112.255 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.52 56.18 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.38 2.47 28.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.04 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.95 68.5 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.701 1.251 . . . . 0.0 108.565 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.52 24.95 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.59 125.27 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.621 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.41 138.73 53.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.079 0.862 . . . . 0.0 110.198 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -78.1 -35.47 49.26 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.18 -39.11 82.62 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.35 1.071 . . . . 0.0 108.111 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.7 ttm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.329 11.0 pt -90.87 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.438 11.7 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.69 67.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.5 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.269 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.223 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.16 -46.2 61.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.04 65.72 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.85 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.34 158.55 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.636 1.21 . . . . 0.0 111.158 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.27 138.48 38.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.94 -163.84 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.493 0.663 . . . . 0.0 111.124 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.62 48.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.51 146.21 34.49 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.115 -2.234 . . . . 0.0 113.808 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.5 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.0 p -137.47 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.62 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.7 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.01 143.52 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.705 4.0 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.77 28.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.06 143.4 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.8 171.51 14.68 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.87 52.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.06 128.72 53.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.524 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 12.0 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.92 75.32 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.15 128.23 29.01 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.913 1.13 . . . . 0.0 111.368 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.4 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.82 113.93 18.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.47 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.57 118.95 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.898 -1.127 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.78 122.82 68.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.575 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.72 33.78 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.758 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -133.1 130.39 39.21 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.254 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.33 -10.56 4.89 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -2.96 68.7 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.636 1.218 . . . . 0.0 108.561 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.0 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.104 0.878 . . . . 0.0 110.24 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.472 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.9 ttm -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.345 9.9 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.441 12.0 t -71.44 131.61 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.295 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.87 30.45 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 62.3 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.11 70.76 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.22 61.82 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.37 158.06 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.177 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.22 158.59 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.19 138.51 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.68 48.35 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.62 16.41 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.37 52.19 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -116.91 153.95 31.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.016 0.913 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.686 4.1 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.72 0.26 39.72 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.606 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.476 1.735 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.08 143.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.859 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.64 127.53 54.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.907 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.22 123.01 48.55 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 124.629 1.206 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.92 -166.7 1.65 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.783 -1.567 . . . . 0.0 108.531 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.859 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.52 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.648 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.4 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.84 119.28 61.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.314 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.956 -1.929 . . . . 0.0 111.743 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.59 63.3 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.68 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.4 2.45 28.71 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.073 -0.651 . . . . 0.0 112.042 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.72 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.59 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.44 112.47 24.9 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 123.597 1.665 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.844 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.57 138.17 49.74 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.524 0.678 . . . . 0.0 109.659 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.56 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -159.73 174.0 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.46 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.62 155.84 13.05 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.633 1.208 . . . . 0.0 111.709 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.77 9.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.25 -39.13 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.381 1.086 . . . . 0.0 108.077 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.77 -40.73 93.63 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -64.17 -45.12 89.82 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 124.009 1.862 . . . . 0.0 109.406 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.359 8.3 ttm -60.18 -41.46 92.95 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.901 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.6 -42.65 97.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.318 11.5 pt -90.95 14.13 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.66 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.25 56.05 Favored Glycine 0 C--O 1.214 -1.108 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.409 10.8 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.95 30.16 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-O 123.037 1.354 . . . . 0.0 114.287 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.79 67.01 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.57 75.01 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 60.5 mtm-85 -63.89 -49.16 73.78 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.76 -10.29 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.6 mt -95.65 152.63 18.28 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.74 80.35 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.981 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.3 158.0 33.01 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.21 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.98 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.755 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.2 158.55 17.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.693 1.245 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.818 0.698 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.464 0.65 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.95 -112.65 4.33 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.69 48.33 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.64 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.23 158.33 38.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.849 1.309 . . . . 0.0 110.578 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.52 124.68 16.39 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.109 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.45 52.15 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.6 p -137.5 167.87 20.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.5 tttt -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.0 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.12 157.37 9.48 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.764 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.66 146.24 22.01 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.9 1.375 . . . . 0.0 111.055 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -108.01 139.18 43.04 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.664 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.59 40.93 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.99 132.97 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.6 131.74 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.91 65.36 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.99 169.16 18.24 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.735 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.63 37.91 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.125 -1.609 . . . . 0.0 106.87 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.96 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.679 3.7 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -81.72 0.33 39.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.85 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.0 144.78 28.77 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.72 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.37 22.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.17 89.16 2.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.103 -3.199 . . . . 0.0 105.103 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.5 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.8 16.33 12.67 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.82 52.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -119.96 128.65 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.58 -162.45 17.71 Favored Glycine 0 CA--C 1.49 -1.505 0 O-C-N 119.9 -1.75 . . . . 0.0 114.223 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 12.0 p-10 -64.54 -25.99 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.14 128.19 28.86 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.841 1.1 . . . . 0.0 111.416 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.6 45.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.77 62.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.88 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.62 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.964 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.76 113.87 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.63 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.587 1.661 . . . . 0.0 109.447 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.88 123.27 49.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.369 0.605 . . . . 0.0 109.774 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.68 122.81 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.644 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.1 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.548 -2.263 . . . . 0.0 109.666 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.61 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.906 0.882 . . . . 0.0 112.112 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.83 124.82 29.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 124.83 1.331 . . . . 0.0 111.906 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.2 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.4 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.7 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.79 52.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -133.12 130.44 39.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.88 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.311 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.54 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.283 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.79 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.199 -179.869 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.6 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.59 63.18 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.39 2.51 28.78 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.033 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.4 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.38 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.663 1.232 . . . . 0.0 108.58 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.224 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -48.64 125.27 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.686 1.241 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.42 138.71 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.147 0.904 . . . . 0.0 110.181 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -78.07 -35.46 49.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.26 -39.05 82.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.357 1.075 . . . . 0.0 108.122 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.389 1.6 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.264 13.1 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.365 17.7 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.89 -33.54 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.233 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.696 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -63.85 -49.19 73.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.419 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.14 70.65 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.23 61.95 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.02 65.55 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.91 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.73 -10.29 58.24 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.73 47.58 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 117.426 -1.71 . . . . 0.0 109.395 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.187 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.289 13.8 pt -117.34 158.56 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.146 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.57 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.23 138.52 38.14 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.75 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.894 0.746 . . . . 0.0 111.948 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 m -97.08 117.15 41.14 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.053 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.45 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.163 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.8 p -137.47 167.98 20.56 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.655 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 84.2 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.062 0.934 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.16 43.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.717 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.29 160.56 40.88 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.64 46.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -127.03 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.117 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.11 120.61 37.79 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.954 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.4 p -78.0 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.388 1.09 . . . . 0.0 111.59 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.532 3.7 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.21 25.97 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -124.57 154.45 40.63 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.743 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.02 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.656 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.12 143.41 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.51 14.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.18 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.629 -3.177 . . . . 0.0 105.174 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.03 128.72 53.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.57 54.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.876 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.363 11.3 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.4 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.8 mt -115.61 122.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.55 162.32 41.17 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.4 20.02 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.513 -2.475 . . . . 0.0 117.247 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -127.54 118.93 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 121.635 -0.665 . . . . 0.0 109.747 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.77 122.83 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.565 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.2 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tt -80.82 124.78 29.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.865 1.353 . . . . 0.0 112.008 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.41 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.52 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.79 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -133.1 130.38 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.357 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -110.1 133.64 53.0 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.65 -32.57 63.31 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.65 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.98 57.93 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.767 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.97 68.46 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.5 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.197 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.267 1.989 0 CA-C-O 121.431 0.634 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.22 9.58 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.74 173.99 15.2 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.05 -35.54 49.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.18 -39.11 82.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.342 10.8 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.38 55.88 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.452 3.741 . . . . 0.0 122.452 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.991 1.895 . . . . 0.0 110.298 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.92 -33.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.704 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.15 62.11 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.01 65.78 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.342 0.968 . . . . 0.0 113.846 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.71 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.379 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.3 158.56 17.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.654 1.216 . . . . 0.0 111.119 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.67 146.54 14.89 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.936 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.23 138.48 38.2 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.761 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.09 117.16 41.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.053 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -137.52 167.87 20.78 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.72 76.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.77 -6.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.795 ' C ' HD21 ' A' ' 61' ' ' ASN . 83.7 tttt -163.67 138.65 6.19 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.408 -1.317 . . . . 0.0 114.366 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.795 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.9 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.33 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.34 160.58 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.06 56.29 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.67 46.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.82 65.75 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.01 169.13 18.3 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.457 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.733 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.02 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.475 1.607 . . . . 0.0 115.085 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.65 37.86 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.936 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -78.03 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.603 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.659 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.14 26.22 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.954 1.941 . . . . 0.0 117.954 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.626 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.42 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.8 171.54 14.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.63 150.47 22.23 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.014 1.326 . . . . 0.0 111.181 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.85 118.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.62 54.61 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.771 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.914 -1.741 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.341 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.94 75.27 78.86 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.22 28.95 Favored 'Trans proline' 0 C--N 1.284 -2.829 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.73 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.053 0.93 . . . . 0.0 109.994 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.63 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 109.013 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.32 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.49 73.15 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 -10.39 19.99 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 115.532 -2.467 . . . . 0.0 117.247 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -152.99 158.73 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -127.52 118.93 24.92 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.89 123.27 49.81 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.591 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.76 33.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.741 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.7 102.74 7.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.511 -2.281 . . . . 0.0 109.687 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.78 29.39 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.42 127.51 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.379 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.75 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.09 130.44 39.3 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.349 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.018 0.824 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.254 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.7 p . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.652 0.739 . . . . 0.0 112.724 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.43 -10.49 4.96 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.179 1.549 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.8 140.41 15.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.623 1.211 . . . . 0.0 108.529 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.73 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.779 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.18 9.5 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.971 1.367 . . . . 0.0 112.63 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.095 0.872 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.77 9.48 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.1 -35.47 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.28 -39.03 82.25 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.396 1.094 . . . . 0.0 108.098 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.82 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.72 -42.56 97.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.99 82.17 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.34 10.8 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.091 -1.844 . . . . 0.0 111.702 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.33 55.88 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.1 t -71.5 131.64 34.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.264 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.96 30.36 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.79 66.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.91 -33.5 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.201 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.65 75.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.24 73.67 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.13 70.69 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.22 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.29 -29.08 65.38 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.429 1.016 . . . . 0.0 113.918 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.74 -10.32 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.786 0.834 . . . . 0.0 109.426 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.79 47.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.38 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.63 152.54 18.35 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.76 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.652 -2.067 . . . . 0.0 110.951 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.177 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.99 126.22 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.247 -2.706 . . . . 0.0 106.687 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.27 158.6 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.18 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.88 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.2 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.016 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.017 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.95 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.445 0.64 . . . . 0.0 111.119 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.52 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.69 48.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -128.25 167.05 17.43 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.017 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.273 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.03 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.38 38.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.855 1.312 . . . . 0.0 110.58 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.7 p -137.45 167.97 20.58 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.662 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.85 -6.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 85.0 tttt -163.74 138.57 6.08 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.431 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.304 1.049 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -116.96 153.89 31.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.15 157.29 9.35 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.782 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.58 146.2 22.09 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.119 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.94 139.24 42.86 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.714 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.65 131.68 47.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.9 65.64 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.9 136.48 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.19 127.44 37.67 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.714 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -127.07 143.54 51.25 Favored 'General case' 0 CA--C 1.588 2.406 0 CA-C-O 123.418 1.58 . . . . 0.0 115.07 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.19 -1.569 . . . . 0.0 106.866 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -77.99 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-O 122.354 1.073 . . . . 0.0 111.654 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.661 3.6 mm? -52.34 -44.21 65.05 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.233 -1.803 . . . . 0.0 114.023 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.7 0.21 39.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.22 25.91 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.29 156.87 17.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.539 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.09 22.33 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.9 m -124.59 154.4 40.74 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.718 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.82 28.72 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.659 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.0 mt -138.07 143.45 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.88 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.194 -3.162 . . . . 0.0 105.194 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.58 -22.55 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.42 12.71 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.861 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.76 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.1 mt -119.97 128.67 53.79 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.78 118.61 57.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.53 52.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.978 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.55 127.55 54.62 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.947 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.27 123.1 48.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 124.669 1.231 . . . . 0.0 108.735 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.67 1.64 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.518 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.44 17.73 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.91 -1.744 . . . . 0.0 114.254 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.95 75.4 78.66 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.17 128.3 29.32 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.913 1.13 . . . . 0.0 111.386 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.92 149.62 45.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.6 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.56 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.013 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.74 113.85 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.861 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.87 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.64 157.25 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.37 41.09 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.48 20.01 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.314 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.74 42.59 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.53 119.0 25.05 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.88 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.599 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.6 119.69 33.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.732 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.21 10.76 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.679 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.79 124.82 29.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.887 1.367 . . . . 0.0 111.992 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.47 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.395 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.51 148.78 49.66 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.75 52.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.02 130.45 39.45 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.922 -1.49 . . . . 0.0 114.269 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.691 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.992 0.807 . . . . 0.0 112.288 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.51 -32.64 63.07 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.729 0.776 . . . . 0.0 112.699 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.37 -10.55 4.94 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.5 28.63 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.076 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 142.98 57.99 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.711 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.33 15.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.39 112.47 24.92 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.28 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.51 138.16 49.69 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.733 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.26 9.64 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.701 1.251 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.42 138.73 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.246 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.007 1.861 . . . . 0.0 109.391 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.3 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.304 13.4 pt -90.94 14.17 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.672 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.415 23.5 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.88 30.38 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.052 1.362 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.84 66.6 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -177.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.89 -33.47 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.295 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.688 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.2 61.92 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.03 65.46 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.38 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.982 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.55 14.86 Favored 'General case' 0 N--CA 1.394 -3.257 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.847 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.758 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.61 4.31 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.22 167.0 17.47 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.85 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.32 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.27 158.36 38.37 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.69 16.43 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.104 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.37 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.2 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 85.0 tttt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.08 126.59 51.12 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.314 1.054 . . . . 0.0 110.197 177.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.4 m -116.96 153.93 31.76 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.6 146.29 22.13 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.109 178.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.19 42.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.29 160.53 40.85 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.91 132.98 56.35 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.61 131.7 46.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.36 128.38 56.28 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.644 1.688 . . . . 0.0 110.517 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.78 136.44 56.22 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.735 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -127.03 143.51 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.108 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.677 3.6 mm? -52.32 -44.27 65.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.024 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -81.71 0.28 39.59 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.34 12.71 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -109.22 123.11 48.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.741 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.41 17.7 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.873 -1.767 . . . . 0.0 114.272 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.357 11.3 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -138.8 149.62 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.8 113.88 18.51 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.95 115.94 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.54 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.8 42.62 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.61 118.98 24.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.94 123.23 49.74 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.681 -0.637 . . . . 0.0 109.722 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.65 122.85 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.617 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.13 10.48 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.8 124.83 29.39 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.737 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.85 49.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.19 146.83 52.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.17 130.43 39.15 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.289 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.49 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.01 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.257 1.598 . . . . 0.0 109.719 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-N 118.701 1.251 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp -48.66 125.25 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.31 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.728 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -78.07 -35.53 49.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.11 82.58 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.404 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.07 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.346 10.1 pt -90.89 14.08 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.117 -1.833 . . . . 0.0 111.691 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.418 23.8 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.89 30.37 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.073 1.374 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.72 -47.68 67.16 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -177.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.52 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.21 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.65 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.18 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.03 65.52 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.868 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.77 -10.27 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.66 18.26 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.3 158.55 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-O 122.616 1.198 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.25 138.52 38.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.75 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.93 143.46 50.74 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.894 0.746 . . . . 0.0 111.923 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.019 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.95 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.881 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.23 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.77 18.95 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.343 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.96 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 50.8 tttm -163.74 138.6 6.1 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.403 -1.319 . . . . 0.0 114.395 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.55 51.0 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -116.92 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.31 9.24 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.801 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.17 42.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.61 40.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.37 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.05 143.48 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.663 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.963 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.59 34.88 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.48 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.55 150.46 22.21 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.108 1.363 . . . . 0.0 111.203 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.95 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.46 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.224 2.74 . . . . 0.0 119.224 -178.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.83 16.41 12.65 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -120.0 128.63 53.73 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.77 118.6 57.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.26 123.07 48.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.777 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.93 75.31 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.19 128.21 29.0 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.85 149.68 45.17 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.902 178.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.2 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -124.81 113.94 18.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -177.73 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.59 118.94 24.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.577 1.18 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.73 122.77 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.594 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.8 33.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.728 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.739 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -133.1 130.39 39.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.349 -178.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.71 133.5 56.16 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.732 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.254 -179.925 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.52 -32.6 63.06 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.674 0.75 . . . . 0.0 112.724 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.79 140.36 15.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.548 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.38 112.51 24.98 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.72 135.36 49.28 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.57 138.14 49.78 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.63 125.18 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.979 1.371 . . . . 0.0 112.569 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.38 138.66 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.15 28.79 9.45 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 178.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.23 -39.07 82.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.431 1.11 . . . . 0.0 108.147 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.81 -40.72 93.8 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.68 97.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.6 -47.82 66.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.95 -33.44 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.64 75.11 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.696 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.15 70.6 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.225 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.2 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.8 -10.32 58.15 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.34 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.28 158.06 32.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.415 2.743 . . . . 0.0 116.172 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.54 14.86 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.875 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.25 138.49 38.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.788 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.055 179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.96 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.273 178.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.37 38.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -141.49 124.69 16.42 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.92 139.36 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -137.51 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.72 76.29 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.689 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 46.0 tttm -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.3 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.31 9.35 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.685 -1.206 . . . . 0.0 109.763 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.717 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.32 160.53 40.82 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -55.65 131.73 47.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.65 -1.9 65.33 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.41 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.657 1.694 . . . . 0.0 110.497 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.5 56.25 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -136.98 169.18 18.22 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.41 37.65 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.744 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.09 143.49 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.074 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.866 177.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -78.0 168.32 20.08 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.59 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.27 -44.33 64.88 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.992 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.12 26.12 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.24 156.86 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.57 178.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -124.57 154.41 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.95 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.669 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.9 50.38 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.84 16.36 12.64 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.79 52.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -119.97 128.66 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.85 126.52 52.55 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.949 -177.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.57 127.56 54.62 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.907 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -109.31 123.07 48.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.702 179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.61 45.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.902 178.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.58 122.37 69.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.076 0.941 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.22 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.4 20.05 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.5 m -110.85 123.19 49.62 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.709 -0.619 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.77 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.73 33.77 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.732 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.77 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.53 -117.21 10.72 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 117.528 -2.272 . . . . 0.0 109.676 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.76 124.78 29.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.885 1.366 . . . . 0.0 111.992 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.44 127.41 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.4 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.47 148.84 49.61 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.2 146.78 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -133.08 130.44 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.91 119.32 61.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.267 -178.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.6 4.99 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.4 2.5 28.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.071 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 142.98 58.01 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.736 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.46 24.87 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.245 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.684 1.24 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.109 0.881 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -64.18 -45.14 89.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.051 1.881 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.402 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.9 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.694 -179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.8 66.83 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.02 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.0 65.6 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.91 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.035 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.25 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.286 -2.688 . . . . 0.0 106.703 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.19 138.54 38.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.846 0.716 . . . . 0.0 111.964 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.22 167.04 17.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.76 18.93 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.347 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -141.44 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.163 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.87 139.41 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 51.0 tttm -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.55 51.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.318 1.056 . . . . 0.0 110.224 177.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.3 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.759 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.61 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.119 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.16 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.99 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.119 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.665 3.6 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -81.74 0.28 39.73 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.5 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.2 123.09 48.66 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.798 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.41 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.67 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.8 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.81 113.9 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.94 115.93 31.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.728 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.1 t -127.57 118.98 24.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.15 10.54 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.82 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.79 119.28 61.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.327 -178.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.58 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.02 57.96 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.93 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.8 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 118.736 1.268 . . . . 0.0 108.592 178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.592 1.663 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . 25.0 t70 -112.42 -43.09 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.698 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.83 173.97 15.17 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.479 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.57 155.83 13.14 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.702 1.251 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.37 138.73 53.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.126 0.891 . . . . 0.0 110.198 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.79 9.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -78.09 -35.4 49.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.8 pt -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.684 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.23 56.09 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.413 23.6 t -71.43 131.62 34.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 119.994 1.897 . . . . 0.0 110.291 179.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 161.91 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 122.99 1.328 . . . . 0.0 114.271 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.9 -49.16 73.79 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.426 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.06 70.98 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-O 121.425 0.631 . . . . 0.0 111.281 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.2 62.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.09 65.59 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.035 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.32 158.06 32.84 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.22 138.5 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.828 0.705 . . . . 0.0 111.948 179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.019 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 1.016 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.24 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 178.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.65 48.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.829 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.21 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.048 -2.261 . . . . 0.0 113.808 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.25 166.98 17.55 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 1.016 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.78 19.0 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.347 178.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.43 124.64 16.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.142 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.39 52.18 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.83 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.794 ' C ' HD21 ' A' ' 61' ' ' ASN . 51.1 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.794 HD21 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.51 50.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.351 1.072 . . . . 0.0 110.219 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.76 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.29 9.22 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.39 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.02 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.098 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.8 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.33 -44.25 65.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.81 0.41 39.46 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.26 26.07 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.29 156.86 17.2 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.614 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.811 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.2 117.63 34.96 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.6 154.39 40.74 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.409 1.693 . . . . 0.0 111.764 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.77 28.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.67 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.1 143.42 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.83 171.44 14.79 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.55 150.41 22.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.048 1.339 . . . . 0.0 111.184 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.64 -22.5 17.99 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.86 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.86 52.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.02 128.69 53.76 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.58 52.7 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.6 54.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.91 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.71 1.65 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.491 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.4 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.93 68.18 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.85 149.64 45.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.78 113.88 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.86 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.92 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -10.47 20.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.582 -2.447 . . . . 0.0 117.314 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.59 119.02 25.02 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.769 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.6 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 117.588 -2.244 . . . . 0.0 109.615 -177.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.63 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.738 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.69 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 12' ' ' ASP . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.06 133.72 52.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.715 179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 12' ' ' ASP . 12.3 mttt -102.28 132.46 48.23 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.991 0.807 . . . . 0.0 112.265 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.319 1.533 . . . . 0.0 110.725 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.694 0.759 . . . . 0.0 112.724 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.57 4.95 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.197 1.561 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.84 68.7 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.82 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.661 1.23 . . . . 0.0 108.541 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.43 112.47 24.9 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.728 -1.578 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.7 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.77 174.0 15.16 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.43 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.39 1.09 . . . . 0.0 108.06 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.36 8.1 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.68 -42.59 97.43 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.98 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.327 11.1 pt -90.95 14.15 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.064 -1.854 . . . . 0.0 111.672 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.98 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.406 11.3 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.75 67.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.201 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.4 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.6 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.951 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.28 158.05 32.63 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.08 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 111.298 -2.683 . . . . 0.0 106.664 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -117.22 158.55 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.629 1.206 . . . . 0.0 111.193 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.31 6.69 48.34 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.3 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.95 134.6 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.22 158.38 38.28 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.87 1.319 . . . . 0.0 110.592 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -137.45 167.96 20.6 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -163.73 138.58 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.1 126.61 51.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.332 1.063 . . . . 0.0 110.181 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.4 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.32 9.41 Favored 'General case' 0 CA--C 1.449 -2.909 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.817 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.61 146.24 22.07 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.119 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.5 mt -55.72 131.71 47.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.39 56.27 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.44 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.735 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.071 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.666 3.6 mm? -52.34 -44.24 65.07 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 114.023 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.66 0.24 39.55 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.543 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.6 154.37 40.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.94 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.659 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.54 17.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.33 12.72 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.58 54.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.882 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.25 123.11 48.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.741 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.45 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.858 -1.776 . . . . 0.0 114.238 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -130.93 75.33 78.78 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.13 128.25 29.1 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.94 31.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.63 157.26 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.52 162.34 41.13 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.4 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.7 122.85 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.617 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.69 102.81 7.78 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.666 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.82 124.87 29.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.93 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.2 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 1.9 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.62 63.2 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.675 0.75 . . . . 0.0 112.668 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.54 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.97 68.55 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.561 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -107.74 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.82 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.63 138.15 49.84 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.722 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -48.6 125.21 9.49 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 123.025 1.393 . . . . 0.0 112.56 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.677 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.81 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.23 -39.1 82.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.431 1.11 . . . . 0.0 108.131 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.77 -40.76 93.74 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.19 -45.15 89.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.013 1.863 . . . . 0.0 109.364 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.619 0.0 OUTLIER -60.21 -41.38 92.89 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.9 179.386 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.65 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.96 82.09 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.5 pt -90.95 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 23.6 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 122.993 1.329 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.217 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 -34.68 75.22 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.654 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -63.87 -49.15 73.87 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.396 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.13 70.68 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.47 0.653 . . . . 0.0 111.288 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.25 61.84 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.8 -10.28 58.18 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.68 -10.75 47.36 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.3 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.56 14.82 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.0 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.07 117.2 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.025 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.23 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.84 -112.56 4.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.54 146.22 34.42 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.815 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.21 167.0 17.46 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.3 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.76 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.681 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.7 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.35 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.753 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.64 146.26 22.06 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.122 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.17 43.01 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.67 131.69 47.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.89 136.5 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.98 169.18 18.21 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.17 127.37 37.62 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.742 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.08 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.704 3.5 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.17 26.09 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 117.911 1.924 . . . . 0.0 117.911 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.23 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.601 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.08 22.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.6 34.9 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.54 154.45 40.57 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.721 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.669 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.94 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.5 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.89 126.62 52.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 123.917 1.817 . . . . 0.0 111.896 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.97 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.533 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.74 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.931 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.62 122.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 122.038 0.923 . . . . 0.0 109.962 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.59 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.5 t -127.6 119.0 24.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -102.96 121.12 53.74 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.508 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.86 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.373 0.606 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.8 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.22 10.78 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.03 -14.63 24.14 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.883 0.873 . . . . 0.0 112.123 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.87 124.88 29.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.714 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.48 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.4 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.82 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.903 0.859 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.327 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.55 4.92 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -3.0 68.51 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.657 1.228 . . . . 0.0 108.592 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.8 p -127.39 138.68 53.06 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.138 0.899 . . . . 0.0 110.22 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.0 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.591 0.0 OUTLIER -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.9 pt -90.9 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.144 -1.822 . . . . 0.0 111.634 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.426 38.4 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 57.1 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.12 70.73 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.25 61.74 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.35 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.95 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 158.06 33.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.321 2.681 . . . . 0.0 116.216 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -117.28 158.59 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.709 1.255 . . . . 0.0 111.172 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.57 4.3 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.67 48.39 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.79 19.01 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -141.45 124.59 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.41 52.18 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 m -116.88 153.93 31.67 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.996 0.903 . . . . 0.0 109.037 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.66 131.64 47.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.649 3.2 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.76 0.31 39.69 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.434 1.709 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.12 143.43 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.83 171.51 14.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.04 128.63 53.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.6 t -109.81 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.25 16.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.96 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.96 31.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.1 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.96 121.17 53.8 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.91 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.688 -0.632 . . . . 0.0 109.738 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 4.0 mp -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.45 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.384 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.11 130.39 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.24 61.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.344 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.11 133.68 52.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.743 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.67 -32.54 63.33 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.61 0.719 . . . . 0.0 112.658 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.05 57.96 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.19 -2.9 68.34 Favored Glycine 0 C--O 1.195 -2.318 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.76 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.698 1.249 . . . . 0.0 108.597 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.77 135.42 49.21 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.844 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -48.59 125.21 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.591 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.17 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.91 15.3 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -165.58 155.86 13.16 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.635 1.209 . . . . 0.0 111.782 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.77 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -78.11 -35.45 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.21 -39.11 82.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.78 -40.8 93.93 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG21 ' A' ' 119' ' ' ILE . 23.7 t80 -64.23 -45.11 89.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 124.0 1.857 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.4 ptm -60.15 -41.46 92.83 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.953 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.293 14.0 pt -90.92 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.32 55.91 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.384 3.714 . . . . 0.0 122.384 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.407 21.9 t -71.46 131.61 34.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 CA-C-N 120.001 1.9 . . . . 0.0 110.316 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.96 30.25 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.92 -33.47 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.72 -10.33 58.21 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.828 0.851 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.86 47.27 Favored 'General case' 0 N--CA 1.419 -2.021 0 C-N-CA 117.478 -1.689 . . . . 0.0 109.365 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.71 80.48 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.004 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.25 158.01 32.71 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.208 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.98 126.24 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.63 1.205 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.87 143.44 50.73 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.919 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.13 117.19 41.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.055 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.19 110.17 0.51 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.87 -112.55 4.29 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.39 6.72 48.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.2 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.086 -2.246 . . . . 0.0 113.834 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.22 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.94 138.77 18.92 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.3 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.3 38.51 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.862 1.315 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.63 16.38 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.164 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.39 52.15 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.71 76.27 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.85 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.446 -1.302 . . . . 0.0 114.386 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.51 50.84 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.337 1.065 . . . . 0.0 110.164 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 m -116.91 153.94 31.69 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.986 0.898 . . . . 0.0 109.046 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.31 9.29 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.91 65.6 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.786 1.075 . . . . 0.0 115.786 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.88 136.48 56.2 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.474 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.24 127.38 37.7 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.713 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.97 143.53 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.2 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.654 3.4 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.69 0.24 39.66 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.06 26.38 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.949 1.94 . . . . 0.0 117.949 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.22 156.9 17.16 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.85 171.95 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.26 117.58 34.83 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -124.58 154.42 40.67 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.453 1.72 . . . . 0.0 111.754 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.85 171.44 14.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.6 150.42 22.27 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.01 1.324 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.17 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -120.02 128.7 53.77 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.8 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -117.82 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.59 54.64 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.918 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.533 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.42 17.69 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.939 -1.725 . . . . 0.0 114.219 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.3 p-10 -64.53 -25.96 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.97 75.34 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.384 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.6 m -138.89 149.66 45.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.14 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.856 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.6 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.064 0.935 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.58 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.009 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -124.76 113.86 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.42 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -153.0 158.75 42.5 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.55 119.0 25.04 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 mt -103.0 121.12 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.526 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -110.85 123.3 49.83 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.434 HG21 ' CE2' ' A' ' 20' ' ' TYR . 3.5 mp -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.767 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.3 tp -124.66 102.84 7.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.09 -14.56 24.13 Favored 'General case' 0 CA--C 1.47 -2.129 0 C-N-CA 123.883 0.873 . . . . 0.0 112.126 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.9 124.81 29.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.83 1.331 . . . . 0.0 111.931 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.7 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.27 61.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.14 133.69 52.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.715 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.33 132.57 48.23 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.005 0.816 . . . . 0.0 112.229 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.228 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.69 63.17 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.35 -10.59 4.96 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.95 57.9 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.736 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 -3.0 68.57 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.609 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.275 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.742 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.82 13.11 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 124.686 1.241 . . . . 0.0 111.766 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.03 -35.53 49.67 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.0 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.405 1.5 ptm -60.24 -41.36 92.98 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.32 11.9 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.411 21.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.029 1.349 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.18 62.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.46 -28.97 65.64 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.931 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.4 pt -117.28 158.54 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.58 14.92 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.872 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.49 38.23 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.85 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.845 0.716 . . . . 0.0 111.924 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.89 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.24 34.31 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.09 -2.244 . . . . 0.0 113.757 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.64 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.45 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.0 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.76 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.33 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.1 127.35 37.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.58 37.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.09 -1.631 . . . . 0.0 106.963 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.614 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.76 0.34 39.57 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.87 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.11 117.53 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.53 154.48 40.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.423 1.702 . . . . 0.0 111.732 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.49 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.61 150.47 22.22 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 125.035 1.334 . . . . 0.0 111.181 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.65 -22.45 18.01 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.211 2.735 . . . . 0.0 119.211 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.56 73.22 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -10.38 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.28 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.7 t -127.54 118.95 24.94 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.3 48.31 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 111.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.6 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.773 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.072 0.857 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.61 -32.56 63.22 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.669 0.747 . . . . 0.0 112.706 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.73 135.42 49.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.64 138.18 49.81 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 123.005 1.383 . . . . 0.0 112.584 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.1 28.78 9.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.19 -39.13 82.56 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.8 -40.75 93.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.6 t80 -64.19 -45.15 89.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.013 1.863 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 10.3 ttm -60.14 -41.48 92.78 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.916 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.99 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.355 9.3 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.401 3.72 . . . . 0.0 122.401 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.465 14.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.95 -33.44 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.24 -34.66 75.15 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 63.9 mtm-85 -63.81 -49.22 73.74 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.15 70.57 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.464 0.649 . . . . 0.0 111.258 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.41 -28.98 65.54 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.361 0.978 . . . . 0.0 113.864 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.79 -10.32 58.17 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.426 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.7 152.58 18.33 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.8 80.32 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.33 158.07 32.8 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.365 2.71 . . . . 0.0 116.153 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.609 1.195 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.55 14.81 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.055 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.8 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.78 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -163.68 138.66 6.18 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.433 -1.307 . . . . 0.0 114.426 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.98 139.21 42.95 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.663 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.7 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.61 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.36 128.47 56.3 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.85 136.48 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.2 18.17 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.482 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.16 127.36 37.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.763 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -127.05 143.49 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.2 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.19 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.606 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.7 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.669 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.84 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.09 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.51 -22.54 18.23 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.04 128.64 53.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -117.85 126.61 52.73 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.59 54.59 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.878 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.42 17.72 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.916 -1.74 . . . . 0.0 114.268 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.349 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -138.85 149.62 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.58 122.39 69.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.038 0.923 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.26 135.6 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.01 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.78 113.86 18.49 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.6 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.96 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.7 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.0 121.09 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.489 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.0 m -110.85 123.25 49.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.625 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.767 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.67 102.82 7.78 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.87 124.86 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.885 1.366 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.43 127.43 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.433 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -133.09 130.4 39.26 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.28 61.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.349 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.988 0.805 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.66 63.02 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.55 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.5 28.62 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.996 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.623 1.211 . . . . 0.0 108.561 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.59 125.22 9.5 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.93 1.347 . . . . 0.0 112.62 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.703 1.252 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.85 9.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.16 -35.45 48.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.08 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.0 108.106 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.8 -40.74 93.78 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 9.2 ttm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.67 97.45 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.0 82.13 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.351 9.6 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.448 13.2 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.018 1.344 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.91 -33.53 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.215 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.68 75.34 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.654 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.47 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.403 0.62 . . . . 0.0 111.281 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.27 61.75 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.01 65.35 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.79 -10.29 58.19 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.6 -10.79 47.48 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.356 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.8 mt -95.64 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.79 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.975 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.894 0.746 . . . . 0.0 111.976 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.023 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.87 138.79 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.345 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.97 134.63 55.19 Favored 'General case' 0 C--O 1.279 2.648 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.28 158.34 38.43 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.553 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.7 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.7 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.32 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.782 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.98 139.17 43.0 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.38 37.59 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.07 143.48 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.107 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.18 120.62 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.924 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.685 3.9 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.69 0.24 39.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.26 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.08 22.32 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.45 40.61 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.93 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.53 54.55 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.907 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.22 123.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -89.96 -166.76 1.67 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.78 62.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.902 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.076 0.941 . . . . 0.0 109.942 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.89 31.06 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.64 157.27 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.522 1.63 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.19 10.68 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.84 124.79 29.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.977 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.39 127.47 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.419 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.8 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.26 146.78 52.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.305 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.68 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.55 4.96 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.99 57.89 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.704 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.691 1.246 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.1 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.11 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.689 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.83 173.96 15.19 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.509 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.56 155.85 13.19 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 124.703 1.252 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -78.06 -35.49 49.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.71 -40.8 93.61 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.8 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.393 1.2 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 9.4 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.99 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.429 24.3 t -71.47 131.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 CA-C-N 120.01 1.905 . . . . 0.0 110.291 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.32 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.019 1.344 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.24 62.0 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.03 65.47 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.413 1.007 . . . . 0.0 113.939 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.28 158.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.65 146.59 14.96 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.902 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.53 38.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.9 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.863 0.727 . . . . 0.0 111.907 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.89 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.21 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.62 48.53 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.57 146.24 34.33 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.081 -2.248 . . . . 0.0 113.757 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.3 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -163.73 138.6 6.1 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 118.463 -1.295 . . . . 0.0 114.371 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.51 50.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.323 1.059 . . . . 0.0 110.225 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.29 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.57 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.089 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.0 139.21 42.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.734 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -1.88 65.63 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.3 128.46 56.28 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.91 136.47 56.16 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.12 18.31 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.515 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.15 127.39 37.61 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.745 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.25 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.17 120.61 37.84 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.945 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.671 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.79 0.39 39.45 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.22 26.17 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.3 156.84 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.609 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.03 22.24 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.9 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.19 117.56 34.82 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.4 m -124.52 154.45 40.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.439 1.712 . . . . 0.0 111.736 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.44 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.47 22.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.998 1.319 . . . . 0.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.67 -22.44 17.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.85 16.49 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.79 126.61 52.74 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.56 127.57 54.63 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.916 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.6 -25.96 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.57 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -10.41 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.289 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.57 118.99 24.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.02 121.19 53.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.504 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.3 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.09 133.74 52.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.737 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.53 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.089 0.868 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.6 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.58 63.29 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.615 0.722 . . . . 0.0 112.62 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.6 5.07 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.43 28.83 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -107.76 135.4 49.25 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.839 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -48.65 125.21 9.56 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.576 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.0 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.617 1.198 . . . . 0.0 111.74 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.08 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.24 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.83 9.3 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.25 -39.08 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.348 1.07 . . . . 0.0 108.123 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.8 -40.74 93.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.1 t80 -64.2 -45.15 89.58 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 124.03 1.871 . . . . 0.0 109.335 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.4 ptm -60.19 -41.4 92.85 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.885 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.64 -42.68 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.02 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.89 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.713 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.29 55.94 Favored Glycine 0 C--O 1.213 -1.16 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.425 23.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.9 30.4 Favored Glycine 0 CA--C 1.49 -1.493 0 CA-C-O 123.003 1.335 . . . . 0.0 114.299 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.65 75.27 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.22 61.94 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -28.94 65.52 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.82 -10.29 58.16 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.355 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.65 152.61 18.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.69 80.43 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.615 -2.084 . . . . 0.0 111.004 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.34 158.06 32.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.403 2.735 . . . . 0.0 116.157 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 CA-C-O 122.675 1.226 . . . . 0.0 111.182 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.16 138.5 38.11 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.797 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.857 0.723 . . . . 0.0 111.976 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.09 117.15 41.15 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.05 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.6 4.31 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.74 48.2 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.25 34.32 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.751 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.21 167.04 17.4 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.99 138.77 18.88 Favored 'General case' 0 C--N 1.263 -3.153 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.3 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -137.52 167.88 20.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.77 76.38 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.703 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.64 146.17 21.97 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.18 42.97 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.6 40.91 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.66 131.69 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.47 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.98 169.14 18.28 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.512 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.713 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.04 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.085 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.61 37.81 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.945 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.616 3.6 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.71 0.29 39.53 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.48 40.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.732 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.5 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.42 22.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.13 89.08 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.54 177.93 50.46 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.55 -22.52 18.16 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.0 128.62 53.71 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.8 118.69 57.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -117.84 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.914 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.883 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.02 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.791 -1.564 . . . . 0.0 108.492 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.45 17.72 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.991 -1.693 . . . . 0.0 114.239 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.53 -25.92 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.384 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.88 149.63 45.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.75 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.88 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.8 mt -115.65 122.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.053 0.93 . . . . 0.0 109.966 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.012 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.54 73.2 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.98 158.74 42.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.2 t -127.56 118.95 24.93 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.3 mt -102.95 121.09 53.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.497 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.79 123.23 49.67 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.69 -0.631 . . . . 0.0 109.804 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.79 68.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.66 102.79 7.77 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.22 10.8 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.04 -14.67 24.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.906 0.882 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.77 29.35 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.785 1.303 . . . . 0.0 111.983 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.45 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.42 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.48 148.8 49.63 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.327 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.283 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.57 56.23 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.196 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.64 63.12 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.671 0.748 . . . . 0.0 112.699 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.56 4.99 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 142.99 58.01 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.704 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.84 69.11 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.84 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.664 1.232 . . . . 0.0 108.524 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.46 24.88 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.602 1.668 . . . . 0.0 110.303 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.661 -1.609 . . . . 0.0 106.784 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.15 3.56 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.7 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.8 173.96 15.2 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.46 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.85 13.03 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.633 1.208 . . . . 0.0 111.728 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.11 28.8 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -78.09 -35.49 49.3 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.15 82.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.77 93.64 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.8 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.051 1.881 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.5 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.96 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.315 12.4 pt -90.93 14.18 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -2.007 0 C-N-CA 117.09 -1.844 . . . . 0.0 111.688 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.417 21.9 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.57 74.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.83 47.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -95.61 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.39 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.982 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.223 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -119.99 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.317 -2.674 . . . . 0.0 106.703 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 pt -117.25 158.59 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.702 1.251 . . . . 0.0 111.207 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.404 0.621 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.56 4.3 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.66 48.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.89 138.86 19.05 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.283 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.03 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.68 16.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.39 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -137.5 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.662 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -120.05 126.54 51.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.297 1.046 . . . . 0.0 110.205 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.29 9.33 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.782 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.6 40.93 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.96 132.98 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.63 131.68 47.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.43 56.28 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.86 136.45 56.17 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.45 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -127.07 143.56 51.25 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.05 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.617 3.5 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.75 0.26 39.88 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.21 25.97 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.909 1.924 . . . . 0.0 117.909 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.543 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.96 110.06 22.3 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.87 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.18 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -124.6 154.41 40.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.72 28.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.695 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -137.98 143.49 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.22 89.15 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.94 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.194 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.63 -22.51 17.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.38 12.73 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.59 127.58 54.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.942 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.25 123.14 48.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.741 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.06 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.502 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.45 17.63 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.51 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -130.91 75.4 78.69 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.63 122.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.086 0.946 . . . . 0.0 109.905 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.5 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.015 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.87 31.02 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.54 157.23 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.57 73.25 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.58 1.657 . . . . 0.0 109.411 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.88 116.39 48.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.676 1.227 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 121.13 53.77 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.89 -1.131 . . . . 0.0 111.504 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.6 mp -113.71 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.644 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.69 33.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.794 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.45 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.42 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.79 49.67 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.269 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.692 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.26 132.46 48.19 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 123.969 0.793 . . . . 0.0 112.245 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.36 1.552 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 143.05 57.94 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.181 1.55 . . . . 0.0 109.687 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.23 -2.95 68.35 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.78 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.609 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.75 135.42 49.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.784 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.265 1.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.0 tp -48.64 125.22 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.743 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.82 173.94 15.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.43 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.763 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.1 -35.49 49.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.72 93.47 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.5 t80 -64.23 -45.15 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.409 1.4 ptm -60.19 -41.45 92.97 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.935 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.61 97.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.01 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.33 11.2 pt -90.92 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.1 -1.84 . . . . 0.0 111.684 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.419 31.1 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.98 30.33 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.47 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.21 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.33 -34.54 74.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.645 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.83 -49.26 73.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.18 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.04 65.5 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.939 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.7 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -95.65 152.66 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.26 158.05 32.58 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.324 2.683 . . . . 0.0 116.263 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 111.358 -2.656 . . . . 0.0 106.733 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 41' ' ' ILE 0.284 12.2 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.62 1.2 . . . . 0.0 111.155 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.27 138.52 38.19 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.91 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.877 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.493 0.663 . . . . 0.0 111.102 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.3 6.65 48.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.58 146.27 34.3 Favored 'General case' 0 N--CA 1.403 -2.807 0 C-N-CA 116.036 -2.266 . . . . 0.0 113.79 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.75 18.93 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.327 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.95 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.7 76.27 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.84 -6.76 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.11 126.55 51.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.283 1.04 . . . . 0.0 110.216 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.17 157.29 9.32 Favored 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.841 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.57 146.24 22.13 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.086 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.65 40.94 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.63 131.63 46.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.86 65.86 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.18 127.37 37.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -126.97 143.52 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.12 120.59 37.77 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.115 -1.615 . . . . 0.0 106.905 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.5 p -78.01 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.631 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.648 3.4 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.13 26.24 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.25 156.9 17.17 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.62 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.87 171.92 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.21 117.61 34.92 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -124.58 154.39 40.72 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.464 1.727 . . . . 0.0 111.764 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.307 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.83 171.45 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.57 150.46 22.22 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.103 1.361 . . . . 0.0 111.169 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.13 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.94 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.194 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 -22.43 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.79 16.38 12.68 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -119.97 128.69 53.81 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.83 118.56 57.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.252 16.6 t-160 -117.76 126.58 52.71 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.816 1.77 . . . . 0.0 111.988 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.91 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -109.29 123.08 48.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.754 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.4 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.2 p-10 -64.54 -26.01 68.23 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -130.93 75.36 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 m -138.89 149.64 45.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.3 135.56 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.008 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -124.77 113.94 18.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.23 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.65 -10.43 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.256 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.5 t -127.57 118.98 24.96 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-O 122.557 1.17 . . . . 0.0 111.181 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.97 121.2 53.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.96 -1.088 . . . . 0.0 111.508 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.437 HG21 ' CE2' ' A' ' 20' ' ' TYR . 15.3 mt -113.69 122.79 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.67 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.75 33.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.735 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.6 148.8 49.73 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.77 52.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.805 0.812 . . . . 0.0 111.408 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.08 130.45 39.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.917 -1.492 . . . . 0.0 114.291 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.722 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.29 132.54 48.19 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.046 0.841 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.714 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.256 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.647 0.736 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.9 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.75 140.34 15.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.545 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.644 1.688 . . . . 0.0 110.282 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.74 135.45 49.13 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.784 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.68 138.15 49.91 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.23 3.55 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.678 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.95 15.24 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.8 9.41 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -78.13 -35.49 49.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.12 82.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.79 -40.78 93.9 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.2 t80 -64.21 -45.13 89.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.0 1.857 . . . . 0.0 109.349 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.15 -41.48 92.85 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.916 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.59 97.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.3 pt -90.92 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.982 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.28 55.94 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.379 3.712 . . . . 0.0 122.379 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.416 23.2 t -71.49 131.63 34.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.289 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.69 67.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.82 47.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.61 152.65 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.951 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.22 158.04 32.45 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.199 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.687 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -117.27 158.59 17.83 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 O-C-N 124.62 1.2 . . . . 0.0 111.191 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.51 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.43 6.73 48.21 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.57 55.22 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.4 p -128.22 158.34 38.37 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.7 t -141.5 124.64 16.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.91 139.43 52.13 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -137.54 167.9 20.73 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.15 126.51 50.89 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.269 1.033 . . . . 0.0 110.176 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.69 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.9 65.7 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.49 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.2 127.42 37.67 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.703 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.687 3.5 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.69 0.21 39.79 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.06 26.27 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.926 1.93 . . . . 0.0 117.926 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -101.17 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.237 -1.385 . . . . 0.0 110.606 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.18 117.55 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.42 40.68 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.75 28.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.659 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.98 143.48 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.87 171.47 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 54.9 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.61 54.65 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.918 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -109.31 123.14 48.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.708 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.07 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.533 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.42 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.941 -1.724 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.49 -25.97 68.23 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.93 149.62 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.59 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.33 135.53 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 117.893 -1.523 . . . . 0.0 108.964 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.78 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.27 16.79 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.53 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.34 48.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.1 m -110.88 123.3 49.85 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.414 HG21 ' CE2' ' A' ' 20' ' ' TYR . 11.8 mt -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.53 119.73 33.79 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -124.62 102.84 7.81 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.88 124.81 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.77 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.691 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.55 48.15 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.984 0.802 . . . . 0.0 112.264 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.8 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.62 -32.58 63.24 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.687 0.756 . . . . 0.0 112.698 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.99 57.93 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.735 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.73 140.37 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.563 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.682 1.706 . . . . 0.0 110.255 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.72 135.39 49.23 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.664 -1.607 . . . . 0.0 106.804 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.65 138.15 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 173.97 15.22 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.505 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -165.63 155.82 13.0 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.78 9.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.1 -35.55 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.15 -39.11 82.74 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.82 -40.75 93.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.5 t80 -64.17 -45.17 89.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 123.987 1.851 . . . . 0.0 109.354 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 8.3 ttm -60.12 -41.46 92.66 Favored 'General case' 0 N--CA 1.41 -2.433 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.95 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.04 82.1 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.299 13.2 pt -90.91 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.974 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.707 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.27 55.99 Favored Glycine 0 C--O 1.214 -1.124 0 N-CA-C 122.411 3.724 . . . . 0.0 122.411 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.434 12.2 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.72 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.08 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.2 mtm-85 -63.8 -49.26 73.58 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.07 65.61 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.346 0.97 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.4 mt -83.73 -10.27 58.25 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.771 0.828 . . . . 0.0 109.433 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt -95.64 152.6 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.71 80.4 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.95 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.23 158.03 32.51 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.333 2.689 . . . . 0.0 116.238 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.748 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.7 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.628 1.204 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.56 14.9 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.92 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.25 138.52 38.16 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.761 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.9 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.945 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.17 117.23 41.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.961 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.91 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.66 48.41 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.2 158.31 38.46 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.803 1.287 . . . . 0.0 110.627 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.5 t -141.49 124.68 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.87 139.44 52.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.7 p -137.51 167.86 20.79 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.24 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.88 -6.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.936 1.397 . . . . 0.0 111.055 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.2 m -107.92 139.22 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.745 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.34 160.62 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.99 133.05 56.29 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.61 131.67 46.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -1.9 65.93 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 115.708 1.043 . . . . 0.0 115.708 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.82 136.45 56.2 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.17 18.22 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.735 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.16 120.63 37.86 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.888 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -77.97 168.43 19.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.637 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.625 4.1 mm? -52.45 -44.2 65.37 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.153 -1.839 . . . . 0.0 113.963 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.4 m -117.92 171.91 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.9 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.61 154.44 40.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.659 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.03 143.4 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.7 p -145.81 171.5 14.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.62 150.43 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.087 1.355 . . . . 0.0 111.189 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.6 177.89 50.4 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 115.635 -3.174 . . . . 0.0 105.183 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.57 -22.47 18.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.265 2.756 . . . . 0.0 119.265 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.81 16.42 12.67 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.03 128.68 53.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -117.85 126.56 52.62 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 123.81 1.767 . . . . 0.0 111.947 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.91 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.31 123.13 48.78 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.719 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.706 -1.598 . . . . 0.0 108.549 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.38 17.71 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.9 -1.75 . . . . 0.0 114.235 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.36 11.3 p-10 -64.59 -25.95 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.93 149.64 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.77 62.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.2 mt -115.62 122.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.59 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 108.988 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -124.8 113.9 18.54 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.94 31.15 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.69 157.21 16.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.33 41.13 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -32.47 73.16 Favored 'General case' 0 N--CA 1.41 -2.443 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.47 19.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 115.503 -2.479 . . . . 0.0 117.274 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.9 158.76 42.61 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.497 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.73 122.84 68.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.625 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.68 33.65 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.8 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.61 102.79 7.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.14 10.53 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.666 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.12 -14.6 24.05 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.871 0.868 . . . . 0.0 112.085 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.83 29.42 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.832 1.332 . . . . 0.0 111.906 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.8 t -120.43 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.436 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.57 148.77 49.71 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.76 52.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -133.08 130.46 39.37 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.291 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.13 133.66 52.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.721 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.13 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.984 0.802 . . . . 0.0 112.283 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.54 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.371 1.558 . . . . 0.0 110.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.52 28.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.77 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.541 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.51 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.56 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.01 15.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.64 155.83 12.99 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.598 1.187 . . . . 0.0 111.759 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.2 -39.18 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.72 -40.76 93.52 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.9 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.349 8.4 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.93 81.85 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.99 14.13 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.149 -1.821 . . . . 0.0 111.66 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.95 23.26 56.01 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.442 12.5 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -73.0 -33.44 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.235 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.89 -49.15 73.81 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.48 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.205 -1.668 0 CA-C-O 122.427 1.015 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.75 47.49 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.67 152.62 18.29 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.25 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.279 14.5 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.666 1.229 . . . . 0.0 111.208 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.56 14.88 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.859 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.758 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.506 0.669 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.29 6.65 48.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.61 55.19 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.37 38.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.876 1.322 . . . . 0.0 110.565 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -163.73 138.62 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.34 9.44 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.788 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 132.97 56.35 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.63 131.72 47.13 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.648 1.69 . . . . 0.0 110.499 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.18 127.4 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.764 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.05 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.508 1.623 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.105 -1.622 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.1 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -101.19 156.87 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.574 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.86 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.659 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.65 -22.46 17.99 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.153 2.713 . . . . 0.0 119.153 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.82 16.33 12.66 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.1 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.46 17.67 Favored Glycine 0 CA--C 1.491 -1.445 0 O-C-N 119.902 -1.749 . . . . 0.0 114.207 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.5 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.908 1.128 . . . . 0.0 111.429 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.8 149.65 45.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.21 119.7 62.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.891 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.55 122.36 69.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -124.74 113.87 18.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.52 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.9 123.23 49.73 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.436 0.636 . . . . 0.0 109.733 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.9 mp -113.65 122.81 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.644 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.17 10.58 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.84 29.41 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.885 1.366 . . . . 0.0 111.915 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.4 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.54 48.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.973 0.796 . . . . 0.0 112.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.52 56.18 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.38 2.47 28.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.04 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.95 68.5 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.701 1.251 . . . . 0.0 108.565 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.52 24.95 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.59 125.27 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.621 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.41 138.73 53.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.079 0.862 . . . . 0.0 110.198 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -78.1 -35.47 49.26 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.18 -39.11 82.62 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.35 1.071 . . . . 0.0 108.111 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.7 ttm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.329 11.0 pt -90.87 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.438 11.7 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.69 67.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.5 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.269 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.223 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.16 -46.2 61.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.04 65.72 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.85 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.34 158.55 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.636 1.21 . . . . 0.0 111.158 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.27 138.48 38.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.94 -163.84 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.493 0.663 . . . . 0.0 111.124 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.62 48.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.51 146.21 34.49 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.115 -2.234 . . . . 0.0 113.808 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.5 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.0 p -137.47 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -163.7 138.62 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.7 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.01 143.52 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.705 4.0 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.77 28.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.06 143.4 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.8 171.51 14.68 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.87 52.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.06 128.72 53.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.524 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 12.0 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.92 75.32 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.15 128.23 29.01 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.913 1.13 . . . . 0.0 111.368 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.4 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.82 113.93 18.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.47 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.99 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.57 118.95 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.898 -1.127 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.78 122.82 68.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.575 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.72 33.78 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.758 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -133.1 130.39 39.21 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.254 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.33 -10.56 4.89 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -2.96 68.7 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.636 1.218 . . . . 0.0 108.561 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.0 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.104 0.878 . . . . 0.0 110.24 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.9 ttm -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.345 9.9 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.441 12.0 t -71.44 131.61 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.295 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.87 30.45 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.11 70.76 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.22 61.82 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.37 158.06 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.177 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.22 158.59 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.19 138.51 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.68 48.35 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.62 16.41 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.37 52.19 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -116.91 153.95 31.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.016 0.913 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.686 4.1 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.72 0.26 39.72 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.606 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.476 1.735 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.08 143.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.64 127.53 54.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.907 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.22 123.01 48.55 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 124.629 1.206 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.92 -166.7 1.65 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.783 -1.567 . . . . 0.0 108.531 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.52 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.648 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.4 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.28 61.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.314 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.956 -1.929 . . . . 0.0 111.743 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.59 63.3 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.68 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.4 2.45 28.71 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.073 -0.651 . . . . 0.0 112.042 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.72 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.59 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.44 112.47 24.9 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 123.597 1.665 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.844 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.57 138.17 49.74 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.524 0.678 . . . . 0.0 109.659 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.56 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -159.73 174.0 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.46 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.62 155.84 13.05 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.633 1.208 . . . . 0.0 111.709 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.77 9.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.381 1.086 . . . . 0.0 108.077 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.77 -40.73 93.63 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -64.17 -45.12 89.82 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 124.009 1.862 . . . . 0.0 109.406 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.359 8.3 ttm -60.18 -41.46 92.95 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.901 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.6 -42.65 97.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.318 11.5 pt -90.95 14.13 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.66 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.25 56.05 Favored Glycine 0 C--O 1.214 -1.108 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.409 10.8 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.95 30.16 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-O 123.037 1.354 . . . . 0.0 114.287 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.79 67.01 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.57 75.01 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.5 mtm-85 -63.89 -49.16 73.78 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.76 -10.29 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.6 mt -95.65 152.63 18.28 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.74 80.35 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.981 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.3 158.0 33.01 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.21 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.98 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.755 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.2 158.55 17.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.693 1.245 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.818 0.698 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.464 0.65 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.95 -112.65 4.33 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.69 48.33 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.64 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.23 158.33 38.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.849 1.309 . . . . 0.0 110.578 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.52 124.68 16.39 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.109 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.45 52.15 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.6 p -137.5 167.87 20.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.0 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.12 157.37 9.48 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.764 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.66 146.24 22.01 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.9 1.375 . . . . 0.0 111.055 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -108.01 139.18 43.04 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.664 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.59 40.93 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.99 132.97 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.6 131.74 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.91 65.36 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.99 169.16 18.24 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.735 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.63 37.91 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.125 -1.609 . . . . 0.0 106.87 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.96 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.679 3.7 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -81.72 0.33 39.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.85 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.0 144.78 28.77 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.72 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.37 22.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.17 89.16 2.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.103 -3.199 . . . . 0.0 105.103 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.5 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.8 16.33 12.67 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.82 52.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -119.96 128.65 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.58 -162.45 17.71 Favored Glycine 0 CA--C 1.49 -1.505 0 O-C-N 119.9 -1.75 . . . . 0.0 114.223 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 12.0 p-10 -64.54 -25.99 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.14 128.19 28.86 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.841 1.1 . . . . 0.0 111.416 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.6 45.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.77 62.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.88 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.62 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.964 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.76 113.87 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.63 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.587 1.661 . . . . 0.0 109.447 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.88 123.27 49.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.369 0.605 . . . . 0.0 109.774 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.68 122.81 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.644 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.1 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.548 -2.263 . . . . 0.0 109.666 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.61 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.906 0.882 . . . . 0.0 112.112 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.83 124.82 29.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 124.83 1.331 . . . . 0.0 111.906 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.2 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.4 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.7 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.79 52.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -133.12 130.44 39.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.88 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.311 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.54 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.283 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.79 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.199 -179.869 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.6 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.59 63.18 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.39 2.51 28.78 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.033 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.4 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.38 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.663 1.232 . . . . 0.0 108.58 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.224 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -48.64 125.27 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.686 1.241 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.42 138.71 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.147 0.904 . . . . 0.0 110.181 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -78.07 -35.46 49.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.26 -39.05 82.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.357 1.075 . . . . 0.0 108.122 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.389 1.6 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.264 13.1 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.365 17.7 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.89 -33.54 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.233 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.696 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -63.85 -49.19 73.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.419 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.14 70.65 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.23 61.95 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.02 65.55 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.91 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.73 -10.29 58.24 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.73 47.58 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 117.426 -1.71 . . . . 0.0 109.395 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.187 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 41' ' ' ILE 0.289 13.8 pt -117.34 158.56 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.146 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.57 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.23 138.52 38.14 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.75 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.894 0.746 . . . . 0.0 111.948 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 m -97.08 117.15 41.14 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.053 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.568 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.45 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.163 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.8 p -137.47 167.98 20.56 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.655 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.062 0.934 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.16 43.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.717 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.29 160.56 40.88 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.64 46.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -127.03 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.117 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.11 120.61 37.79 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.954 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.4 p -78.0 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.388 1.09 . . . . 0.0 111.59 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.532 3.7 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.21 25.97 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -124.57 154.45 40.63 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.743 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.02 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.656 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.12 143.41 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.51 14.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.18 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.629 -3.177 . . . . 0.0 105.174 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.03 128.72 53.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.57 54.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.876 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.363 11.3 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.4 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.8 mt -115.61 122.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.55 162.32 41.17 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.4 20.02 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.513 -2.475 . . . . 0.0 117.247 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -127.54 118.93 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 121.635 -0.665 . . . . 0.0 109.747 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.77 122.83 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.565 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.2 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tt -80.82 124.78 29.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.865 1.353 . . . . 0.0 112.008 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.41 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.52 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.79 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -133.1 130.38 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.357 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -110.1 133.64 53.0 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.65 -32.57 63.31 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.65 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.98 57.93 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.767 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.97 68.46 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.5 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.197 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.267 1.989 0 CA-C-O 121.431 0.634 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.22 9.58 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.74 173.99 15.2 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.05 -35.54 49.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.18 -39.11 82.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.342 10.8 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.38 55.88 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.452 3.741 . . . . 0.0 122.452 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.991 1.895 . . . . 0.0 110.298 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.92 -33.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.704 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.15 62.11 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.01 65.78 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.342 0.968 . . . . 0.0 113.846 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.71 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.379 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.3 158.56 17.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.654 1.216 . . . . 0.0 111.119 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.67 146.54 14.89 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.936 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.23 138.48 38.2 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.761 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.09 117.16 41.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.053 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -137.52 167.87 20.78 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.72 76.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.77 -6.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -163.67 138.65 6.19 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.408 -1.317 . . . . 0.0 114.366 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.9 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.33 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.34 160.58 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.06 56.29 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.67 46.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.82 65.75 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.01 169.13 18.3 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.457 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.733 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.02 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.475 1.607 . . . . 0.0 115.085 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.65 37.86 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.936 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -78.03 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.603 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.659 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.14 26.22 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.954 1.941 . . . . 0.0 117.954 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.626 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.42 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.8 171.54 14.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.63 150.47 22.23 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.014 1.326 . . . . 0.0 111.181 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.85 118.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.62 54.61 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.771 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.914 -1.741 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.341 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.94 75.27 78.86 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.22 28.95 Favored 'Trans proline' 0 C--N 1.284 -2.829 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.73 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.053 0.93 . . . . 0.0 109.994 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.63 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 109.013 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.32 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.49 73.15 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 -10.39 19.99 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 115.532 -2.467 . . . . 0.0 117.247 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -152.99 158.73 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -127.52 118.93 24.92 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.89 123.27 49.81 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.591 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.76 33.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.741 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.7 102.74 7.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.511 -2.281 . . . . 0.0 109.687 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.78 29.39 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.42 127.51 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.379 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.75 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.09 130.44 39.3 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.349 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.018 0.824 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.254 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.7 p . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.652 0.739 . . . . 0.0 112.724 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.43 -10.49 4.96 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.179 1.549 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.8 140.41 15.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.623 1.211 . . . . 0.0 108.529 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.73 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.779 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.18 9.5 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.971 1.367 . . . . 0.0 112.63 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.095 0.872 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.77 9.48 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.1 -35.47 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.28 -39.03 82.25 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.396 1.094 . . . . 0.0 108.098 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.82 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.72 -42.56 97.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.99 82.17 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.34 10.8 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.091 -1.844 . . . . 0.0 111.702 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.33 55.88 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.1 t -71.5 131.64 34.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.264 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.96 30.36 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.79 66.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.91 -33.5 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.201 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.65 75.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.24 73.67 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.13 70.69 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.22 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.29 -29.08 65.38 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.429 1.016 . . . . 0.0 113.918 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.74 -10.32 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.786 0.834 . . . . 0.0 109.426 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.79 47.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.38 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.63 152.54 18.35 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.76 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.652 -2.067 . . . . 0.0 110.951 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.177 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.99 126.22 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.247 -2.706 . . . . 0.0 106.687 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.27 158.6 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.18 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.88 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.2 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.016 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.95 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.445 0.64 . . . . 0.0 111.119 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.52 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.69 48.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -128.25 167.05 17.43 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.273 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.03 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.727 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.38 38.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.855 1.312 . . . . 0.0 110.58 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.7 p -137.45 167.97 20.58 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.662 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.85 -6.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -163.74 138.57 6.08 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.431 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.304 1.049 . . . . 0.0 110.203 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -116.96 153.89 31.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.15 157.29 9.35 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.782 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.58 146.2 22.09 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.119 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.94 139.24 42.86 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.714 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.65 131.68 47.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.9 65.64 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.9 136.48 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.19 127.44 37.67 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.714 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -127.07 143.54 51.25 Favored 'General case' 0 CA--C 1.588 2.406 0 CA-C-O 123.418 1.58 . . . . 0.0 115.07 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.19 -1.569 . . . . 0.0 106.866 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -77.99 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-O 122.354 1.073 . . . . 0.0 111.654 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.661 3.6 mm? -52.34 -44.21 65.05 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.233 -1.803 . . . . 0.0 114.023 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.7 0.21 39.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.22 25.91 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.29 156.87 17.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.539 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.09 22.33 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.9 m -124.59 154.4 40.74 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.718 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.82 28.72 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.659 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.0 mt -138.07 143.45 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.88 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.194 -3.162 . . . . 0.0 105.194 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.58 -22.55 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.42 12.71 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.76 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.1 mt -119.97 128.67 53.79 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.78 118.61 57.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.53 52.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.978 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.55 127.55 54.62 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.947 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.27 123.1 48.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 124.669 1.231 . . . . 0.0 108.735 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.67 1.64 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.518 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.44 17.73 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.91 -1.744 . . . . 0.0 114.254 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.95 75.4 78.66 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.17 128.3 29.32 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.913 1.13 . . . . 0.0 111.386 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.92 149.62 45.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.6 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.56 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.013 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.74 113.85 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.87 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.64 157.25 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.37 41.09 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.48 20.01 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.314 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.9 158.74 42.59 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.53 119.0 25.05 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.88 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.599 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.6 119.69 33.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.732 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.21 10.76 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.679 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.79 124.82 29.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.887 1.367 . . . . 0.0 111.992 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.47 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.395 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.51 148.78 49.66 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.75 52.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.02 130.45 39.45 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.922 -1.49 . . . . 0.0 114.269 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.691 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.992 0.807 . . . . 0.0 112.288 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.51 -32.64 63.07 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.729 0.776 . . . . 0.0 112.699 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.37 -10.55 4.94 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.5 28.63 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.076 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 142.98 57.99 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.711 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.33 15.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.39 112.47 24.92 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.28 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.51 138.16 49.69 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.733 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.26 9.64 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.701 1.251 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.42 138.73 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.246 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 29.0 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.007 1.861 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.3 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.304 13.4 pt -90.94 14.17 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.672 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.415 23.5 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.88 30.38 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.052 1.362 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.84 66.6 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -177.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.89 -33.47 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.295 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.688 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.2 61.92 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.03 65.46 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.38 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.982 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.55 14.86 Favored 'General case' 0 N--CA 1.394 -3.257 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.847 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.758 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.61 4.31 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.22 167.0 17.47 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.85 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.32 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.27 158.36 38.37 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.69 16.43 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.104 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.37 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.2 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -120.08 126.59 51.12 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.314 1.054 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.4 m -116.96 153.93 31.76 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.6 146.29 22.13 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.109 178.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.19 42.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.29 160.53 40.85 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.91 132.98 56.35 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.61 131.7 46.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.36 128.38 56.28 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.644 1.688 . . . . 0.0 110.517 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.78 136.44 56.22 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.735 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -127.03 143.51 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.108 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.677 3.6 mm? -52.32 -44.27 65.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.024 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -81.71 0.28 39.59 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.34 12.71 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -109.22 123.11 48.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.741 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.41 17.7 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.873 -1.767 . . . . 0.0 114.272 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.357 11.3 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -138.8 149.62 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.8 113.88 18.51 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.95 115.94 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.54 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.96 158.8 42.62 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.61 118.98 24.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.94 123.23 49.74 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.681 -0.637 . . . . 0.0 109.722 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.6 mt -113.65 122.85 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.617 -179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.13 10.48 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.8 124.83 29.39 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.85 49.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.19 146.83 52.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.17 130.43 39.15 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.289 -178.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.49 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.01 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.257 1.598 . . . . 0.0 109.719 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-N 118.701 1.251 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp -48.66 125.25 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.728 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -78.07 -35.53 49.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.11 82.58 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.4 ' CE2' HG21 ' A' ' 119' ' ' ILE . 27.7 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.404 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.07 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.346 10.1 pt -90.89 14.08 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.117 -1.833 . . . . 0.0 111.691 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.418 23.8 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.89 30.37 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.073 1.374 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.72 -47.68 67.16 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -177.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.52 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.21 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.65 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.18 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.03 65.52 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.868 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.77 -10.27 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.66 18.26 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.3 158.55 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-O 122.616 1.198 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.25 138.52 38.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.75 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.93 143.46 50.74 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.894 0.746 . . . . 0.0 111.923 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.019 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.95 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.881 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.23 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.77 18.95 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.343 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.96 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -163.74 138.6 6.1 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.403 -1.319 . . . . 0.0 114.395 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.55 51.0 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -116.92 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.31 9.24 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.801 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.17 42.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.61 40.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.37 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.05 143.48 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.663 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.963 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.59 34.88 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.48 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.55 150.46 22.21 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.108 1.363 . . . . 0.0 111.203 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.95 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.46 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.224 2.74 . . . . 0.0 119.224 -178.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.83 16.41 12.65 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -120.0 128.63 53.73 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.77 118.6 57.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.26 123.07 48.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.777 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.93 75.31 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.19 128.21 29.0 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.85 149.68 45.17 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.902 178.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.2 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -124.81 113.94 18.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -177.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.59 118.94 24.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.577 1.18 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.8 mt -113.73 122.77 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.594 -179.228 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.8 33.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.728 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -133.1 130.39 39.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.349 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.71 133.5 56.16 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.732 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.254 -179.925 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.52 -32.6 63.06 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.674 0.75 . . . . 0.0 112.724 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.79 140.36 15.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.548 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.38 112.51 24.98 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.72 135.36 49.28 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.57 138.14 49.78 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.63 125.18 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.979 1.371 . . . . 0.0 112.569 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.38 138.66 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.15 28.79 9.45 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 178.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.23 -39.07 82.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.431 1.11 . . . . 0.0 108.147 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.81 -40.72 93.8 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.68 97.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.6 -47.82 66.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.95 -33.44 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.64 75.11 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.696 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.15 70.6 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.225 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.2 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.8 -10.32 58.15 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.34 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.28 158.06 32.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.415 2.743 . . . . 0.0 116.172 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.54 14.86 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.875 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.25 138.49 38.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.788 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.055 179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.96 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.273 178.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.37 38.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -141.49 124.69 16.42 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.92 139.36 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -137.51 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.72 76.29 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.689 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.3 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.31 9.35 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.685 -1.206 . . . . 0.0 109.763 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.717 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.32 160.53 40.82 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -55.65 131.73 47.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.65 -1.9 65.33 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.41 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.657 1.694 . . . . 0.0 110.497 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.5 56.25 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -136.98 169.18 18.22 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.41 37.65 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.744 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.09 143.49 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.074 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.866 177.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -78.0 168.32 20.08 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.59 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.27 -44.33 64.88 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.992 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.12 26.12 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.24 156.86 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.57 178.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -124.57 154.41 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.95 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.669 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.9 50.38 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.84 16.36 12.64 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.79 52.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -119.97 128.66 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.85 126.52 52.55 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.949 -177.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.57 127.56 54.62 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.907 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -109.31 123.07 48.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.702 179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.61 45.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.902 178.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.58 122.37 69.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.076 0.941 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.22 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.4 20.05 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.5 m -110.85 123.19 49.62 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.709 -0.619 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.73 33.77 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.732 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.53 -117.21 10.72 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 117.528 -2.272 . . . . 0.0 109.676 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.76 124.78 29.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.885 1.366 . . . . 0.0 111.992 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.44 127.41 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.4 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.47 148.84 49.61 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.2 146.78 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -133.08 130.44 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.91 119.32 61.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.267 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.6 4.99 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.4 2.5 28.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.071 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 142.98 58.01 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.736 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.46 24.87 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.245 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.684 1.24 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.109 0.881 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -64.18 -45.14 89.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.051 1.881 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.402 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.9 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.694 -179.06 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.8 66.83 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.02 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.0 65.6 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.91 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.035 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.25 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.286 -2.688 . . . . 0.0 106.703 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.19 138.54 38.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.846 0.716 . . . . 0.0 111.964 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.22 167.04 17.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.76 18.93 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.347 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -141.44 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.163 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.87 139.41 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.09 126.55 51.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.318 1.056 . . . . 0.0 110.224 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.3 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.61 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.119 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.16 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.99 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.119 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.665 3.6 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -81.74 0.28 39.73 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.5 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.2 123.09 48.66 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.798 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.41 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.67 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.8 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.81 113.9 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.94 115.93 31.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.1 t -127.57 118.98 24.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.15 10.54 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.82 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.79 119.28 61.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.327 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.58 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.02 57.96 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.93 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.8 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 118.736 1.268 . . . . 0.0 108.592 178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.592 1.663 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.42 -43.09 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.698 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.83 173.97 15.17 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.479 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.57 155.83 13.14 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.702 1.251 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.37 138.73 53.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.126 0.891 . . . . 0.0 110.198 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.79 9.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -78.09 -35.4 49.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.8 pt -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.684 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.23 56.09 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.413 23.6 t -71.43 131.62 34.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 119.994 1.897 . . . . 0.0 110.291 179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 161.91 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 122.99 1.328 . . . . 0.0 114.271 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.9 -49.16 73.79 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.426 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.06 70.98 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-O 121.425 0.631 . . . . 0.0 111.281 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.2 62.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.09 65.59 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.035 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.32 158.06 32.84 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.22 138.5 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.828 0.705 . . . . 0.0 111.948 179.609 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.019 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.24 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 178.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.65 48.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.829 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.21 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.048 -2.261 . . . . 0.0 113.808 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.25 166.98 17.55 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.78 19.0 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.347 178.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.43 124.64 16.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.142 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.39 52.18 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.83 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -120.09 126.51 50.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.351 1.072 . . . . 0.0 110.219 177.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.29 9.22 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.39 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.02 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.098 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.8 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.33 -44.25 65.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.81 0.41 39.46 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.26 26.07 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.29 156.86 17.2 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.614 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.2 117.63 34.96 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.6 154.39 40.74 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.409 1.693 . . . . 0.0 111.764 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.77 28.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.67 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.1 143.42 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.83 171.44 14.79 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.55 150.41 22.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.048 1.339 . . . . 0.0 111.184 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.64 -22.5 17.99 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.86 52.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.02 128.69 53.76 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.58 52.7 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.6 54.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.91 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.71 1.65 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.491 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.4 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.93 68.18 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.85 149.64 45.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.78 113.88 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.92 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -10.47 20.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.582 -2.447 . . . . 0.0 117.314 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.59 119.02 25.02 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.6 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 117.588 -2.244 . . . . 0.0 109.615 -177.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.63 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.69 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.06 133.72 52.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.715 179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.46 48.23 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.991 0.807 . . . . 0.0 112.265 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.319 1.533 . . . . 0.0 110.725 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.694 0.759 . . . . 0.0 112.724 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.57 4.95 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.197 1.561 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.84 68.7 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.82 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.661 1.23 . . . . 0.0 108.541 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.43 112.47 24.9 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.728 -1.578 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.7 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.77 174.0 15.16 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.43 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.39 1.09 . . . . 0.0 108.06 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.36 8.1 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.68 -42.59 97.43 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.98 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.327 11.1 pt -90.95 14.15 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.064 -1.854 . . . . 0.0 111.672 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.98 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.406 11.3 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.75 67.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.201 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.4 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.6 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.951 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.28 158.05 32.63 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.08 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 111.298 -2.683 . . . . 0.0 106.664 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -117.22 158.55 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.629 1.206 . . . . 0.0 111.193 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.31 6.69 48.34 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.3 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.95 134.6 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.22 158.38 38.28 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.87 1.319 . . . . 0.0 110.592 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -137.45 167.96 20.6 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -163.73 138.58 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.1 126.61 51.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.332 1.063 . . . . 0.0 110.181 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.4 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.32 9.41 Favored 'General case' 0 CA--C 1.449 -2.909 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.817 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.61 146.24 22.07 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.119 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.5 mt -55.72 131.71 47.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.39 56.27 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.44 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.735 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.071 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.666 3.6 mm? -52.34 -44.24 65.07 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 114.023 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.66 0.24 39.55 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.543 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.6 154.37 40.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.94 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.659 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.54 17.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.33 12.72 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.58 54.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.882 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.25 123.11 48.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.741 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.45 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.858 -1.776 . . . . 0.0 114.238 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -130.93 75.33 78.78 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.13 128.25 29.1 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.94 31.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.63 157.26 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.52 162.34 41.13 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.4 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.7 122.85 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.617 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.69 102.81 7.78 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.666 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.82 124.87 29.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.93 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.2 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 1.9 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.62 63.2 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.675 0.75 . . . . 0.0 112.668 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.54 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.97 68.55 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.561 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -107.74 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.82 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.63 138.15 49.84 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.722 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -48.6 125.21 9.49 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 123.025 1.393 . . . . 0.0 112.56 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.677 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.81 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.23 -39.1 82.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.431 1.11 . . . . 0.0 108.131 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.77 -40.76 93.74 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.19 -45.15 89.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.013 1.863 . . . . 0.0 109.364 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.619 0.0 OUTLIER -60.21 -41.38 92.89 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.9 179.386 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.65 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.96 82.09 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.5 pt -90.95 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 23.6 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 122.993 1.329 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.217 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 -34.68 75.22 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.654 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -63.87 -49.15 73.87 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.396 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.13 70.68 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.47 0.653 . . . . 0.0 111.288 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.25 61.84 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.8 -10.28 58.18 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.68 -10.75 47.36 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.3 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.56 14.82 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.0 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.07 117.2 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.025 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.23 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.84 -112.56 4.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.54 146.22 34.42 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.815 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.21 167.0 17.46 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.3 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.76 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.681 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.7 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.35 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.753 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.64 146.26 22.06 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.122 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.17 43.01 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.67 131.69 47.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.89 136.5 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.98 169.18 18.21 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.17 127.37 37.62 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.742 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.08 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.704 3.5 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.17 26.09 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 117.911 1.924 . . . . 0.0 117.911 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.23 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.601 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.08 22.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.6 34.9 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.54 154.45 40.57 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.721 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.669 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.94 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.5 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.89 126.62 52.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 123.917 1.817 . . . . 0.0 111.896 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.97 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.533 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.74 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.931 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.62 122.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 122.038 0.923 . . . . 0.0 109.962 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.59 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.5 t -127.6 119.0 24.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -102.96 121.12 53.74 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.508 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.86 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.373 0.606 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.8 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.22 10.78 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.03 -14.63 24.14 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.883 0.873 . . . . 0.0 112.123 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.87 124.88 29.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.714 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.48 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.4 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.82 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.903 0.859 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.327 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.55 4.92 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -3.0 68.51 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.657 1.228 . . . . 0.0 108.592 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.8 p -127.39 138.68 53.06 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.138 0.899 . . . . 0.0 110.22 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.0 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.591 0.0 OUTLIER -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.9 pt -90.9 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.144 -1.822 . . . . 0.0 111.634 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.426 38.4 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 57.1 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.12 70.73 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.25 61.74 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.35 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.95 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 158.06 33.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.321 2.681 . . . . 0.0 116.216 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -117.28 158.59 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.709 1.255 . . . . 0.0 111.172 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.57 4.3 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.67 48.39 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.79 19.01 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -141.45 124.59 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.41 52.18 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 m -116.88 153.93 31.67 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.996 0.903 . . . . 0.0 109.037 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.66 131.64 47.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.649 3.2 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.76 0.31 39.69 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.434 1.709 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.12 143.43 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.83 171.51 14.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.04 128.63 53.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.6 t -109.81 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.25 16.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.96 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.96 31.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.1 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.96 121.17 53.8 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.91 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.688 -0.632 . . . . 0.0 109.738 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 4.0 mp -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.45 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.384 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.11 130.39 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.24 61.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.344 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.11 133.68 52.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.743 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.67 -32.54 63.33 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.61 0.719 . . . . 0.0 112.658 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.05 57.96 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.19 -2.9 68.34 Favored Glycine 0 C--O 1.195 -2.318 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.76 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.698 1.249 . . . . 0.0 108.597 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.77 135.42 49.21 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.844 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -48.59 125.21 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.591 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.17 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.91 15.3 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -165.58 155.86 13.16 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.635 1.209 . . . . 0.0 111.782 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.77 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -78.11 -35.45 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.21 -39.11 82.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.78 -40.8 93.93 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG21 ' A' ' 119' ' ' ILE . 23.7 t80 -64.23 -45.11 89.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 124.0 1.857 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.4 ptm -60.15 -41.46 92.83 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.953 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.293 14.0 pt -90.92 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.32 55.91 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.384 3.714 . . . . 0.0 122.384 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.407 21.9 t -71.46 131.61 34.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 CA-C-N 120.001 1.9 . . . . 0.0 110.316 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.96 30.25 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.92 -33.47 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.72 -10.33 58.21 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.828 0.851 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.86 47.27 Favored 'General case' 0 N--CA 1.419 -2.021 0 C-N-CA 117.478 -1.689 . . . . 0.0 109.365 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.71 80.48 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.004 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.25 158.01 32.71 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.208 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.98 126.24 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.63 1.205 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.87 143.44 50.73 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.919 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.13 117.19 41.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.055 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.19 110.17 0.51 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.87 -112.55 4.29 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.39 6.72 48.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.2 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.086 -2.246 . . . . 0.0 113.834 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.22 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.94 138.77 18.92 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.3 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.3 38.51 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.862 1.315 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.63 16.38 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.164 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.39 52.15 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.71 76.27 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.85 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.446 -1.302 . . . . 0.0 114.386 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.51 50.84 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.337 1.065 . . . . 0.0 110.164 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 m -116.91 153.94 31.69 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.986 0.898 . . . . 0.0 109.046 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.31 9.29 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.91 65.6 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.786 1.075 . . . . 0.0 115.786 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.88 136.48 56.2 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.474 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.24 127.38 37.7 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.713 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.97 143.53 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.2 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.654 3.4 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.69 0.24 39.66 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.06 26.38 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.949 1.94 . . . . 0.0 117.949 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.22 156.9 17.16 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.85 171.95 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.26 117.58 34.83 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -124.58 154.42 40.67 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.453 1.72 . . . . 0.0 111.754 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.85 171.44 14.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.6 150.42 22.27 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.01 1.324 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.17 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -120.02 128.7 53.77 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.8 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -117.82 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.59 54.64 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.918 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.533 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.42 17.69 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.939 -1.725 . . . . 0.0 114.219 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.3 p-10 -64.53 -25.96 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.97 75.34 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.384 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.6 m -138.89 149.66 45.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.14 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.856 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.6 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.064 0.935 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.58 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.009 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -124.76 113.86 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.42 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -153.0 158.75 42.5 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.55 119.0 25.04 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 mt -103.0 121.12 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.526 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -110.85 123.3 49.83 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.434 HG21 ' CE2' ' A' ' 20' ' ' TYR . 3.5 mp -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.767 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.3 tp -124.66 102.84 7.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.09 -14.56 24.13 Favored 'General case' 0 CA--C 1.47 -2.129 0 C-N-CA 123.883 0.873 . . . . 0.0 112.126 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.9 124.81 29.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.83 1.331 . . . . 0.0 111.931 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.7 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.27 61.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.14 133.69 52.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.715 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.33 132.57 48.23 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.005 0.816 . . . . 0.0 112.229 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.228 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.69 63.17 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.35 -10.59 4.96 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.95 57.9 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.736 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 -3.0 68.57 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.609 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.275 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.742 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.82 13.11 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 124.686 1.241 . . . . 0.0 111.766 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.03 -35.53 49.67 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.0 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.405 1.5 ptm -60.24 -41.36 92.98 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.32 11.9 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.411 21.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.029 1.349 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.18 62.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.46 -28.97 65.64 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.931 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.4 pt -117.28 158.54 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.58 14.92 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.872 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.49 38.23 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.85 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.845 0.716 . . . . 0.0 111.924 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.89 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.24 34.31 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.09 -2.244 . . . . 0.0 113.757 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.64 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.45 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.0 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.76 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.33 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.1 127.35 37.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.58 37.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.09 -1.631 . . . . 0.0 106.963 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.614 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.76 0.34 39.57 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.87 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.11 117.53 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.53 154.48 40.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.423 1.702 . . . . 0.0 111.732 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.49 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.61 150.47 22.22 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 125.035 1.334 . . . . 0.0 111.181 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.65 -22.45 18.01 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.211 2.735 . . . . 0.0 119.211 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.56 73.22 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -10.38 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.28 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.7 t -127.54 118.95 24.94 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.3 48.31 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 111.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.6 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.773 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.072 0.857 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.61 -32.56 63.22 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.669 0.747 . . . . 0.0 112.706 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.73 135.42 49.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.64 138.18 49.81 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 123.005 1.383 . . . . 0.0 112.584 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.1 28.78 9.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.19 -39.13 82.56 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.8 -40.75 93.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.6 t80 -64.19 -45.15 89.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.013 1.863 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 10.3 ttm -60.14 -41.48 92.78 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.916 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.99 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.355 9.3 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.401 3.72 . . . . 0.0 122.401 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.465 14.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.95 -33.44 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.24 -34.66 75.15 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 63.9 mtm-85 -63.81 -49.22 73.74 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.15 70.57 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.464 0.649 . . . . 0.0 111.258 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.41 -28.98 65.54 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.361 0.978 . . . . 0.0 113.864 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.79 -10.32 58.17 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.426 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.7 152.58 18.33 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.8 80.32 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.33 158.07 32.8 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.365 2.71 . . . . 0.0 116.153 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.609 1.195 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.55 14.81 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.055 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.8 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.78 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -163.68 138.66 6.18 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.433 -1.307 . . . . 0.0 114.426 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.98 139.21 42.95 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.663 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.7 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.61 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.36 128.47 56.3 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.85 136.48 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.2 18.17 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.482 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.16 127.36 37.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.763 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -127.05 143.49 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.2 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.19 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.606 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.7 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.669 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.84 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.09 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.51 -22.54 18.23 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.04 128.64 53.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -117.85 126.61 52.73 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.59 54.59 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.878 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.42 17.72 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.916 -1.74 . . . . 0.0 114.268 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.349 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -138.85 149.62 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.58 122.39 69.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.038 0.923 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.26 135.6 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.01 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.78 113.86 18.49 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.6 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.96 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.7 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.0 121.09 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.489 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.0 m -110.85 123.25 49.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.625 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.767 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.67 102.82 7.78 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.87 124.86 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.885 1.366 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.43 127.43 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.433 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -133.09 130.4 39.26 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.28 61.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.349 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.988 0.805 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.66 63.02 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.55 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.5 28.62 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.996 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.623 1.211 . . . . 0.0 108.561 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.59 125.22 9.5 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.93 1.347 . . . . 0.0 112.62 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.703 1.252 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.85 9.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.16 -35.45 48.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.08 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.0 108.106 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.8 -40.74 93.78 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 9.2 ttm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.67 97.45 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.0 82.13 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.351 9.6 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.448 13.2 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.018 1.344 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.91 -33.53 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.215 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.68 75.34 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.654 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.47 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.403 0.62 . . . . 0.0 111.281 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.27 61.75 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.01 65.35 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.79 -10.29 58.19 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.6 -10.79 47.48 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.356 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.8 mt -95.64 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.79 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.975 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.894 0.746 . . . . 0.0 111.976 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.023 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.87 138.79 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.345 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.97 134.63 55.19 Favored 'General case' 0 C--O 1.279 2.648 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.28 158.34 38.43 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.553 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.7 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.7 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.32 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.782 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.98 139.17 43.0 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.38 37.59 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.07 143.48 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.107 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.18 120.62 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.924 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.685 3.9 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.69 0.24 39.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.26 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.08 22.32 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.45 40.61 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.93 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.53 54.55 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.907 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.22 123.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -89.96 -166.76 1.67 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.78 62.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.902 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.076 0.941 . . . . 0.0 109.942 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.89 31.06 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.64 157.27 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.522 1.63 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.19 10.68 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.84 124.79 29.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.977 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.39 127.47 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.419 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.8 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.26 146.78 52.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.305 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.68 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.55 4.96 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.99 57.89 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.704 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.691 1.246 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.1 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.11 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.689 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.83 173.96 15.19 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.509 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.56 155.85 13.19 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 124.703 1.252 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -78.06 -35.49 49.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.71 -40.8 93.61 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.8 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.393 1.2 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 9.4 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.99 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.429 24.3 t -71.47 131.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 CA-C-N 120.01 1.905 . . . . 0.0 110.291 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.32 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.019 1.344 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.24 62.0 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.03 65.47 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.413 1.007 . . . . 0.0 113.939 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.28 158.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.65 146.59 14.96 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.902 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.53 38.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.9 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.863 0.727 . . . . 0.0 111.907 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.89 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.21 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.62 48.53 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.57 146.24 34.33 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.081 -2.248 . . . . 0.0 113.757 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.3 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -163.73 138.6 6.1 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 118.463 -1.295 . . . . 0.0 114.371 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.51 50.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.323 1.059 . . . . 0.0 110.225 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.29 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.57 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.089 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.0 139.21 42.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.734 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -1.88 65.63 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.3 128.46 56.28 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.91 136.47 56.16 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.12 18.31 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.515 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.15 127.39 37.61 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.745 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.25 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.17 120.61 37.84 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.945 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.671 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.79 0.39 39.45 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.22 26.17 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.3 156.84 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.609 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.03 22.24 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.9 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.19 117.56 34.82 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.4 m -124.52 154.45 40.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.439 1.712 . . . . 0.0 111.736 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.44 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.47 22.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.998 1.319 . . . . 0.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.67 -22.44 17.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.85 16.49 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.79 126.61 52.74 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.56 127.57 54.63 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.916 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.6 -25.96 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.57 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -10.41 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.289 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.57 118.99 24.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.02 121.19 53.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.504 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.3 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.09 133.74 52.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.737 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.53 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.089 0.868 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.6 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.58 63.29 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.615 0.722 . . . . 0.0 112.62 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.6 5.07 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.43 28.83 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -107.76 135.4 49.25 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.839 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -48.65 125.21 9.56 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.576 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.0 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.617 1.198 . . . . 0.0 111.74 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.08 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.24 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.83 9.3 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.25 -39.08 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.348 1.07 . . . . 0.0 108.123 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.8 -40.74 93.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.1 t80 -64.2 -45.15 89.58 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 124.03 1.871 . . . . 0.0 109.335 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.4 ptm -60.19 -41.4 92.85 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.885 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.64 -42.68 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.02 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.89 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.713 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.29 55.94 Favored Glycine 0 C--O 1.213 -1.16 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.425 23.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.9 30.4 Favored Glycine 0 CA--C 1.49 -1.493 0 CA-C-O 123.003 1.335 . . . . 0.0 114.299 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.65 75.27 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.22 61.94 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -28.94 65.52 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.82 -10.29 58.16 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.355 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.65 152.61 18.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.69 80.43 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.615 -2.084 . . . . 0.0 111.004 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.34 158.06 32.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.403 2.735 . . . . 0.0 116.157 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 CA-C-O 122.675 1.226 . . . . 0.0 111.182 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.16 138.5 38.11 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.797 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.857 0.723 . . . . 0.0 111.976 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.09 117.15 41.15 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.05 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.6 4.31 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.74 48.2 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.25 34.32 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.751 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.21 167.04 17.4 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.99 138.77 18.88 Favored 'General case' 0 C--N 1.263 -3.153 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.3 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -137.52 167.88 20.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.77 76.38 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.703 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.64 146.17 21.97 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.18 42.97 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.6 40.91 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.66 131.69 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.47 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.98 169.14 18.28 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.512 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.713 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.04 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.085 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.61 37.81 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.945 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.616 3.6 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.71 0.29 39.53 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.48 40.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.732 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.5 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.42 22.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.13 89.08 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.54 177.93 50.46 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.55 -22.52 18.16 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.0 128.62 53.71 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.8 118.69 57.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -117.84 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.914 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.883 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.02 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.791 -1.564 . . . . 0.0 108.492 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.45 17.72 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.991 -1.693 . . . . 0.0 114.239 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.53 -25.92 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.384 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.88 149.63 45.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.75 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.88 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.8 mt -115.65 122.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.053 0.93 . . . . 0.0 109.966 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.012 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.54 73.2 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.98 158.74 42.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.2 t -127.56 118.95 24.93 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.3 mt -102.95 121.09 53.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.497 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.79 123.23 49.67 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.69 -0.631 . . . . 0.0 109.804 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.79 68.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.66 102.79 7.77 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.22 10.8 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.04 -14.67 24.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.906 0.882 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.77 29.35 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.785 1.303 . . . . 0.0 111.983 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.45 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.42 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.48 148.8 49.63 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.327 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.283 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.57 56.23 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.196 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.64 63.12 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.671 0.748 . . . . 0.0 112.699 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.56 4.99 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 142.99 58.01 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.704 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.84 69.11 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.84 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.664 1.232 . . . . 0.0 108.524 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.46 24.88 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.602 1.668 . . . . 0.0 110.303 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.661 -1.609 . . . . 0.0 106.784 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.15 3.56 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.7 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.8 173.96 15.2 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.46 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.85 13.03 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.633 1.208 . . . . 0.0 111.728 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.11 28.8 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -78.09 -35.49 49.3 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.15 82.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.77 93.64 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.8 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.051 1.881 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.5 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.96 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.315 12.4 pt -90.93 14.18 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -2.007 0 C-N-CA 117.09 -1.844 . . . . 0.0 111.688 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.417 21.9 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.57 74.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.83 47.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -95.61 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.39 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.982 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.223 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -119.99 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.317 -2.674 . . . . 0.0 106.703 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 pt -117.25 158.59 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.702 1.251 . . . . 0.0 111.207 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.404 0.621 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.56 4.3 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.66 48.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.89 138.86 19.05 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.283 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.03 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.68 16.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.39 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -137.5 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.662 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -120.05 126.54 51.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.297 1.046 . . . . 0.0 110.205 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.29 9.33 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.782 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.6 40.93 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.96 132.98 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.63 131.68 47.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.43 56.28 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.86 136.45 56.17 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.45 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -127.07 143.56 51.25 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.05 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.617 3.5 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.75 0.26 39.88 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.21 25.97 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.909 1.924 . . . . 0.0 117.909 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.543 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.96 110.06 22.3 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.87 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.18 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -124.6 154.41 40.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.72 28.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.695 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -137.98 143.49 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.22 89.15 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.94 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.194 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.63 -22.51 17.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.38 12.73 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.59 127.58 54.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.942 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.25 123.14 48.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.741 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.06 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.502 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.45 17.63 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.51 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -130.91 75.4 78.69 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.63 122.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.086 0.946 . . . . 0.0 109.905 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.5 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.015 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.87 31.02 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.54 157.23 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.57 73.25 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.58 1.657 . . . . 0.0 109.411 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.88 116.39 48.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.676 1.227 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 121.13 53.77 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.89 -1.131 . . . . 0.0 111.504 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.6 mp -113.71 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.644 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.69 33.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.794 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.45 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.42 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.79 49.67 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.269 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.692 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.26 132.46 48.19 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 123.969 0.793 . . . . 0.0 112.245 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.36 1.552 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 143.05 57.94 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.181 1.55 . . . . 0.0 109.687 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.23 -2.95 68.35 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.78 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.609 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.75 135.42 49.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.784 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.265 1.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.0 tp -48.64 125.22 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.743 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.82 173.94 15.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.43 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.763 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.1 -35.49 49.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.72 93.47 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.5 t80 -64.23 -45.15 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.409 1.4 ptm -60.19 -41.45 92.97 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.935 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.61 97.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.01 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.33 11.2 pt -90.92 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.1 -1.84 . . . . 0.0 111.684 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.419 31.1 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.98 30.33 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.47 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.21 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.33 -34.54 74.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.645 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.83 -49.26 73.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.18 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.04 65.5 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.939 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.7 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -95.65 152.66 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.26 158.05 32.58 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.324 2.683 . . . . 0.0 116.263 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 111.358 -2.656 . . . . 0.0 106.733 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 41' ' ' ILE 0.284 12.2 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.62 1.2 . . . . 0.0 111.155 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.27 138.52 38.19 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.91 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.877 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.493 0.663 . . . . 0.0 111.102 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.3 6.65 48.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.58 146.27 34.3 Favored 'General case' 0 N--CA 1.403 -2.807 0 C-N-CA 116.036 -2.266 . . . . 0.0 113.79 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.75 18.93 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.327 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.95 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.7 76.27 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.84 -6.76 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.11 126.55 51.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.283 1.04 . . . . 0.0 110.216 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.17 157.29 9.32 Favored 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.841 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.57 146.24 22.13 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.086 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.65 40.94 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.63 131.63 46.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.86 65.86 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.18 127.37 37.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -126.97 143.52 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.12 120.59 37.77 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.115 -1.615 . . . . 0.0 106.905 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.5 p -78.01 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.631 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.648 3.4 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.13 26.24 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.25 156.9 17.17 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.62 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.87 171.92 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.21 117.61 34.92 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -124.58 154.39 40.72 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.464 1.727 . . . . 0.0 111.764 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.307 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.83 171.45 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.57 150.46 22.22 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.103 1.361 . . . . 0.0 111.169 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.13 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.94 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.194 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 -22.43 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.79 16.38 12.68 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -119.97 128.69 53.81 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.83 118.56 57.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.252 16.6 t-160 -117.76 126.58 52.71 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.816 1.77 . . . . 0.0 111.988 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.91 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -109.29 123.08 48.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.754 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.4 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.2 p-10 -64.54 -26.01 68.23 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -130.93 75.36 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 m -138.89 149.64 45.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.3 135.56 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.008 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -124.77 113.94 18.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.23 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.65 -10.43 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.256 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.5 t -127.57 118.98 24.96 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-O 122.557 1.17 . . . . 0.0 111.181 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.97 121.2 53.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.96 -1.088 . . . . 0.0 111.508 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.437 HG21 ' CE2' ' A' ' 20' ' ' TYR . 15.3 mt -113.69 122.79 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.67 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.75 33.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.735 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.6 148.8 49.73 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.77 52.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.805 0.812 . . . . 0.0 111.408 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.08 130.45 39.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.917 -1.492 . . . . 0.0 114.291 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.722 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.29 132.54 48.19 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.046 0.841 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.714 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.256 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.647 0.736 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.9 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.75 140.34 15.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.545 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.644 1.688 . . . . 0.0 110.282 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.74 135.45 49.13 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.784 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.68 138.15 49.91 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.23 3.55 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.678 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.95 15.24 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.8 9.41 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -78.13 -35.49 49.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.12 82.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.79 -40.78 93.9 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.2 t80 -64.21 -45.13 89.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.0 1.857 . . . . 0.0 109.349 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.15 -41.48 92.85 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.916 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.59 97.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.3 pt -90.92 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.982 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.28 55.94 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.379 3.712 . . . . 0.0 122.379 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.416 23.2 t -71.49 131.63 34.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.289 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.69 67.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.82 47.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.61 152.65 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.951 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.22 158.04 32.45 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.199 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.687 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -117.27 158.59 17.83 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 O-C-N 124.62 1.2 . . . . 0.0 111.191 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.51 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.43 6.73 48.21 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.57 55.22 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.4 p -128.22 158.34 38.37 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.7 t -141.5 124.64 16.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.91 139.43 52.13 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -137.54 167.9 20.73 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.15 126.51 50.89 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.269 1.033 . . . . 0.0 110.176 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.69 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.9 65.7 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.49 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.2 127.42 37.67 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.703 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.687 3.5 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.69 0.21 39.79 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.06 26.27 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.926 1.93 . . . . 0.0 117.926 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -101.17 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.237 -1.385 . . . . 0.0 110.606 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.18 117.55 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.42 40.68 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.75 28.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.659 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.98 143.48 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.87 171.47 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 54.9 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.61 54.65 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.918 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -109.31 123.14 48.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.708 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.07 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.533 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.42 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.941 -1.724 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.49 -25.97 68.23 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.93 149.62 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.59 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.33 135.53 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 117.893 -1.523 . . . . 0.0 108.964 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.78 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.27 16.79 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.53 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.34 48.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.1 m -110.88 123.3 49.85 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.414 HG21 ' CE2' ' A' ' 20' ' ' TYR . 11.8 mt -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.53 119.73 33.79 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -124.62 102.84 7.81 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.88 124.81 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.77 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.691 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.55 48.15 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.984 0.802 . . . . 0.0 112.264 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.8 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.62 -32.58 63.24 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.687 0.756 . . . . 0.0 112.698 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.99 57.93 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.735 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.73 140.37 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.563 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.682 1.706 . . . . 0.0 110.255 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.72 135.39 49.23 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.664 -1.607 . . . . 0.0 106.804 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.65 138.15 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 173.97 15.22 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.505 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -165.63 155.82 13.0 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.78 9.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.1 -35.55 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.15 -39.11 82.74 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.82 -40.75 93.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.5 t80 -64.17 -45.17 89.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 123.987 1.851 . . . . 0.0 109.354 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 8.3 ttm -60.12 -41.46 92.66 Favored 'General case' 0 N--CA 1.41 -2.433 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.95 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.04 82.1 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.299 13.2 pt -90.91 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.974 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.707 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.27 55.99 Favored Glycine 0 C--O 1.214 -1.124 0 N-CA-C 122.411 3.724 . . . . 0.0 122.411 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.434 12.2 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.72 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.08 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.2 mtm-85 -63.8 -49.26 73.58 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.07 65.61 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.346 0.97 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.4 mt -83.73 -10.27 58.25 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.771 0.828 . . . . 0.0 109.433 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt -95.64 152.6 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.71 80.4 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.95 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.23 158.03 32.51 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.333 2.689 . . . . 0.0 116.238 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.748 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.7 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.628 1.204 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.56 14.9 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.92 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.25 138.52 38.16 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.761 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.9 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.945 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.17 117.23 41.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.961 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.91 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.66 48.41 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.2 158.31 38.46 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.803 1.287 . . . . 0.0 110.627 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.5 t -141.49 124.68 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.87 139.44 52.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.7 p -137.51 167.86 20.79 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.24 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.88 -6.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.936 1.397 . . . . 0.0 111.055 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.2 m -107.92 139.22 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.745 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.34 160.62 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.99 133.05 56.29 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.61 131.67 46.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -1.9 65.93 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 115.708 1.043 . . . . 0.0 115.708 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.82 136.45 56.2 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.17 18.22 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.735 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.16 120.63 37.86 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.888 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -77.97 168.43 19.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.637 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.625 4.1 mm? -52.45 -44.2 65.37 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.153 -1.839 . . . . 0.0 113.963 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.4 m -117.92 171.91 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.9 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.61 154.44 40.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.659 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.03 143.4 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.7 p -145.81 171.5 14.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.62 150.43 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.087 1.355 . . . . 0.0 111.189 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.6 177.89 50.4 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 115.635 -3.174 . . . . 0.0 105.183 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.57 -22.47 18.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.265 2.756 . . . . 0.0 119.265 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.81 16.42 12.67 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.03 128.68 53.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -117.85 126.56 52.62 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 123.81 1.767 . . . . 0.0 111.947 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.91 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.31 123.13 48.78 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.719 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.706 -1.598 . . . . 0.0 108.549 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.38 17.71 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.9 -1.75 . . . . 0.0 114.235 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.36 11.3 p-10 -64.59 -25.95 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.93 149.64 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.77 62.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.2 mt -115.62 122.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.59 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 108.988 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -124.8 113.9 18.54 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.94 31.15 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.69 157.21 16.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.33 41.13 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -32.47 73.16 Favored 'General case' 0 N--CA 1.41 -2.443 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.47 19.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 115.503 -2.479 . . . . 0.0 117.274 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.9 158.76 42.61 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.497 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.73 122.84 68.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.625 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.68 33.65 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.8 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.61 102.79 7.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.14 10.53 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.666 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.12 -14.6 24.05 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.871 0.868 . . . . 0.0 112.085 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.83 29.42 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.832 1.332 . . . . 0.0 111.906 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.8 t -120.43 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.436 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.57 148.77 49.71 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.76 52.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -133.08 130.46 39.37 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.291 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.13 133.66 52.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.721 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.13 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.984 0.802 . . . . 0.0 112.283 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.54 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.371 1.558 . . . . 0.0 110.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 -179.923 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.52 28.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.77 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.541 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.51 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.56 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.01 15.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.64 155.83 12.99 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.598 1.187 . . . . 0.0 111.759 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.2 -39.18 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.72 -40.76 93.52 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.9 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.349 8.4 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.93 81.85 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.99 14.13 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.149 -1.821 . . . . 0.0 111.66 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.95 23.26 56.01 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.442 12.5 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -73.0 -33.44 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.235 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.89 -49.15 73.81 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.48 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.205 -1.668 0 CA-C-O 122.427 1.015 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.75 47.49 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.67 152.62 18.29 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.25 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.279 14.5 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.666 1.229 . . . . 0.0 111.208 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.56 14.88 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.859 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.758 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.506 0.669 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.29 6.65 48.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.61 55.19 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.37 38.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.876 1.322 . . . . 0.0 110.565 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -163.73 138.62 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.34 9.44 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.788 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 132.97 56.35 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.63 131.72 47.13 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.648 1.69 . . . . 0.0 110.499 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.18 127.4 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.764 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.05 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.508 1.623 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.105 -1.622 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.1 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -101.19 156.87 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.574 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.86 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.659 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.65 -22.46 17.99 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.153 2.713 . . . . 0.0 119.153 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.82 16.33 12.66 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.1 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.46 17.67 Favored Glycine 0 CA--C 1.491 -1.445 0 O-C-N 119.902 -1.749 . . . . 0.0 114.207 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.5 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.908 1.128 . . . . 0.0 111.429 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.8 149.65 45.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.21 119.7 62.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.891 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.55 122.36 69.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -124.74 113.87 18.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.52 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.9 123.23 49.73 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.436 0.636 . . . . 0.0 109.733 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.9 mp -113.65 122.81 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.644 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.17 10.58 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.84 29.41 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.885 1.366 . . . . 0.0 111.915 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.4 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.54 48.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.973 0.796 . . . . 0.0 112.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.52 56.18 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.38 2.47 28.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.04 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.95 68.5 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.701 1.251 . . . . 0.0 108.565 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.52 24.95 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.59 125.27 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.621 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.41 138.73 53.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.079 0.862 . . . . 0.0 110.198 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -78.1 -35.47 49.26 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.18 -39.11 82.62 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.35 1.071 . . . . 0.0 108.111 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.7 ttm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.329 11.0 pt -90.87 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.438 11.7 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.69 67.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.5 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.269 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.223 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.16 -46.2 61.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.04 65.72 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.85 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.34 158.55 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.636 1.21 . . . . 0.0 111.158 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.27 138.48 38.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.94 -163.84 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.493 0.663 . . . . 0.0 111.124 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.62 48.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.51 146.21 34.49 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.115 -2.234 . . . . 0.0 113.808 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.5 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.0 p -137.47 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -163.7 138.62 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.7 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.01 143.52 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.705 4.0 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.77 28.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.06 143.4 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.8 171.51 14.68 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.87 52.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.06 128.72 53.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.524 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 12.0 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.92 75.32 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.15 128.23 29.01 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.913 1.13 . . . . 0.0 111.368 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.4 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.82 113.93 18.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.47 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.99 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.57 118.95 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.898 -1.127 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.78 122.82 68.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.575 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.72 33.78 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.758 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -133.1 130.39 39.21 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.254 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.33 -10.56 4.89 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -2.96 68.7 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.636 1.218 . . . . 0.0 108.561 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.0 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.104 0.878 . . . . 0.0 110.24 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.9 ttm -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.345 9.9 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.441 12.0 t -71.44 131.61 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.295 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.87 30.45 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.11 70.76 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.22 61.82 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.37 158.06 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.177 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.22 158.59 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.19 138.51 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.68 48.35 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.62 16.41 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.37 52.19 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -116.91 153.95 31.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.016 0.913 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.686 4.1 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.72 0.26 39.72 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.606 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.476 1.735 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.08 143.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.64 127.53 54.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.907 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.22 123.01 48.55 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 124.629 1.206 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.92 -166.7 1.65 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.783 -1.567 . . . . 0.0 108.531 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.52 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.648 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.4 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.28 61.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.314 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.956 -1.929 . . . . 0.0 111.743 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.59 63.3 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.68 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.4 2.45 28.71 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.073 -0.651 . . . . 0.0 112.042 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.72 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.59 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.44 112.47 24.9 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 123.597 1.665 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.844 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.57 138.17 49.74 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.524 0.678 . . . . 0.0 109.659 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.56 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -159.73 174.0 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.46 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.62 155.84 13.05 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.633 1.208 . . . . 0.0 111.709 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.77 9.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.381 1.086 . . . . 0.0 108.077 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.77 -40.73 93.63 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -64.17 -45.12 89.82 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 124.009 1.862 . . . . 0.0 109.406 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.359 8.3 ttm -60.18 -41.46 92.95 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.901 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.6 -42.65 97.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.318 11.5 pt -90.95 14.13 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.66 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.25 56.05 Favored Glycine 0 C--O 1.214 -1.108 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.409 10.8 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.95 30.16 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-O 123.037 1.354 . . . . 0.0 114.287 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.79 67.01 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.57 75.01 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.5 mtm-85 -63.89 -49.16 73.78 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.76 -10.29 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.6 mt -95.65 152.63 18.28 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.74 80.35 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.981 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.3 158.0 33.01 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.21 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.98 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.755 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.2 158.55 17.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.693 1.245 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.818 0.698 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.464 0.65 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.95 -112.65 4.33 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.69 48.33 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.64 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.23 158.33 38.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.849 1.309 . . . . 0.0 110.578 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.52 124.68 16.39 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.109 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.45 52.15 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.6 p -137.5 167.87 20.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.0 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.12 157.37 9.48 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.764 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.66 146.24 22.01 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.9 1.375 . . . . 0.0 111.055 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -108.01 139.18 43.04 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.664 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.59 40.93 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.99 132.97 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.6 131.74 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.91 65.36 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.99 169.16 18.24 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.735 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.63 37.91 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.125 -1.609 . . . . 0.0 106.87 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.96 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.679 3.7 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -81.72 0.33 39.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.85 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.0 144.78 28.77 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.72 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.37 22.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.17 89.16 2.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.103 -3.199 . . . . 0.0 105.103 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.5 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.8 16.33 12.67 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.82 52.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -119.96 128.65 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.58 -162.45 17.71 Favored Glycine 0 CA--C 1.49 -1.505 0 O-C-N 119.9 -1.75 . . . . 0.0 114.223 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 12.0 p-10 -64.54 -25.99 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.14 128.19 28.86 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.841 1.1 . . . . 0.0 111.416 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.6 45.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.77 62.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.88 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.62 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.964 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.76 113.87 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.63 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.587 1.661 . . . . 0.0 109.447 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.88 123.27 49.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.369 0.605 . . . . 0.0 109.774 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.68 122.81 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.644 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.1 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.548 -2.263 . . . . 0.0 109.666 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.61 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.906 0.882 . . . . 0.0 112.112 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.83 124.82 29.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 124.83 1.331 . . . . 0.0 111.906 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.2 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.4 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.7 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.79 52.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -133.12 130.44 39.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.88 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.311 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.54 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.283 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.79 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.199 -179.869 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.6 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.59 63.18 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.39 2.51 28.78 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.033 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.4 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.38 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.663 1.232 . . . . 0.0 108.58 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.224 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -48.64 125.27 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.686 1.241 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.42 138.71 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.147 0.904 . . . . 0.0 110.181 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -78.07 -35.46 49.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.26 -39.05 82.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.357 1.075 . . . . 0.0 108.122 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.389 1.6 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.264 13.1 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.365 17.7 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.89 -33.54 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.233 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.696 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -63.85 -49.19 73.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.419 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.14 70.65 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.23 61.95 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.02 65.55 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.91 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.73 -10.29 58.24 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.73 47.58 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 117.426 -1.71 . . . . 0.0 109.395 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.187 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 41' ' ' ILE 0.289 13.8 pt -117.34 158.56 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.146 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.57 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.23 138.52 38.14 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.75 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.894 0.746 . . . . 0.0 111.948 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 m -97.08 117.15 41.14 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.053 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.568 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.45 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.163 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.8 p -137.47 167.98 20.56 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.655 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.062 0.934 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.16 43.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.717 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.29 160.56 40.88 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.64 46.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -127.03 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.117 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.11 120.61 37.79 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.954 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.4 p -78.0 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.388 1.09 . . . . 0.0 111.59 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.532 3.7 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.21 25.97 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -124.57 154.45 40.63 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.743 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.02 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.656 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.12 143.41 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.51 14.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.18 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.629 -3.177 . . . . 0.0 105.174 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.03 128.72 53.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.57 54.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.876 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.363 11.3 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.4 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.8 mt -115.61 122.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.55 162.32 41.17 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.4 20.02 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.513 -2.475 . . . . 0.0 117.247 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -127.54 118.93 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 121.635 -0.665 . . . . 0.0 109.747 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.77 122.83 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.565 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.2 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tt -80.82 124.78 29.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.865 1.353 . . . . 0.0 112.008 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.41 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.52 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.79 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -133.1 130.38 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.357 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -110.1 133.64 53.0 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.65 -32.57 63.31 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.65 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.98 57.93 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.767 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.97 68.46 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.5 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.197 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.267 1.989 0 CA-C-O 121.431 0.634 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.22 9.58 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.74 173.99 15.2 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.05 -35.54 49.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.18 -39.11 82.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.342 10.8 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.38 55.88 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.452 3.741 . . . . 0.0 122.452 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.991 1.895 . . . . 0.0 110.298 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.92 -33.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.704 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.15 62.11 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.01 65.78 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.342 0.968 . . . . 0.0 113.846 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.71 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.379 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.3 158.56 17.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.654 1.216 . . . . 0.0 111.119 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.67 146.54 14.89 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.936 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.23 138.48 38.2 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.761 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.09 117.16 41.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.053 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -137.52 167.87 20.78 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.72 76.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.77 -6.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -163.67 138.65 6.19 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.408 -1.317 . . . . 0.0 114.366 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.9 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.33 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.34 160.58 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.06 56.29 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.67 46.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.82 65.75 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.01 169.13 18.3 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.457 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.733 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.02 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.475 1.607 . . . . 0.0 115.085 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.65 37.86 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.936 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -78.03 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.603 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.659 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.14 26.22 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.954 1.941 . . . . 0.0 117.954 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.626 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.42 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.8 171.54 14.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.63 150.47 22.23 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.014 1.326 . . . . 0.0 111.181 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.85 118.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.62 54.61 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.771 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.914 -1.741 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.341 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.94 75.27 78.86 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.22 28.95 Favored 'Trans proline' 0 C--N 1.284 -2.829 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.73 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.053 0.93 . . . . 0.0 109.994 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.63 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 109.013 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.32 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.49 73.15 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 -10.39 19.99 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 115.532 -2.467 . . . . 0.0 117.247 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -152.99 158.73 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -127.52 118.93 24.92 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.89 123.27 49.81 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.591 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.76 33.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.741 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.7 102.74 7.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.511 -2.281 . . . . 0.0 109.687 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.78 29.39 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.42 127.51 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.379 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.75 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.09 130.44 39.3 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.349 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.018 0.824 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.254 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.7 p . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.652 0.739 . . . . 0.0 112.724 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.43 -10.49 4.96 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.179 1.549 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.8 140.41 15.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.623 1.211 . . . . 0.0 108.529 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.73 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.779 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.18 9.5 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.971 1.367 . . . . 0.0 112.63 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.095 0.872 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.77 9.48 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.1 -35.47 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.28 -39.03 82.25 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.396 1.094 . . . . 0.0 108.098 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.82 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.72 -42.56 97.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.99 82.17 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.34 10.8 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.091 -1.844 . . . . 0.0 111.702 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.33 55.88 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.1 t -71.5 131.64 34.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.264 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.96 30.36 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.79 66.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.91 -33.5 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.201 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.65 75.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.24 73.67 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.13 70.69 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.22 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.29 -29.08 65.38 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.429 1.016 . . . . 0.0 113.918 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.74 -10.32 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.786 0.834 . . . . 0.0 109.426 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.79 47.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.38 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.63 152.54 18.35 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.76 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.652 -2.067 . . . . 0.0 110.951 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.177 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.99 126.22 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.247 -2.706 . . . . 0.0 106.687 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.27 158.6 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.18 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.88 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.2 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.016 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.95 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.445 0.64 . . . . 0.0 111.119 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.52 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.69 48.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -128.25 167.05 17.43 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.273 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.03 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.727 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.38 38.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.855 1.312 . . . . 0.0 110.58 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.7 p -137.45 167.97 20.58 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.662 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.85 -6.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -163.74 138.57 6.08 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.431 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.304 1.049 . . . . 0.0 110.203 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -116.96 153.89 31.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.15 157.29 9.35 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.782 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.58 146.2 22.09 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.119 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.94 139.24 42.86 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.714 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.65 131.68 47.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.9 65.64 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.9 136.48 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.19 127.44 37.67 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.714 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -127.07 143.54 51.25 Favored 'General case' 0 CA--C 1.588 2.406 0 CA-C-O 123.418 1.58 . . . . 0.0 115.07 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.19 -1.569 . . . . 0.0 106.866 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -77.99 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-O 122.354 1.073 . . . . 0.0 111.654 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.661 3.6 mm? -52.34 -44.21 65.05 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.233 -1.803 . . . . 0.0 114.023 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.7 0.21 39.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.22 25.91 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.29 156.87 17.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.539 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.09 22.33 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.9 m -124.59 154.4 40.74 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.718 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.82 28.72 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.659 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.0 mt -138.07 143.45 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.88 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.194 -3.162 . . . . 0.0 105.194 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.58 -22.55 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.42 12.71 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.76 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.1 mt -119.97 128.67 53.79 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.78 118.61 57.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.53 52.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.978 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.55 127.55 54.62 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.947 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.27 123.1 48.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 124.669 1.231 . . . . 0.0 108.735 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.67 1.64 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.518 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.44 17.73 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.91 -1.744 . . . . 0.0 114.254 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.95 75.4 78.66 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.17 128.3 29.32 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.913 1.13 . . . . 0.0 111.386 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.92 149.62 45.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.6 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.56 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.013 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.74 113.85 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.87 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.64 157.25 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.37 41.09 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.48 20.01 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.314 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.9 158.74 42.59 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.53 119.0 25.05 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.88 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.599 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.6 119.69 33.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.732 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.21 10.76 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.679 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.79 124.82 29.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.887 1.367 . . . . 0.0 111.992 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.47 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.395 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.51 148.78 49.66 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.75 52.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.02 130.45 39.45 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.922 -1.49 . . . . 0.0 114.269 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.691 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.992 0.807 . . . . 0.0 112.288 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.51 -32.64 63.07 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.729 0.776 . . . . 0.0 112.699 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.37 -10.55 4.94 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.5 28.63 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.076 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 142.98 57.99 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.711 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.33 15.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.39 112.47 24.92 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.28 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.51 138.16 49.69 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.733 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.26 9.64 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.701 1.251 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.42 138.73 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.246 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 29.0 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.007 1.861 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.3 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.304 13.4 pt -90.94 14.17 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.672 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.415 23.5 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.88 30.38 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.052 1.362 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.84 66.6 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -177.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.89 -33.47 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.295 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.688 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.2 61.92 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.03 65.46 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.38 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.982 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.55 14.86 Favored 'General case' 0 N--CA 1.394 -3.257 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.847 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.758 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.61 4.31 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.22 167.0 17.47 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.85 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.32 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.27 158.36 38.37 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.69 16.43 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.104 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.37 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.2 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -120.08 126.59 51.12 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.314 1.054 . . . . 0.0 110.197 177.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.4 m -116.96 153.93 31.76 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.6 146.29 22.13 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.109 178.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.19 42.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.29 160.53 40.85 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.91 132.98 56.35 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.61 131.7 46.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.36 128.38 56.28 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.644 1.688 . . . . 0.0 110.517 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.78 136.44 56.22 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.735 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -127.03 143.51 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.108 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.677 3.6 mm? -52.32 -44.27 65.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.024 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -81.71 0.28 39.59 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.34 12.71 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -109.22 123.11 48.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.741 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.41 17.7 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.873 -1.767 . . . . 0.0 114.272 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.357 11.3 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -138.8 149.62 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.8 113.88 18.51 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.95 115.94 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.54 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.96 158.8 42.62 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.61 118.98 24.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.94 123.23 49.74 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.681 -0.637 . . . . 0.0 109.722 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.6 mt -113.65 122.85 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.617 -179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.13 10.48 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.8 124.83 29.39 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.85 49.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.19 146.83 52.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.17 130.43 39.15 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.289 -178.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.49 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.01 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.257 1.598 . . . . 0.0 109.719 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-N 118.701 1.251 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp -48.66 125.25 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.728 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -78.07 -35.53 49.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.11 82.58 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' CE2' HG21 ' A' ' 119' ' ' ILE . 27.7 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.404 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.07 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.346 10.1 pt -90.89 14.08 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.117 -1.833 . . . . 0.0 111.691 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.418 23.8 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.89 30.37 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.073 1.374 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.72 -47.68 67.16 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -177.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.52 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.21 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.65 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.18 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.03 65.52 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.868 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.77 -10.27 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.66 18.26 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.3 158.55 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-O 122.616 1.198 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.25 138.52 38.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.75 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.93 143.46 50.74 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.894 0.746 . . . . 0.0 111.923 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.019 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.95 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.881 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.23 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.77 18.95 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.343 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.96 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -163.74 138.6 6.1 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.403 -1.319 . . . . 0.0 114.395 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.12 126.55 51.0 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -116.92 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.31 9.24 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.801 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.17 42.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.61 40.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.37 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.05 143.48 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.663 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.963 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.59 34.88 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.48 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.55 150.46 22.21 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.108 1.363 . . . . 0.0 111.203 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.95 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.46 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.224 2.74 . . . . 0.0 119.224 -178.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.83 16.41 12.65 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -120.0 128.63 53.73 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.77 118.6 57.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.26 123.07 48.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.777 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.93 75.31 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.19 128.21 29.0 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.85 149.68 45.17 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.902 178.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.2 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -124.81 113.94 18.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -177.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.59 118.94 24.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.577 1.18 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.8 mt -113.73 122.77 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.594 -179.228 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.8 33.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.728 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -133.1 130.39 39.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.349 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.71 133.5 56.16 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.732 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.254 -179.925 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.52 -32.6 63.06 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.674 0.75 . . . . 0.0 112.724 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.79 140.36 15.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.548 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.38 112.51 24.98 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.72 135.36 49.28 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.57 138.14 49.78 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.63 125.18 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.979 1.371 . . . . 0.0 112.569 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.38 138.66 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.15 28.79 9.45 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 178.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.23 -39.07 82.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.431 1.11 . . . . 0.0 108.147 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.81 -40.72 93.8 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.68 97.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.6 -47.82 66.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.95 -33.44 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.64 75.11 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.696 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.15 70.6 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.225 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.2 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.8 -10.32 58.15 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.34 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.28 158.06 32.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.415 2.743 . . . . 0.0 116.172 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.54 14.86 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.875 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.25 138.49 38.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.788 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.055 179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.96 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.273 178.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.37 38.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -141.49 124.69 16.42 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.92 139.36 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -137.51 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.72 76.29 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.689 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.3 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.31 9.35 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.685 -1.206 . . . . 0.0 109.763 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.717 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.32 160.53 40.82 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -55.65 131.73 47.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.65 -1.9 65.33 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.41 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.657 1.694 . . . . 0.0 110.497 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.5 56.25 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -136.98 169.18 18.22 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.41 37.65 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.744 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.09 143.49 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.074 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.866 177.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -78.0 168.32 20.08 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.59 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.27 -44.33 64.88 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.992 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.12 26.12 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.24 156.86 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.57 178.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -124.57 154.41 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.95 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.669 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.9 50.38 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.84 16.36 12.64 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.79 52.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -119.97 128.66 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.85 126.52 52.55 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.949 -177.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.57 127.56 54.62 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.907 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -109.31 123.07 48.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.702 179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.61 45.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.902 178.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.58 122.37 69.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.076 0.941 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.22 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.4 20.05 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 1.2 mt-30 -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.5 m -110.85 123.19 49.62 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.709 -0.619 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.73 33.77 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.732 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.53 -117.21 10.72 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 117.528 -2.272 . . . . 0.0 109.676 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.76 124.78 29.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.885 1.366 . . . . 0.0 111.992 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.44 127.41 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.4 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.47 148.84 49.61 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.2 146.78 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -133.08 130.44 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.91 119.32 61.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.267 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.6 4.99 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.4 2.5 28.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.071 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 142.98 58.01 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.736 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.46 24.87 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.245 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.684 1.24 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.109 0.881 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -64.18 -45.14 89.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.051 1.881 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.402 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.9 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.694 -179.06 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.8 66.83 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.02 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.0 65.6 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.91 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.035 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.25 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.286 -2.688 . . . . 0.0 106.703 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.19 138.54 38.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.846 0.716 . . . . 0.0 111.964 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.22 167.04 17.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.76 18.93 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.347 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -141.44 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.163 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.87 139.41 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -120.09 126.55 51.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.318 1.056 . . . . 0.0 110.224 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.3 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.61 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.119 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.16 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.99 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.119 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.665 3.6 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -81.74 0.28 39.73 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.5 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.2 123.09 48.66 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.798 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.41 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.67 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.8 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.81 113.9 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.94 115.93 31.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.1 t -127.57 118.98 24.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.15 10.54 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.82 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.79 119.28 61.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.327 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.58 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.02 57.96 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.93 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.8 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 118.736 1.268 . . . . 0.0 108.592 178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.592 1.663 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.42 -43.09 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.698 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.83 173.97 15.17 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.479 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.57 155.83 13.14 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.702 1.251 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.37 138.73 53.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.126 0.891 . . . . 0.0 110.198 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.79 9.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -78.09 -35.4 49.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.8 pt -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.684 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.23 56.09 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.413 23.6 t -71.43 131.62 34.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 119.994 1.897 . . . . 0.0 110.291 179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 161.91 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 122.99 1.328 . . . . 0.0 114.271 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.9 -49.16 73.79 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.426 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.06 70.98 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-O 121.425 0.631 . . . . 0.0 111.281 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.2 62.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.09 65.59 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.035 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.32 158.06 32.84 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.22 138.5 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.828 0.705 . . . . 0.0 111.948 179.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.019 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.24 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 178.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.65 48.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.829 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.21 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.048 -2.261 . . . . 0.0 113.808 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.25 166.98 17.55 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.78 19.0 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.347 178.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.43 124.64 16.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.142 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.39 52.18 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.83 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -120.09 126.51 50.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.351 1.072 . . . . 0.0 110.219 177.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.29 9.22 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.39 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.02 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.098 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.8 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.33 -44.25 65.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.81 0.41 39.46 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.26 26.07 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.29 156.86 17.2 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.614 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.2 117.63 34.96 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.6 154.39 40.74 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.409 1.693 . . . . 0.0 111.764 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.77 28.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.67 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.1 143.42 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.83 171.44 14.79 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.55 150.41 22.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.048 1.339 . . . . 0.0 111.184 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.64 -22.5 17.99 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.86 52.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.02 128.69 53.76 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.58 52.7 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.6 54.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.91 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.71 1.65 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.491 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.4 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.93 68.18 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.85 149.64 45.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.78 113.88 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.92 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -10.47 20.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.582 -2.447 . . . . 0.0 117.314 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 1.2 mt-30 -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.59 119.02 25.02 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.6 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 117.588 -2.244 . . . . 0.0 109.615 -177.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.63 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.69 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.06 133.72 52.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.715 179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.46 48.23 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.991 0.807 . . . . 0.0 112.265 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.319 1.533 . . . . 0.0 110.725 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.694 0.759 . . . . 0.0 112.724 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.57 4.95 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.197 1.561 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.84 68.7 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.82 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.661 1.23 . . . . 0.0 108.541 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.43 112.47 24.9 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.728 -1.578 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.7 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.77 174.0 15.16 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.43 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.39 1.09 . . . . 0.0 108.06 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.36 8.1 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.68 -42.59 97.43 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.98 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.327 11.1 pt -90.95 14.15 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.064 -1.854 . . . . 0.0 111.672 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.98 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.406 11.3 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.75 67.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.201 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.4 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.6 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.951 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.28 158.05 32.63 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.08 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 111.298 -2.683 . . . . 0.0 106.664 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -117.22 158.55 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.629 1.206 . . . . 0.0 111.193 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.31 6.69 48.34 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.3 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.95 134.6 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.22 158.38 38.28 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.87 1.319 . . . . 0.0 110.592 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -137.45 167.96 20.6 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 18.7 ttmm -163.73 138.58 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.1 126.61 51.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.332 1.063 . . . . 0.0 110.181 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.4 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.32 9.41 Favored 'General case' 0 CA--C 1.449 -2.909 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.817 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.61 146.24 22.07 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.119 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.5 mt -55.72 131.71 47.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.39 56.27 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.44 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.735 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.071 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.666 3.6 mm? -52.34 -44.24 65.07 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 114.023 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.66 0.24 39.55 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.543 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.6 154.37 40.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.94 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.659 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.54 17.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.33 12.72 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.58 54.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.882 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.25 123.11 48.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.741 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.45 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.858 -1.776 . . . . 0.0 114.238 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -130.93 75.33 78.78 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.13 128.25 29.1 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.94 31.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.63 157.26 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.52 162.34 41.13 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.4 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.7 122.85 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.617 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.69 102.81 7.78 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.666 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.82 124.87 29.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.93 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.2 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 1.9 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.62 63.2 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.675 0.75 . . . . 0.0 112.668 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.54 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.97 68.55 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.561 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -107.74 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.82 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.63 138.15 49.84 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.722 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -48.6 125.21 9.49 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 123.025 1.393 . . . . 0.0 112.56 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.677 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.81 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.23 -39.1 82.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.431 1.11 . . . . 0.0 108.131 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.77 -40.76 93.74 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.19 -45.15 89.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.013 1.863 . . . . 0.0 109.364 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.619 0.0 OUTLIER -60.21 -41.38 92.89 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.9 179.386 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.65 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.96 82.09 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.5 pt -90.95 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 23.6 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 122.993 1.329 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.217 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 -34.68 75.22 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.654 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -63.87 -49.15 73.87 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.396 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.13 70.68 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.47 0.653 . . . . 0.0 111.288 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.25 61.84 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.8 -10.28 58.18 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.68 -10.75 47.36 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.3 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.56 14.82 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.0 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.07 117.2 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.025 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.23 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.84 -112.56 4.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.54 146.22 34.42 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.815 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.21 167.0 17.46 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.3 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.76 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.681 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.7 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.35 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.753 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.64 146.26 22.06 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.122 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.17 43.01 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.67 131.69 47.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.89 136.5 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.98 169.18 18.21 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.17 127.37 37.62 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.742 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.08 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.704 3.5 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.17 26.09 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 117.911 1.924 . . . . 0.0 117.911 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.23 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.601 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.08 22.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.6 34.9 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.54 154.45 40.57 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.721 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.669 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.94 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.5 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.89 126.62 52.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 123.917 1.817 . . . . 0.0 111.896 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.97 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.533 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.74 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.931 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.62 122.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 122.038 0.923 . . . . 0.0 109.962 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.59 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.5 t -127.6 119.0 24.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -102.96 121.12 53.74 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.508 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.86 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.373 0.606 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.8 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.22 10.78 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.03 -14.63 24.14 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.883 0.873 . . . . 0.0 112.123 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.87 124.88 29.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.714 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.48 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.4 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.82 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.903 0.859 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.327 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.55 4.92 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -3.0 68.51 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.657 1.228 . . . . 0.0 108.592 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.8 p -127.39 138.68 53.06 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.138 0.899 . . . . 0.0 110.22 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.0 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.591 0.0 OUTLIER -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.9 pt -90.9 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.144 -1.822 . . . . 0.0 111.634 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.426 38.4 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 57.1 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.12 70.73 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.25 61.74 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.35 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.95 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 158.06 33.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.321 2.681 . . . . 0.0 116.216 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -117.28 158.59 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.709 1.255 . . . . 0.0 111.172 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.57 4.3 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.67 48.39 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.79 19.01 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -141.45 124.59 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.41 52.18 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 20.1 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 m -116.88 153.93 31.67 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.996 0.903 . . . . 0.0 109.037 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.66 131.64 47.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.649 3.2 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.76 0.31 39.69 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.434 1.709 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.12 143.43 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.83 171.51 14.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.04 128.63 53.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.6 t -109.81 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.25 16.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.96 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.96 31.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.1 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.96 121.17 53.8 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.91 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.688 -0.632 . . . . 0.0 109.738 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 4.0 mp -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.45 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.384 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.11 130.39 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.24 61.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.344 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.11 133.68 52.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.743 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.67 -32.54 63.33 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.61 0.719 . . . . 0.0 112.658 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.05 57.96 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.19 -2.9 68.34 Favored Glycine 0 C--O 1.195 -2.318 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.76 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.698 1.249 . . . . 0.0 108.597 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.77 135.42 49.21 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.844 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -48.59 125.21 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.591 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.17 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.91 15.3 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -165.58 155.86 13.16 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.635 1.209 . . . . 0.0 111.782 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.77 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -78.11 -35.45 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.21 -39.11 82.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.78 -40.8 93.93 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG21 ' A' ' 119' ' ' ILE . 23.7 t80 -64.23 -45.11 89.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 124.0 1.857 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.4 ptm -60.15 -41.46 92.83 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.953 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.293 14.0 pt -90.92 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.32 55.91 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.384 3.714 . . . . 0.0 122.384 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.407 21.9 t -71.46 131.61 34.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 CA-C-N 120.001 1.9 . . . . 0.0 110.316 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.96 30.25 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.92 -33.47 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.72 -10.33 58.21 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.828 0.851 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.86 47.27 Favored 'General case' 0 N--CA 1.419 -2.021 0 C-N-CA 117.478 -1.689 . . . . 0.0 109.365 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.71 80.48 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.004 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.25 158.01 32.71 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.208 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.98 126.24 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.63 1.205 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.87 143.44 50.73 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.919 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.13 117.19 41.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.055 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.19 110.17 0.51 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.87 -112.55 4.29 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.39 6.72 48.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.2 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.086 -2.246 . . . . 0.0 113.834 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.22 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.94 138.77 18.92 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.3 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.3 38.51 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.862 1.315 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.63 16.38 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.164 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.39 52.15 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.71 76.27 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.85 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.446 -1.302 . . . . 0.0 114.386 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.51 50.84 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.337 1.065 . . . . 0.0 110.164 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 m -116.91 153.94 31.69 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.986 0.898 . . . . 0.0 109.046 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.31 9.29 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.91 65.6 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.786 1.075 . . . . 0.0 115.786 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.88 136.48 56.2 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.474 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.24 127.38 37.7 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.713 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.97 143.53 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.2 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.654 3.4 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.69 0.24 39.66 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.06 26.38 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.949 1.94 . . . . 0.0 117.949 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.22 156.9 17.16 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.85 171.95 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.26 117.58 34.83 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -124.58 154.42 40.67 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.453 1.72 . . . . 0.0 111.754 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.85 171.44 14.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.6 150.42 22.27 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.01 1.324 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.17 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -120.02 128.7 53.77 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.8 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -117.82 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.59 54.64 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.918 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.533 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.42 17.69 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.939 -1.725 . . . . 0.0 114.219 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.3 p-10 -64.53 -25.96 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.97 75.34 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.384 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.6 m -138.89 149.66 45.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.14 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.856 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.6 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.064 0.935 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.58 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.009 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -124.76 113.86 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.42 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.75 42.5 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.55 119.0 25.04 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 mt -103.0 121.12 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.526 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -110.85 123.3 49.83 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.434 HG21 ' CE2' ' A' ' 20' ' ' TYR . 3.5 mp -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.767 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.3 tp -124.66 102.84 7.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.09 -14.56 24.13 Favored 'General case' 0 CA--C 1.47 -2.129 0 C-N-CA 123.883 0.873 . . . . 0.0 112.126 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.9 124.81 29.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.83 1.331 . . . . 0.0 111.931 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.7 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.27 61.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.14 133.69 52.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.715 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.33 132.57 48.23 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.005 0.816 . . . . 0.0 112.229 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.228 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.69 63.17 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.35 -10.59 4.96 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.95 57.9 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.736 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 -3.0 68.57 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.609 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.275 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.742 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.82 13.11 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 124.686 1.241 . . . . 0.0 111.766 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.03 -35.53 49.67 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.0 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.405 1.5 ptm -60.24 -41.36 92.98 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.32 11.9 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.411 21.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.029 1.349 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.18 62.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.46 -28.97 65.64 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.931 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.4 pt -117.28 158.54 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.58 14.92 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.872 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.49 38.23 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.85 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.845 0.716 . . . . 0.0 111.924 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.89 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.24 34.31 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.09 -2.244 . . . . 0.0 113.757 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.64 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.45 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.0 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.76 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.33 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.1 127.35 37.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.58 37.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.09 -1.631 . . . . 0.0 106.963 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.614 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.76 0.34 39.57 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.87 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.11 117.53 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.53 154.48 40.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.423 1.702 . . . . 0.0 111.732 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.49 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.61 150.47 22.22 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 125.035 1.334 . . . . 0.0 111.181 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.65 -22.45 18.01 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.211 2.735 . . . . 0.0 119.211 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.56 73.22 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -10.38 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.28 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.7 t -127.54 118.95 24.94 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.3 48.31 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 111.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.6 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.773 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.072 0.857 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.61 -32.56 63.22 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.669 0.747 . . . . 0.0 112.706 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.73 135.42 49.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.64 138.18 49.81 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 123.005 1.383 . . . . 0.0 112.584 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.1 28.78 9.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.19 -39.13 82.56 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.8 -40.75 93.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.6 t80 -64.19 -45.15 89.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.013 1.863 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 10.3 ttm -60.14 -41.48 92.78 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.916 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.99 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.355 9.3 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.401 3.72 . . . . 0.0 122.401 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.465 14.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.95 -33.44 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.24 -34.66 75.15 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 63.9 mtm-85 -63.81 -49.22 73.74 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.15 70.57 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.464 0.649 . . . . 0.0 111.258 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.41 -28.98 65.54 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.361 0.978 . . . . 0.0 113.864 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.79 -10.32 58.17 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.426 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.7 152.58 18.33 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.8 80.32 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.33 158.07 32.8 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.365 2.71 . . . . 0.0 116.153 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.609 1.195 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.55 14.81 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.055 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.8 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.78 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.68 138.66 6.18 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.433 -1.307 . . . . 0.0 114.426 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.98 139.21 42.95 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.663 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.7 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.61 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.36 128.47 56.3 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.85 136.48 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.2 18.17 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.482 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.16 127.36 37.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.763 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -127.05 143.49 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.2 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.19 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.606 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.7 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.669 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.84 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.09 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.51 -22.54 18.23 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.04 128.64 53.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -117.85 126.61 52.73 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.59 54.59 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.878 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.42 17.72 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.916 -1.74 . . . . 0.0 114.268 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.349 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -138.85 149.62 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.58 122.39 69.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.038 0.923 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.26 135.6 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.01 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.78 113.86 18.49 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.6 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.96 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.7 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.0 121.09 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.489 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.0 m -110.85 123.25 49.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.625 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.767 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.67 102.82 7.78 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.87 124.86 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.885 1.366 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.43 127.43 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.433 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -133.09 130.4 39.26 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.28 61.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.349 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.988 0.805 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.66 63.02 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.55 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.5 28.62 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.996 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.623 1.211 . . . . 0.0 108.561 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.59 125.22 9.5 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.93 1.347 . . . . 0.0 112.62 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.703 1.252 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.85 9.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.16 -35.45 48.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.08 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.0 108.106 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.8 -40.74 93.78 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 9.2 ttm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.67 97.45 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.0 82.13 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.351 9.6 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.448 13.2 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.018 1.344 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.91 -33.53 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.215 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.68 75.34 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.654 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.47 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.403 0.62 . . . . 0.0 111.281 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.27 61.75 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.01 65.35 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.79 -10.29 58.19 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.6 -10.79 47.48 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.356 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.8 mt -95.64 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.79 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.975 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.894 0.746 . . . . 0.0 111.976 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.023 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.87 138.79 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.345 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.97 134.63 55.19 Favored 'General case' 0 C--O 1.279 2.648 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.28 158.34 38.43 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.553 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.7 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 18.9 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.7 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.32 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.782 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.98 139.17 43.0 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.38 37.59 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.07 143.48 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.107 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.18 120.62 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.924 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.685 3.9 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.69 0.24 39.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.26 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.08 22.32 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.45 40.61 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.93 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.53 54.55 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.907 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.22 123.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -89.96 -166.76 1.67 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.78 62.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.902 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.076 0.941 . . . . 0.0 109.942 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.89 31.06 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.64 157.27 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.522 1.63 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.19 10.68 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.84 124.79 29.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.977 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.39 127.47 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.419 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.8 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.26 146.78 52.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.305 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.68 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.55 4.96 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.99 57.89 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.704 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.691 1.246 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.1 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.11 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.689 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.83 173.96 15.19 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.509 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.56 155.85 13.19 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 124.703 1.252 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -78.06 -35.49 49.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.71 -40.8 93.61 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.8 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.393 1.2 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 9.4 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.99 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.429 24.3 t -71.47 131.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 CA-C-N 120.01 1.905 . . . . 0.0 110.291 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.32 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.019 1.344 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.24 62.0 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.03 65.47 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.413 1.007 . . . . 0.0 113.939 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.28 158.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.65 146.59 14.96 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.902 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.53 38.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.9 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.863 0.727 . . . . 0.0 111.907 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.89 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.21 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.62 48.53 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.57 146.24 34.33 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.081 -2.248 . . . . 0.0 113.757 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.3 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.788 ' C ' HD22 ' A' ' 61' ' ' ASN . 84.5 tttt -163.73 138.6 6.1 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 118.463 -1.295 . . . . 0.0 114.371 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.788 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.51 50.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.323 1.059 . . . . 0.0 110.225 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.29 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.57 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.089 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.0 139.21 42.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.734 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -1.88 65.63 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.3 128.46 56.28 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.91 136.47 56.16 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.12 18.31 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.515 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.15 127.39 37.61 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.745 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.25 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.17 120.61 37.84 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.945 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.671 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.79 0.39 39.45 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.22 26.17 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.3 156.84 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.609 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.03 22.24 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.9 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.19 117.56 34.82 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.4 m -124.52 154.45 40.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.439 1.712 . . . . 0.0 111.736 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.44 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.47 22.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.998 1.319 . . . . 0.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.67 -22.44 17.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.85 16.49 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.79 126.61 52.74 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.56 127.57 54.63 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.916 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.6 -25.96 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.57 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -10.41 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.289 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.57 118.99 24.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.02 121.19 53.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.504 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.3 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.09 133.74 52.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.737 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.53 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.089 0.868 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.6 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.58 63.29 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.615 0.722 . . . . 0.0 112.62 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.6 5.07 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.43 28.83 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -107.76 135.4 49.25 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.839 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -48.65 125.21 9.56 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.576 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.0 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.617 1.198 . . . . 0.0 111.74 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.08 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.24 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.83 9.3 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.25 -39.08 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.348 1.07 . . . . 0.0 108.123 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.8 -40.74 93.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.1 t80 -64.2 -45.15 89.58 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 124.03 1.871 . . . . 0.0 109.335 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.4 ptm -60.19 -41.4 92.85 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.885 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.64 -42.68 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.02 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.89 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.713 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.29 55.94 Favored Glycine 0 C--O 1.213 -1.16 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.425 23.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.9 30.4 Favored Glycine 0 CA--C 1.49 -1.493 0 CA-C-O 123.003 1.335 . . . . 0.0 114.299 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.65 75.27 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.22 61.94 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -28.94 65.52 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.82 -10.29 58.16 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.355 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.65 152.61 18.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.69 80.43 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.615 -2.084 . . . . 0.0 111.004 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.34 158.06 32.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.403 2.735 . . . . 0.0 116.157 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 CA-C-O 122.675 1.226 . . . . 0.0 111.182 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.16 138.5 38.11 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.797 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.857 0.723 . . . . 0.0 111.976 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.09 117.15 41.15 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.05 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.6 4.31 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.74 48.2 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.25 34.32 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.751 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.21 167.04 17.4 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.99 138.77 18.88 Favored 'General case' 0 C--N 1.263 -3.153 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.3 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -137.52 167.88 20.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.77 76.38 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.703 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 84.4 tttt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.64 146.17 21.97 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.18 42.97 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.6 40.91 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.66 131.69 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.47 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.98 169.14 18.28 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.512 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.713 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.04 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.085 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.61 37.81 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.945 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.616 3.6 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.71 0.29 39.53 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.48 40.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.732 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.5 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.42 22.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.13 89.08 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.54 177.93 50.46 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.55 -22.52 18.16 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.0 128.62 53.71 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.8 118.69 57.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -117.84 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.914 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.883 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.02 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.791 -1.564 . . . . 0.0 108.492 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.45 17.72 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.991 -1.693 . . . . 0.0 114.239 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.53 -25.92 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.384 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.88 149.63 45.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.75 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.88 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.8 mt -115.65 122.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.053 0.93 . . . . 0.0 109.966 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.012 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.54 73.2 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.74 42.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.2 t -127.56 118.95 24.93 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.3 mt -102.95 121.09 53.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.497 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.79 123.23 49.67 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.69 -0.631 . . . . 0.0 109.804 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.79 68.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.66 102.79 7.77 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.22 10.8 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.04 -14.67 24.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.906 0.882 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.77 29.35 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.785 1.303 . . . . 0.0 111.983 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.45 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.42 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.48 148.8 49.63 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.327 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.283 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.57 56.23 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.196 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.64 63.12 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.671 0.748 . . . . 0.0 112.699 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.56 4.99 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 142.99 58.01 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.704 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.84 69.11 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.84 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.664 1.232 . . . . 0.0 108.524 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.46 24.88 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.602 1.668 . . . . 0.0 110.303 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.661 -1.609 . . . . 0.0 106.784 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.15 3.56 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.7 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.8 173.96 15.2 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.46 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.85 13.03 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.633 1.208 . . . . 0.0 111.728 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.11 28.8 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -78.09 -35.49 49.3 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.15 82.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.77 93.64 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.8 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.051 1.881 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.5 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.96 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.315 12.4 pt -90.93 14.18 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -2.007 0 C-N-CA 117.09 -1.844 . . . . 0.0 111.688 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.417 21.9 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.57 74.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.83 47.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -95.61 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.39 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.982 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.223 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -119.99 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.317 -2.674 . . . . 0.0 106.703 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 pt -117.25 158.59 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.702 1.251 . . . . 0.0 111.207 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.404 0.621 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.56 4.3 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.66 48.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.89 138.86 19.05 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.283 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.03 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.68 16.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.39 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -137.5 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.662 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 53.3 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.05 126.54 51.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.297 1.046 . . . . 0.0 110.205 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.29 9.33 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.782 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.6 40.93 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.96 132.98 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.63 131.68 47.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.43 56.28 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.86 136.45 56.17 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.45 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -127.07 143.56 51.25 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.05 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.617 3.5 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.75 0.26 39.88 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.21 25.97 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.909 1.924 . . . . 0.0 117.909 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.543 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.96 110.06 22.3 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.87 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.18 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -124.6 154.41 40.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.72 28.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.695 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -137.98 143.49 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.22 89.15 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.94 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.194 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.63 -22.51 17.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.38 12.73 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.59 127.58 54.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.942 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.25 123.14 48.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.741 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.06 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.502 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.45 17.63 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.51 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -130.91 75.4 78.69 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.63 122.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.086 0.946 . . . . 0.0 109.905 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.5 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.015 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.87 31.02 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.54 157.23 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.57 73.25 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.58 1.657 . . . . 0.0 109.411 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.88 116.39 48.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.676 1.227 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 121.13 53.77 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.89 -1.131 . . . . 0.0 111.504 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.6 mp -113.71 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.644 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.69 33.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.794 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.45 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.42 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.79 49.67 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.269 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.692 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.26 132.46 48.19 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 123.969 0.793 . . . . 0.0 112.245 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.36 1.552 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 143.05 57.94 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.181 1.55 . . . . 0.0 109.687 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.23 -2.95 68.35 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.78 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.609 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.75 135.42 49.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.784 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.265 1.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.0 tp -48.64 125.22 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.743 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.82 173.94 15.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.43 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.763 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.1 -35.49 49.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.72 93.47 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.5 t80 -64.23 -45.15 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.409 1.4 ptm -60.19 -41.45 92.97 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.935 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.61 97.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.01 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.33 11.2 pt -90.92 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.1 -1.84 . . . . 0.0 111.684 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.419 31.1 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.98 30.33 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.47 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.21 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.33 -34.54 74.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.645 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.83 -49.26 73.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.18 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.04 65.5 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.939 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.7 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -95.65 152.66 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.26 158.05 32.58 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.324 2.683 . . . . 0.0 116.263 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 111.358 -2.656 . . . . 0.0 106.733 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 41' ' ' ILE 0.284 12.2 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.62 1.2 . . . . 0.0 111.155 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.27 138.52 38.19 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.91 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.877 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.493 0.663 . . . . 0.0 111.102 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.3 6.65 48.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.58 146.27 34.3 Favored 'General case' 0 N--CA 1.403 -2.807 0 C-N-CA 116.036 -2.266 . . . . 0.0 113.79 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.75 18.93 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.327 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.95 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.7 76.27 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.84 -6.76 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 55.0 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.11 126.55 51.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.283 1.04 . . . . 0.0 110.216 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.17 157.29 9.32 Favored 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.841 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.57 146.24 22.13 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.086 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.65 40.94 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.63 131.63 46.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.86 65.86 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.18 127.37 37.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -126.97 143.52 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.12 120.59 37.77 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.115 -1.615 . . . . 0.0 106.905 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.5 p -78.01 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.631 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.648 3.4 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.13 26.24 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.25 156.9 17.17 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.62 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.87 171.92 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.21 117.61 34.92 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -124.58 154.39 40.72 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.464 1.727 . . . . 0.0 111.764 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.307 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.83 171.45 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.57 150.46 22.22 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.103 1.361 . . . . 0.0 111.169 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.13 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.94 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.194 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 -22.43 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.79 16.38 12.68 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -119.97 128.69 53.81 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.83 118.56 57.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.252 16.6 t-160 -117.76 126.58 52.71 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.816 1.77 . . . . 0.0 111.988 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.91 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -109.29 123.08 48.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.754 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.4 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.2 p-10 -64.54 -26.01 68.23 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -130.93 75.36 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 m -138.89 149.64 45.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.3 135.56 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.008 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -124.77 113.94 18.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.23 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.65 -10.43 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.256 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.5 t -127.57 118.98 24.96 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-O 122.557 1.17 . . . . 0.0 111.181 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.97 121.2 53.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.96 -1.088 . . . . 0.0 111.508 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.437 HG21 ' CE2' ' A' ' 20' ' ' TYR . 15.3 mt -113.69 122.79 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.67 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.75 33.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.735 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.6 148.8 49.73 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.77 52.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.805 0.812 . . . . 0.0 111.408 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.08 130.45 39.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.917 -1.492 . . . . 0.0 114.291 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.722 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.29 132.54 48.19 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.046 0.841 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.714 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.256 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.647 0.736 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.9 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.75 140.34 15.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.545 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.644 1.688 . . . . 0.0 110.282 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.74 135.45 49.13 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.784 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.68 138.15 49.91 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.23 3.55 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.678 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.95 15.24 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.8 9.41 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -78.13 -35.49 49.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.12 82.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.79 -40.78 93.9 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.2 t80 -64.21 -45.13 89.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.0 1.857 . . . . 0.0 109.349 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.15 -41.48 92.85 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.916 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.59 97.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.3 pt -90.92 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.982 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.28 55.94 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.379 3.712 . . . . 0.0 122.379 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.416 23.2 t -71.49 131.63 34.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.289 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.69 67.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.82 47.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.61 152.65 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.951 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.22 158.04 32.45 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.199 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.687 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -117.27 158.59 17.83 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 O-C-N 124.62 1.2 . . . . 0.0 111.191 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.51 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.43 6.73 48.21 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.57 55.22 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.4 p -128.22 158.34 38.37 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.7 t -141.5 124.64 16.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.91 139.43 52.13 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -137.54 167.9 20.73 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 53.8 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.15 126.51 50.89 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.269 1.033 . . . . 0.0 110.176 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.69 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.9 65.7 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.49 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.2 127.42 37.67 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.703 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.687 3.5 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.69 0.21 39.79 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.06 26.27 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.926 1.93 . . . . 0.0 117.926 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -101.17 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.237 -1.385 . . . . 0.0 110.606 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.18 117.55 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.42 40.68 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.75 28.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.659 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.98 143.48 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.87 171.47 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 54.9 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.61 54.65 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.918 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -109.31 123.14 48.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.708 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.07 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.533 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.42 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.941 -1.724 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.49 -25.97 68.23 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.93 149.62 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.59 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.33 135.53 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 117.893 -1.523 . . . . 0.0 108.964 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.78 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.27 16.79 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.53 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.34 48.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.1 m -110.88 123.3 49.85 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.414 HG21 ' CE2' ' A' ' 20' ' ' TYR . 11.8 mt -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.53 119.73 33.79 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -124.62 102.84 7.81 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.88 124.81 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.77 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.691 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.55 48.15 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.984 0.802 . . . . 0.0 112.264 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.8 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.62 -32.58 63.24 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.687 0.756 . . . . 0.0 112.698 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.99 57.93 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.735 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.73 140.37 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.563 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.682 1.706 . . . . 0.0 110.255 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.72 135.39 49.23 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.664 -1.607 . . . . 0.0 106.804 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.65 138.15 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 173.97 15.22 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.505 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -165.63 155.82 13.0 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.78 9.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.1 -35.55 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.15 -39.11 82.74 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.82 -40.75 93.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.5 t80 -64.17 -45.17 89.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 123.987 1.851 . . . . 0.0 109.354 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 8.3 ttm -60.12 -41.46 92.66 Favored 'General case' 0 N--CA 1.41 -2.433 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.95 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.04 82.1 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.299 13.2 pt -90.91 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.974 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.707 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.27 55.99 Favored Glycine 0 C--O 1.214 -1.124 0 N-CA-C 122.411 3.724 . . . . 0.0 122.411 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.434 12.2 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.72 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.08 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.2 mtm-85 -63.8 -49.26 73.58 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.07 65.61 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.346 0.97 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.4 mt -83.73 -10.27 58.25 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.771 0.828 . . . . 0.0 109.433 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt -95.64 152.6 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.71 80.4 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.95 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.23 158.03 32.51 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.333 2.689 . . . . 0.0 116.238 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.748 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.7 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.628 1.204 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.56 14.9 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.92 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.25 138.52 38.16 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.761 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.9 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.945 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.17 117.23 41.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.961 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.91 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.66 48.41 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.2 158.31 38.46 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.803 1.287 . . . . 0.0 110.627 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.5 t -141.49 124.68 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.87 139.44 52.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.7 p -137.51 167.86 20.79 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.24 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.88 -6.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 50.1 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.936 1.397 . . . . 0.0 111.055 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.2 m -107.92 139.22 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.745 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.34 160.62 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.99 133.05 56.29 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.61 131.67 46.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -1.9 65.93 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 115.708 1.043 . . . . 0.0 115.708 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.82 136.45 56.2 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.17 18.22 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.735 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.16 120.63 37.86 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.888 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -77.97 168.43 19.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.637 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.625 4.1 mm? -52.45 -44.2 65.37 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.153 -1.839 . . . . 0.0 113.963 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.4 m -117.92 171.91 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.9 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.61 154.44 40.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.659 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.03 143.4 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.7 p -145.81 171.5 14.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.62 150.43 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.087 1.355 . . . . 0.0 111.189 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.6 177.89 50.4 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 115.635 -3.174 . . . . 0.0 105.183 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.57 -22.47 18.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.265 2.756 . . . . 0.0 119.265 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.81 16.42 12.67 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.03 128.68 53.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -117.85 126.56 52.62 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 123.81 1.767 . . . . 0.0 111.947 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.91 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.31 123.13 48.78 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.719 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.706 -1.598 . . . . 0.0 108.549 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.38 17.71 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.9 -1.75 . . . . 0.0 114.235 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.36 11.3 p-10 -64.59 -25.95 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.93 149.64 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.77 62.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.2 mt -115.62 122.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.59 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 108.988 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -124.8 113.9 18.54 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.94 31.15 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.69 157.21 16.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.33 41.13 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -32.47 73.16 Favored 'General case' 0 N--CA 1.41 -2.443 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.47 19.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 115.503 -2.479 . . . . 0.0 117.274 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.76 42.61 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.497 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.73 122.84 68.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.625 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.68 33.65 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.8 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.61 102.79 7.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.14 10.53 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.666 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.12 -14.6 24.05 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.871 0.868 . . . . 0.0 112.085 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.83 29.42 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.832 1.332 . . . . 0.0 111.906 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.8 t -120.43 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.436 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.57 148.77 49.71 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.76 52.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -133.08 130.46 39.37 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.291 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.13 133.66 52.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.721 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.13 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.984 0.802 . . . . 0.0 112.283 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.54 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.371 1.558 . . . . 0.0 110.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.52 28.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.77 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.541 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.51 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.56 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.01 15.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.64 155.83 12.99 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.598 1.187 . . . . 0.0 111.759 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.2 -39.18 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.72 -40.76 93.52 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.9 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.349 8.4 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.93 81.85 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.99 14.13 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.149 -1.821 . . . . 0.0 111.66 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.95 23.26 56.01 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.442 12.5 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -73.0 -33.44 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.235 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.89 -49.15 73.81 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.48 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.205 -1.668 0 CA-C-O 122.427 1.015 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.75 47.49 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.67 152.62 18.29 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.25 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.279 14.5 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.666 1.229 . . . . 0.0 111.208 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.56 14.88 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.859 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.758 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.506 0.669 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.29 6.65 48.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.61 55.19 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.37 38.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.876 1.322 . . . . 0.0 110.565 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.6 tttt -163.73 138.62 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.34 9.44 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.788 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 132.97 56.35 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.63 131.72 47.13 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.648 1.69 . . . . 0.0 110.499 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.18 127.4 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.764 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.05 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.508 1.623 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.105 -1.622 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.1 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -101.19 156.87 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.574 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.86 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.659 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.65 -22.46 17.99 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.153 2.713 . . . . 0.0 119.153 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.82 16.33 12.66 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.1 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.46 17.67 Favored Glycine 0 CA--C 1.491 -1.445 0 O-C-N 119.902 -1.749 . . . . 0.0 114.207 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.5 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.908 1.128 . . . . 0.0 111.429 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.8 149.65 45.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.21 119.7 62.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.891 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.55 122.36 69.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -124.74 113.87 18.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.52 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.9 123.23 49.73 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.436 0.636 . . . . 0.0 109.733 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.9 mp -113.65 122.81 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.644 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.17 10.58 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.84 29.41 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.885 1.366 . . . . 0.0 111.915 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.4 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.54 48.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.973 0.796 . . . . 0.0 112.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.52 56.18 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.38 2.47 28.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.04 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.95 68.5 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.701 1.251 . . . . 0.0 108.565 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.52 24.95 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.59 125.27 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.621 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.41 138.73 53.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.079 0.862 . . . . 0.0 110.198 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -78.1 -35.47 49.26 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.18 -39.11 82.62 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.35 1.071 . . . . 0.0 108.111 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.7 ttm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.329 11.0 pt -90.87 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.438 11.7 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.69 67.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.5 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.269 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.223 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.16 -46.2 61.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.04 65.72 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.85 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.34 158.55 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.636 1.21 . . . . 0.0 111.158 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.27 138.48 38.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.94 -163.84 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.493 0.663 . . . . 0.0 111.124 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.62 48.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.51 146.21 34.49 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.115 -2.234 . . . . 0.0 113.808 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.5 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.0 p -137.47 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.62 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.7 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.01 143.52 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.705 4.0 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.77 28.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.06 143.4 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.8 171.51 14.68 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.87 52.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.06 128.72 53.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.524 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 12.0 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.92 75.32 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.15 128.23 29.01 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.913 1.13 . . . . 0.0 111.368 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.4 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.82 113.93 18.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.47 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.57 118.95 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.898 -1.127 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.78 122.82 68.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.575 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.72 33.78 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.758 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -133.1 130.39 39.21 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.254 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.33 -10.56 4.89 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -2.96 68.7 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.636 1.218 . . . . 0.0 108.561 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.0 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.104 0.878 . . . . 0.0 110.24 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.9 ttm -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.345 9.9 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.441 12.0 t -71.44 131.61 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.295 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.87 30.45 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.11 70.76 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.22 61.82 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.37 158.06 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.177 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.22 158.59 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.19 138.51 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.68 48.35 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.62 16.41 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.37 52.19 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -116.91 153.95 31.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.016 0.913 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.686 4.1 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.72 0.26 39.72 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.606 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.476 1.735 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.08 143.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.64 127.53 54.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.907 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.22 123.01 48.55 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 124.629 1.206 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.92 -166.7 1.65 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.783 -1.567 . . . . 0.0 108.531 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.52 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.648 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.4 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.28 61.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.314 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.956 -1.929 . . . . 0.0 111.743 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.59 63.3 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.68 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.4 2.45 28.71 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.073 -0.651 . . . . 0.0 112.042 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.72 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.59 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.44 112.47 24.9 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 123.597 1.665 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.844 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.57 138.17 49.74 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.524 0.678 . . . . 0.0 109.659 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.56 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -159.73 174.0 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.46 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.62 155.84 13.05 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.633 1.208 . . . . 0.0 111.709 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.77 9.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.381 1.086 . . . . 0.0 108.077 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.77 -40.73 93.63 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -64.17 -45.12 89.82 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 124.009 1.862 . . . . 0.0 109.406 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.359 8.3 ttm -60.18 -41.46 92.95 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.901 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.6 -42.65 97.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.318 11.5 pt -90.95 14.13 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.66 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.25 56.05 Favored Glycine 0 C--O 1.214 -1.108 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.409 10.8 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.95 30.16 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-O 123.037 1.354 . . . . 0.0 114.287 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.79 67.01 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.57 75.01 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.5 mtm-85 -63.89 -49.16 73.78 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.76 -10.29 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.6 mt -95.65 152.63 18.28 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.74 80.35 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.981 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.3 158.0 33.01 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.21 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.98 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.755 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.2 158.55 17.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.693 1.245 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.818 0.698 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.464 0.65 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.95 -112.65 4.33 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.69 48.33 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.64 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.23 158.33 38.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.849 1.309 . . . . 0.0 110.578 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.52 124.68 16.39 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.109 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.45 52.15 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.6 p -137.5 167.87 20.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.5 tttt -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.0 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.12 157.37 9.48 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.764 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.66 146.24 22.01 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.9 1.375 . . . . 0.0 111.055 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -108.01 139.18 43.04 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.664 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.59 40.93 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.99 132.97 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.6 131.74 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.91 65.36 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.99 169.16 18.24 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.735 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.63 37.91 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.125 -1.609 . . . . 0.0 106.87 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.96 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.679 3.7 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -81.72 0.33 39.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.85 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.0 144.78 28.77 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.72 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.37 22.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.17 89.16 2.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.103 -3.199 . . . . 0.0 105.103 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.5 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.8 16.33 12.67 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.82 52.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -119.96 128.65 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.58 -162.45 17.71 Favored Glycine 0 CA--C 1.49 -1.505 0 O-C-N 119.9 -1.75 . . . . 0.0 114.223 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 12.0 p-10 -64.54 -25.99 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.14 128.19 28.86 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.841 1.1 . . . . 0.0 111.416 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.6 45.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.77 62.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.88 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.62 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.964 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.76 113.87 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.63 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.587 1.661 . . . . 0.0 109.447 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.88 123.27 49.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.369 0.605 . . . . 0.0 109.774 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.68 122.81 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.644 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.1 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.548 -2.263 . . . . 0.0 109.666 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.61 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.906 0.882 . . . . 0.0 112.112 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.83 124.82 29.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 124.83 1.331 . . . . 0.0 111.906 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.2 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.4 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.7 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.79 52.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -133.12 130.44 39.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.88 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.311 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.54 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.283 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.79 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.199 -179.869 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.6 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.59 63.18 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.39 2.51 28.78 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.033 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.4 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.38 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.663 1.232 . . . . 0.0 108.58 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.224 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -48.64 125.27 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.686 1.241 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.42 138.71 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.147 0.904 . . . . 0.0 110.181 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -78.07 -35.46 49.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.26 -39.05 82.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.357 1.075 . . . . 0.0 108.122 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.389 1.6 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.264 13.1 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.365 17.7 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.89 -33.54 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.233 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.696 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -63.85 -49.19 73.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.419 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.14 70.65 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.23 61.95 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.02 65.55 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.91 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.73 -10.29 58.24 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.73 47.58 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 117.426 -1.71 . . . . 0.0 109.395 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.187 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 41' ' ' ILE 0.289 13.8 pt -117.34 158.56 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.146 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.57 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.23 138.52 38.14 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.75 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.894 0.746 . . . . 0.0 111.948 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 m -97.08 117.15 41.14 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.053 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.568 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.45 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.163 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.8 p -137.47 167.98 20.56 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.655 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 84.2 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.062 0.934 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.16 43.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.717 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.29 160.56 40.88 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.64 46.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -127.03 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.117 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.11 120.61 37.79 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.954 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.4 p -78.0 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.388 1.09 . . . . 0.0 111.59 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.532 3.7 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.21 25.97 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -124.57 154.45 40.63 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.743 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.02 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.656 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.12 143.41 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.51 14.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.18 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.629 -3.177 . . . . 0.0 105.174 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.03 128.72 53.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.57 54.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.876 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.363 11.3 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.4 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.8 mt -115.61 122.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.55 162.32 41.17 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.4 20.02 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.513 -2.475 . . . . 0.0 117.247 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -127.54 118.93 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 121.635 -0.665 . . . . 0.0 109.747 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.77 122.83 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.565 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.2 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tt -80.82 124.78 29.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.865 1.353 . . . . 0.0 112.008 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.41 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.52 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.79 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -133.1 130.38 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.357 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -110.1 133.64 53.0 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.65 -32.57 63.31 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.65 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.98 57.93 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.767 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.97 68.46 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.5 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.197 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.267 1.989 0 CA-C-O 121.431 0.634 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.22 9.58 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.74 173.99 15.2 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.05 -35.54 49.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.18 -39.11 82.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.342 10.8 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.38 55.88 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.452 3.741 . . . . 0.0 122.452 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.991 1.895 . . . . 0.0 110.298 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.92 -33.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.704 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.15 62.11 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.01 65.78 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.342 0.968 . . . . 0.0 113.846 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.71 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.379 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.3 158.56 17.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.654 1.216 . . . . 0.0 111.119 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.67 146.54 14.89 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.936 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.23 138.48 38.2 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.761 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.09 117.16 41.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.053 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -137.52 167.87 20.78 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.72 76.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.77 -6.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.7 tttt -163.67 138.65 6.19 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.408 -1.317 . . . . 0.0 114.366 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.9 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.33 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.34 160.58 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.06 56.29 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.67 46.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.82 65.75 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.01 169.13 18.3 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.457 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.733 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.02 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.475 1.607 . . . . 0.0 115.085 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.65 37.86 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.936 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -78.03 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.603 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.659 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.14 26.22 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.954 1.941 . . . . 0.0 117.954 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.626 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.42 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.8 171.54 14.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.63 150.47 22.23 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.014 1.326 . . . . 0.0 111.181 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.85 118.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.62 54.61 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.771 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.914 -1.741 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.341 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.94 75.27 78.86 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.22 28.95 Favored 'Trans proline' 0 C--N 1.284 -2.829 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.73 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.053 0.93 . . . . 0.0 109.994 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.63 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 109.013 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.32 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.49 73.15 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 -10.39 19.99 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 115.532 -2.467 . . . . 0.0 117.247 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -152.99 158.73 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -127.52 118.93 24.92 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.89 123.27 49.81 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.591 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.76 33.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.741 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.7 102.74 7.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.511 -2.281 . . . . 0.0 109.687 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.78 29.39 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.42 127.51 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.379 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.75 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.09 130.44 39.3 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.349 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.018 0.824 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.254 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.7 p . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.652 0.739 . . . . 0.0 112.724 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.43 -10.49 4.96 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.179 1.549 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.8 140.41 15.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.623 1.211 . . . . 0.0 108.529 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.73 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.779 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.18 9.5 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.971 1.367 . . . . 0.0 112.63 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.095 0.872 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.77 9.48 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.1 -35.47 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.28 -39.03 82.25 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.396 1.094 . . . . 0.0 108.098 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.82 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.72 -42.56 97.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.99 82.17 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.34 10.8 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.091 -1.844 . . . . 0.0 111.702 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.33 55.88 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.1 t -71.5 131.64 34.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.264 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.96 30.36 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.79 66.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.91 -33.5 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.201 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.65 75.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.24 73.67 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.13 70.69 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.22 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.29 -29.08 65.38 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.429 1.016 . . . . 0.0 113.918 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.74 -10.32 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.786 0.834 . . . . 0.0 109.426 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.79 47.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.38 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.63 152.54 18.35 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.76 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.652 -2.067 . . . . 0.0 110.951 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.177 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.99 126.22 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.247 -2.706 . . . . 0.0 106.687 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.27 158.6 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.18 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.88 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.2 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.016 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.95 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.445 0.64 . . . . 0.0 111.119 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.52 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.69 48.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -128.25 167.05 17.43 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.273 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.03 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.727 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.38 38.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.855 1.312 . . . . 0.0 110.58 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.7 p -137.45 167.97 20.58 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.662 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.85 -6.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 85.0 tttt -163.74 138.57 6.08 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.431 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.304 1.049 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -116.96 153.89 31.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.15 157.29 9.35 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.782 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.58 146.2 22.09 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.119 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.94 139.24 42.86 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.714 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.65 131.68 47.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.9 65.64 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.9 136.48 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.19 127.44 37.67 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.714 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -127.07 143.54 51.25 Favored 'General case' 0 CA--C 1.588 2.406 0 CA-C-O 123.418 1.58 . . . . 0.0 115.07 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.19 -1.569 . . . . 0.0 106.866 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -77.99 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-O 122.354 1.073 . . . . 0.0 111.654 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.661 3.6 mm? -52.34 -44.21 65.05 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.233 -1.803 . . . . 0.0 114.023 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.7 0.21 39.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.22 25.91 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.29 156.87 17.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.539 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.09 22.33 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.9 m -124.59 154.4 40.74 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.718 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.82 28.72 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.659 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.0 mt -138.07 143.45 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.88 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.194 -3.162 . . . . 0.0 105.194 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.58 -22.55 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.42 12.71 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.76 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.1 mt -119.97 128.67 53.79 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.78 118.61 57.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.53 52.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.978 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.55 127.55 54.62 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.947 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.27 123.1 48.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 124.669 1.231 . . . . 0.0 108.735 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.67 1.64 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.518 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.44 17.73 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.91 -1.744 . . . . 0.0 114.254 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.95 75.4 78.66 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.17 128.3 29.32 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.913 1.13 . . . . 0.0 111.386 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.92 149.62 45.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.6 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.56 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.013 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.74 113.85 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.87 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.64 157.25 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.37 41.09 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.48 20.01 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.314 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.74 42.59 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.53 119.0 25.05 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.88 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.599 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.6 119.69 33.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.732 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.21 10.76 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.679 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.79 124.82 29.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.887 1.367 . . . . 0.0 111.992 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.47 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.395 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.51 148.78 49.66 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.75 52.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.02 130.45 39.45 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.922 -1.49 . . . . 0.0 114.269 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.691 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.992 0.807 . . . . 0.0 112.288 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.51 -32.64 63.07 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.729 0.776 . . . . 0.0 112.699 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.37 -10.55 4.94 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.5 28.63 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.076 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 142.98 57.99 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.711 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.33 15.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.39 112.47 24.92 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.28 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.51 138.16 49.69 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.733 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.26 9.64 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.701 1.251 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.42 138.73 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.246 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 29.0 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.007 1.861 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.3 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.304 13.4 pt -90.94 14.17 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.672 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.415 23.5 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.88 30.38 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.052 1.362 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.84 66.6 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -177.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.89 -33.47 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.295 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.688 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.2 61.92 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.03 65.46 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.38 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.982 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.55 14.86 Favored 'General case' 0 N--CA 1.394 -3.257 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.847 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.758 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.61 4.31 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.22 167.0 17.47 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.85 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.32 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.27 158.36 38.37 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.69 16.43 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.104 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.37 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.2 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 85.0 tttt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.08 126.59 51.12 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.314 1.054 . . . . 0.0 110.197 177.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.4 m -116.96 153.93 31.76 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.6 146.29 22.13 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.109 178.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.19 42.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.29 160.53 40.85 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.91 132.98 56.35 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.61 131.7 46.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.36 128.38 56.28 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.644 1.688 . . . . 0.0 110.517 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.78 136.44 56.22 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.735 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -127.03 143.51 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.108 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.677 3.6 mm? -52.32 -44.27 65.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.024 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -81.71 0.28 39.59 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.34 12.71 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -109.22 123.11 48.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.741 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.41 17.7 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.873 -1.767 . . . . 0.0 114.272 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.357 11.3 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -138.8 149.62 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.8 113.88 18.51 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.95 115.94 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.54 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.8 42.62 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.61 118.98 24.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.94 123.23 49.74 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.681 -0.637 . . . . 0.0 109.722 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.6 mt -113.65 122.85 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.617 -179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.13 10.48 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.8 124.83 29.39 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.85 49.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.19 146.83 52.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.17 130.43 39.15 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.289 -178.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.49 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.01 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.257 1.598 . . . . 0.0 109.719 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-N 118.701 1.251 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp -48.66 125.25 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.728 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -78.07 -35.53 49.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.11 82.58 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.4 ' CE2' HG21 ' A' ' 119' ' ' ILE . 27.7 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.404 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.07 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.346 10.1 pt -90.89 14.08 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.117 -1.833 . . . . 0.0 111.691 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.418 23.8 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.89 30.37 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.073 1.374 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.72 -47.68 67.16 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -177.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.52 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.21 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.65 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.18 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.03 65.52 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.868 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.77 -10.27 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.66 18.26 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.3 158.55 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-O 122.616 1.198 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.25 138.52 38.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.75 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.93 143.46 50.74 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.894 0.746 . . . . 0.0 111.923 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.019 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.95 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.881 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.23 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.77 18.95 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.343 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.96 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 50.8 tttm -163.74 138.6 6.1 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.403 -1.319 . . . . 0.0 114.395 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.55 51.0 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -116.92 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.31 9.24 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.801 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.17 42.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.61 40.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.37 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.05 143.48 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.663 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.963 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.59 34.88 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.48 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.55 150.46 22.21 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.108 1.363 . . . . 0.0 111.203 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.95 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.46 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.224 2.74 . . . . 0.0 119.224 -178.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.83 16.41 12.65 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -120.0 128.63 53.73 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.77 118.6 57.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.26 123.07 48.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.777 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.93 75.31 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.19 128.21 29.0 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.85 149.68 45.17 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.902 178.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.2 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -124.81 113.94 18.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -177.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.59 118.94 24.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.577 1.18 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.8 mt -113.73 122.77 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.594 -179.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.8 33.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.728 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -133.1 130.39 39.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.349 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.71 133.5 56.16 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.732 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.254 -179.925 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.52 -32.6 63.06 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.674 0.75 . . . . 0.0 112.724 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.79 140.36 15.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.548 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.38 112.51 24.98 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.72 135.36 49.28 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.57 138.14 49.78 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.63 125.18 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.979 1.371 . . . . 0.0 112.569 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.38 138.66 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.15 28.79 9.45 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 178.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.23 -39.07 82.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.431 1.11 . . . . 0.0 108.147 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.81 -40.72 93.8 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.68 97.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.6 -47.82 66.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.95 -33.44 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.64 75.11 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.696 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.15 70.6 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.225 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.2 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.8 -10.32 58.15 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.34 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.28 158.06 32.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.415 2.743 . . . . 0.0 116.172 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.54 14.86 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.875 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.25 138.49 38.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.788 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.055 179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.96 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.273 178.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.37 38.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -141.49 124.69 16.42 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.92 139.36 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -137.51 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.72 76.29 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.689 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 46.0 tttm -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.3 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.31 9.35 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.685 -1.206 . . . . 0.0 109.763 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.717 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.32 160.53 40.82 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -55.65 131.73 47.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.65 -1.9 65.33 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.41 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.657 1.694 . . . . 0.0 110.497 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.5 56.25 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -136.98 169.18 18.22 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.41 37.65 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.744 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.09 143.49 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.074 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.866 177.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -78.0 168.32 20.08 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.59 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.27 -44.33 64.88 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.992 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.12 26.12 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.24 156.86 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.57 178.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -124.57 154.41 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.95 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.669 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.9 50.38 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.84 16.36 12.64 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.79 52.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -119.97 128.66 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.85 126.52 52.55 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.949 -177.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.57 127.56 54.62 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.907 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -109.31 123.07 48.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.702 179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.61 45.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.902 178.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.58 122.37 69.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.076 0.941 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.22 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.4 20.05 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.5 m -110.85 123.19 49.62 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.709 -0.619 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.73 33.77 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.732 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.53 -117.21 10.72 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 117.528 -2.272 . . . . 0.0 109.676 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.76 124.78 29.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.885 1.366 . . . . 0.0 111.992 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.44 127.41 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.4 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.47 148.84 49.61 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.2 146.78 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -133.08 130.44 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.91 119.32 61.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.267 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.6 4.99 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.4 2.5 28.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.071 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 142.98 58.01 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.736 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.46 24.87 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.245 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.684 1.24 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.109 0.881 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -64.18 -45.14 89.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.051 1.881 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.402 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.9 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.694 -179.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.8 66.83 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.02 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.0 65.6 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.91 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.035 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.25 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.286 -2.688 . . . . 0.0 106.703 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.19 138.54 38.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.846 0.716 . . . . 0.0 111.964 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.22 167.04 17.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.76 18.93 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.347 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -141.44 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.163 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.87 139.41 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 51.0 tttm -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.55 51.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.318 1.056 . . . . 0.0 110.224 177.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.3 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.61 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.119 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.16 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.99 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.119 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.665 3.6 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -81.74 0.28 39.73 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.5 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.2 123.09 48.66 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.798 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.41 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.67 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.8 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.81 113.9 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.94 115.93 31.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.1 t -127.57 118.98 24.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.15 10.54 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.82 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.79 119.28 61.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.327 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.58 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.02 57.96 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.93 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.8 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 118.736 1.268 . . . . 0.0 108.592 178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.592 1.663 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.42 -43.09 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.698 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.83 173.97 15.17 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.479 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.57 155.83 13.14 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.702 1.251 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.37 138.73 53.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.126 0.891 . . . . 0.0 110.198 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.79 9.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -78.09 -35.4 49.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.8 pt -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.684 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.23 56.09 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.413 23.6 t -71.43 131.62 34.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 119.994 1.897 . . . . 0.0 110.291 179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 161.91 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 122.99 1.328 . . . . 0.0 114.271 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.9 -49.16 73.79 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.426 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.06 70.98 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-O 121.425 0.631 . . . . 0.0 111.281 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.2 62.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.09 65.59 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.035 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.32 158.06 32.84 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.22 138.5 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.828 0.705 . . . . 0.0 111.948 179.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.019 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.24 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 178.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.65 48.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.829 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.21 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.048 -2.261 . . . . 0.0 113.808 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.25 166.98 17.55 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.78 19.0 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.347 178.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.43 124.64 16.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.142 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.39 52.18 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.83 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 51.1 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.51 50.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.351 1.072 . . . . 0.0 110.219 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.29 9.22 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.39 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.02 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.098 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.8 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.33 -44.25 65.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.81 0.41 39.46 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.26 26.07 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.29 156.86 17.2 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.614 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.2 117.63 34.96 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.6 154.39 40.74 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.409 1.693 . . . . 0.0 111.764 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.77 28.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.67 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.1 143.42 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.83 171.44 14.79 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.55 150.41 22.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.048 1.339 . . . . 0.0 111.184 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.64 -22.5 17.99 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.86 52.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.02 128.69 53.76 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.58 52.7 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.6 54.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.91 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.71 1.65 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.491 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.4 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.93 68.18 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.85 149.64 45.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.78 113.88 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.92 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -10.47 20.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.582 -2.447 . . . . 0.0 117.314 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.59 119.02 25.02 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.6 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 117.588 -2.244 . . . . 0.0 109.615 -177.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.63 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.69 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.06 133.72 52.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.715 179.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.46 48.23 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.991 0.807 . . . . 0.0 112.265 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.319 1.533 . . . . 0.0 110.725 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.694 0.759 . . . . 0.0 112.724 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.57 4.95 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.197 1.561 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.84 68.7 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.82 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.661 1.23 . . . . 0.0 108.541 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.43 112.47 24.9 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.728 -1.578 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.7 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.77 174.0 15.16 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.43 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.39 1.09 . . . . 0.0 108.06 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.36 8.1 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.68 -42.59 97.43 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.98 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.327 11.1 pt -90.95 14.15 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.064 -1.854 . . . . 0.0 111.672 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.98 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.406 11.3 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.75 67.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.201 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.4 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.6 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.663 -2.062 . . . . 0.0 110.951 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.28 158.05 32.63 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.08 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 111.298 -2.683 . . . . 0.0 106.664 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -117.22 158.55 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.629 1.206 . . . . 0.0 111.193 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.31 6.69 48.34 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.3 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.95 134.6 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.22 158.38 38.28 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.87 1.319 . . . . 0.0 110.592 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.6 p -137.45 167.96 20.6 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 18.7 ttmm -163.73 138.58 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.1 126.61 51.15 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.332 1.063 . . . . 0.0 110.181 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.4 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.32 9.41 Favored 'General case' 0 CA--C 1.449 -2.909 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.817 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.61 146.24 22.07 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.119 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.5 mt -55.72 131.71 47.32 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.39 56.27 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.44 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.735 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.071 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.666 3.6 mm? -52.34 -44.24 65.07 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 114.023 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.66 0.24 39.55 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.543 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.6 154.37 40.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.94 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.659 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.54 17.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.33 12.72 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.2 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.58 54.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.882 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.25 123.11 48.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.741 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.45 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.858 -1.776 . . . . 0.0 114.238 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -130.93 75.33 78.78 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.13 128.25 29.1 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.94 31.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.63 157.26 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.52 162.34 41.13 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.4 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.0 mt -113.7 122.85 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.617 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.69 102.81 7.78 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.666 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.82 124.87 29.43 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.93 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.2 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 1.9 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.62 63.2 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.675 0.75 . . . . 0.0 112.668 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.54 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.97 68.55 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.561 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -107.74 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.82 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.63 138.15 49.84 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.722 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -48.6 125.21 9.49 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 123.025 1.393 . . . . 0.0 112.56 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.677 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.81 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.23 -39.1 82.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.431 1.11 . . . . 0.0 108.131 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.77 -40.76 93.74 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -64.19 -45.15 89.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 124.013 1.863 . . . . 0.0 109.364 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.619 0.0 OUTLIER -60.21 -41.38 92.89 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.9 179.386 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.65 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.96 82.09 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.5 pt -90.95 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.626 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 23.6 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 122.993 1.329 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.217 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 -34.68 75.22 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.654 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -63.87 -49.15 73.87 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.396 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.13 70.68 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.47 0.653 . . . . 0.0 111.288 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.25 61.84 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.8 -10.28 58.18 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.68 -10.75 47.36 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.3 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.56 14.82 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.0 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.07 117.2 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.025 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.23 0.52 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.84 -112.56 4.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.54 146.22 34.42 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.815 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.21 167.0 17.46 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.3 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.76 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.681 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.7 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.35 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.753 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -155.64 146.26 22.06 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.122 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.99 139.17 43.01 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.67 131.69 47.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.89 136.5 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.98 169.18 18.21 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.17 127.37 37.62 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.742 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.08 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.704 3.5 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.17 26.09 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 117.911 1.924 . . . . 0.0 117.911 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.23 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.601 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.08 22.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.6 34.9 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.54 154.45 40.57 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.721 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.455 -1.702 . . . . 0.0 108.669 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.94 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.5 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.89 126.62 52.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 123.917 1.817 . . . . 0.0 111.896 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.883 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.97 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.533 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.74 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.931 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.62 122.4 69.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 122.038 0.923 . . . . 0.0 109.962 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.59 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.5 t -127.6 119.0 24.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -102.96 121.12 53.74 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.508 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.86 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.373 0.606 . . . . 0.0 109.748 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.8 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.22 10.78 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.03 -14.63 24.14 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.883 0.873 . . . . 0.0 112.123 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.87 124.88 29.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.714 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.48 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.4 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.82 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.903 0.859 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.6 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.327 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.55 4.92 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -3.0 68.51 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.657 1.228 . . . . 0.0 108.592 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.7 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.8 p -127.39 138.68 53.06 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.138 0.899 . . . . 0.0 110.22 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.0 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.591 0.0 OUTLIER -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.9 pt -90.9 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.144 -1.822 . . . . 0.0 111.634 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.426 38.4 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 57.1 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.12 70.73 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.25 61.74 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.35 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.95 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 158.06 33.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.321 2.681 . . . . 0.0 116.216 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 pt -117.28 158.59 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.709 1.255 . . . . 0.0 111.172 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.2 138.5 38.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.765 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.57 4.3 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.67 48.39 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.79 19.01 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -141.45 124.59 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.41 52.18 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 20.1 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.6 m -116.88 153.93 31.67 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.996 0.903 . . . . 0.0 109.037 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.66 131.64 47.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.3 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.649 3.2 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.76 0.31 39.69 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.84 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.434 1.709 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.12 143.43 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.83 171.51 14.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.04 128.63 53.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.6 t -109.81 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.25 16.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.96 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.96 31.17 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.1 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.96 121.17 53.8 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.91 123.22 49.7 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.688 -0.632 . . . . 0.0 109.738 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 4.0 mp -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.4 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.45 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.384 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.11 130.39 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.24 61.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.344 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.11 133.68 52.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.743 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.67 -32.54 63.33 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.61 0.719 . . . . 0.0 112.658 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.05 57.96 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.19 -2.9 68.34 Favored Glycine 0 C--O 1.195 -2.318 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.76 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.698 1.249 . . . . 0.0 108.597 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.77 135.42 49.21 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.844 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.1 tp -48.59 125.21 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.591 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.17 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.676 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.91 15.3 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -165.58 155.86 13.16 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.635 1.209 . . . . 0.0 111.782 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.77 9.3 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -78.11 -35.45 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.512 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.21 -39.11 82.48 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.78 -40.8 93.93 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' HG21 ' A' ' 119' ' ' ILE . 23.7 t80 -64.23 -45.11 89.64 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 124.0 1.857 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.4 ptm -60.15 -41.46 92.83 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.953 179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.293 14.0 pt -90.92 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.32 55.91 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.384 3.714 . . . . 0.0 122.384 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.407 21.9 t -71.46 131.61 34.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 CA-C-N 120.001 1.9 . . . . 0.0 110.316 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.96 30.25 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.92 -33.47 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.72 -10.33 58.21 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.828 0.851 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.86 47.27 Favored 'General case' 0 N--CA 1.419 -2.021 0 C-N-CA 117.478 -1.689 . . . . 0.0 109.365 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.64 152.61 18.29 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.71 80.48 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.637 -2.074 . . . . 0.0 111.004 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.25 158.01 32.71 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.208 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.98 126.24 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.63 1.205 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.87 143.44 50.73 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.919 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.13 117.19 41.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.055 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.19 110.17 0.51 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.87 -112.55 4.29 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.39 6.72 48.24 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.2 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.086 -2.246 . . . . 0.0 113.834 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.22 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.94 138.77 18.92 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.3 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.3 38.51 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.862 1.315 . . . . 0.0 110.559 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.63 16.38 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.164 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.39 52.15 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.5 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.71 76.27 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.85 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.446 -1.302 . . . . 0.0 114.386 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.51 50.84 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.337 1.065 . . . . 0.0 110.164 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 m -116.91 153.94 31.69 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.986 0.898 . . . . 0.0 109.046 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.31 9.29 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.5 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.91 65.6 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.786 1.075 . . . . 0.0 115.786 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.88 136.48 56.2 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.474 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.24 127.38 37.7 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.713 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.97 143.53 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.2 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.654 3.4 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -81.69 0.24 39.66 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.06 26.38 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.949 1.94 . . . . 0.0 117.949 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.22 156.9 17.16 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.2 -1.4 . . . . 0.0 110.62 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.85 171.95 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.26 117.58 34.83 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -124.58 154.42 40.67 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.453 1.72 . . . . 0.0 111.754 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.1 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.85 171.44 14.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.6 150.42 22.27 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.01 1.324 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.17 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -120.02 128.7 53.77 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.8 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -117.82 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.59 54.64 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.918 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.533 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.42 17.69 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.939 -1.725 . . . . 0.0 114.219 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.3 p-10 -64.53 -25.96 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.97 75.34 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.384 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.6 m -138.89 149.66 45.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.14 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.806 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.856 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.6 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.064 0.935 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.58 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.009 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -124.76 113.86 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.42 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.75 42.5 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.55 119.0 25.04 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 mt -103.0 121.12 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.526 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -110.85 123.3 49.83 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.434 HG21 ' CE2' ' A' ' 20' ' ' TYR . 3.5 mp -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.767 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.3 tp -124.66 102.84 7.8 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.09 -14.56 24.13 Favored 'General case' 0 CA--C 1.47 -2.129 0 C-N-CA 123.883 0.873 . . . . 0.0 112.126 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.9 124.81 29.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.83 1.331 . . . . 0.0 111.931 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.7 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.27 61.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -110.14 133.69 52.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.02 -1.9 . . . . 0.0 111.715 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.33 132.57 48.23 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.005 0.816 . . . . 0.0 112.229 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.228 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.69 63.17 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.35 -10.59 4.96 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.95 57.9 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.736 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 -3.0 68.57 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.657 1.228 . . . . 0.0 108.609 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.275 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.742 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.82 13.11 Favored 'General case' 0 CA--C 1.486 -1.489 0 O-C-N 124.686 1.241 . . . . 0.0 111.766 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.03 -35.53 49.67 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.511 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.0 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.405 1.5 ptm -60.24 -41.36 92.98 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.32 11.9 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.411 21.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.25 1.131 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.029 1.349 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.18 62.01 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.46 -28.97 65.64 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.931 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.4 pt -117.28 158.54 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.58 14.92 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.872 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.49 38.23 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.85 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.845 0.716 . . . . 0.0 111.924 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.89 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.63 48.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.24 34.31 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.09 -2.244 . . . . 0.0 113.757 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.64 16.39 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.83 139.45 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.0 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.76 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.5 ptmt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.33 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.99 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.64 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.1 127.35 37.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.58 37.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.09 -1.631 . . . . 0.0 106.963 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.614 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.76 0.34 39.57 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.26 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.87 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.11 117.53 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.53 154.48 40.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.423 1.702 . . . . 0.0 111.732 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.49 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.61 150.47 22.22 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 125.035 1.334 . . . . 0.0 111.181 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.65 -22.45 18.01 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.211 2.735 . . . . 0.0 119.211 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.63 127.57 54.58 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.876 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.56 73.22 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 -10.38 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.28 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.7 t -127.54 118.95 24.94 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.3 48.31 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 111.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.6 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.773 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.072 0.857 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 1.9 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.61 -32.56 63.22 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.669 0.747 . . . . 0.0 112.706 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -107.73 135.42 49.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.64 138.18 49.81 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.712 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 123.005 1.383 . . . . 0.0 112.584 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.1 28.78 9.32 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.19 -39.13 82.56 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.8 -40.75 93.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.6 t80 -64.19 -45.15 89.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.013 1.863 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 10.3 ttm -60.14 -41.48 92.78 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.916 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.99 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.355 9.3 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.401 3.72 . . . . 0.0 122.401 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.465 14.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.95 -33.44 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.24 -34.66 75.15 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 63.9 mtm-85 -63.81 -49.22 73.74 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.15 70.57 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.464 0.649 . . . . 0.0 111.258 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.41 -28.98 65.54 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.361 0.978 . . . . 0.0 113.864 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.79 -10.32 58.17 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.426 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.7 152.58 18.33 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.8 80.32 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.33 158.07 32.8 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.365 2.71 . . . . 0.0 116.153 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.609 1.195 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.73 146.55 14.81 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.872 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.055 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.474 0.654 . . . . 0.0 111.135 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.34 38.41 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.8 p -137.51 167.9 20.72 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 pp -98.78 -6.87 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 19.7 ptmt -163.68 138.66 6.18 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.433 -1.307 . . . . 0.0 114.426 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.98 139.21 42.95 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.663 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.7 mt -55.64 131.68 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.61 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.36 128.47 56.3 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.85 136.48 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.0 169.2 18.17 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.482 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.16 127.36 37.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.763 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -127.05 143.49 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.2 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.68 0.24 39.65 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.19 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.606 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.7 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.669 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.0 mt -138.05 143.46 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.84 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.09 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.51 -22.54 18.23 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.9 mt -120.04 128.64 53.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -117.85 126.61 52.73 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.901 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.59 54.59 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.878 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.09 48.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.57 -162.42 17.72 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.916 -1.74 . . . . 0.0 114.268 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.349 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -138.85 149.62 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.58 122.39 69.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.038 0.923 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.26 135.6 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 109.01 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.78 113.86 18.49 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.68 157.23 16.84 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.48 162.31 41.17 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -32.6 73.23 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-O 123.522 1.63 . . . . 0.0 109.45 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.96 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.7 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.31 48.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.0 121.09 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.489 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.0 m -110.85 123.25 49.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.7 122.81 68.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.625 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.48 119.73 33.85 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.767 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.67 102.82 7.78 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.22 10.79 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.527 -2.273 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.87 124.86 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.885 1.366 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.43 127.43 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.433 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.87 0.843 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -133.09 130.4 39.26 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.28 61.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.349 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.988 0.805 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.66 63.02 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.55 4.99 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.46 2.5 28.62 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.996 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.623 1.211 . . . . 0.0 108.561 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.59 125.22 9.5 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.93 1.347 . . . . 0.0 112.62 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.703 1.252 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.24 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.85 9.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.16 -35.45 48.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.08 82.34 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.0 108.106 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.8 -40.74 93.78 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 9.2 ttm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.67 97.45 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.0 82.13 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.351 9.6 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.448 13.2 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.87 30.4 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.018 1.344 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.91 -33.53 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.215 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.68 75.34 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.654 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.47 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.403 0.62 . . . . 0.0 111.281 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.27 61.75 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.01 65.35 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.79 -10.29 58.19 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.6 -10.79 47.48 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.356 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.8 mt -95.64 152.55 18.35 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.79 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.975 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.36 158.09 32.86 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.148 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.182 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.18 138.5 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.777 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.894 0.746 . . . . 0.0 111.976 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.023 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.87 138.79 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.345 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 mt -119.97 134.63 55.19 Favored 'General case' 0 C--O 1.279 2.648 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.28 158.34 38.43 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.553 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.45 124.66 16.44 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.9 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.7 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 18.9 ptmt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.7 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.32 9.29 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.782 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -155.62 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.099 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.98 139.17 43.0 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.708 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.6 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.38 37.59 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.07 143.48 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.107 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.18 120.62 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.924 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.685 3.9 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.69 0.24 39.7 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.26 156.85 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.08 22.32 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.45 40.61 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.08 2.56 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.465 -2.421 . . . . 0.0 104.465 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.55 177.93 50.45 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.173 -3.171 . . . . 0.0 105.173 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.53 54.55 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.907 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.22 123.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -89.96 -166.76 1.67 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.82 -1.552 . . . . 0.0 108.502 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.78 62.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.902 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.8 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.076 0.941 . . . . 0.0 109.942 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.89 31.06 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.64 157.27 16.8 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.522 1.63 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.19 10.68 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.657 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.84 124.79 29.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.977 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.39 127.47 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.419 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.8 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.26 146.78 52.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.8 mtp85 -133.04 130.39 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.305 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.28 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.68 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.656 0.741 . . . . 0.0 112.639 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.55 4.96 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.72 142.99 57.89 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.704 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.089 1.596 . . . . 0.0 117.089 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.691 1.246 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.47 24.88 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -107.71 135.42 49.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.621 -1.627 . . . . 0.0 106.843 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.267 1.98 0 CA-C-O 121.41 0.624 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.1 tp -48.62 125.25 9.59 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.35 -43.11 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.689 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.83 173.96 15.19 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.509 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.56 155.85 13.19 Favored 'General case' 0 CA--C 1.486 -1.513 0 O-C-N 124.703 1.252 . . . . 0.0 111.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.33 138.72 53.11 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.054 0.846 . . . . 0.0 110.257 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -78.06 -35.49 49.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.71 -40.8 93.61 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.8 t80 -64.18 -45.19 89.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.028 1.87 . . . . 0.0 109.321 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.393 1.2 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.03 82.21 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 9.4 pt -90.89 14.13 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.65 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.28 55.99 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.429 24.3 t -71.47 131.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.174 0 CA-C-N 120.01 1.905 . . . . 0.0 110.291 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.32 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.019 1.344 . . . . 0.0 114.23 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.78 67.07 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.54 75.0 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.693 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.91 -49.19 73.64 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.09 70.83 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.419 0.628 . . . . 0.0 111.304 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.24 62.0 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.03 65.47 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.413 1.007 . . . . 0.0 113.939 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.73 -10.23 58.28 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.73 -10.74 47.26 Favored 'General case' 0 N--CA 1.418 -2.028 0 C-N-CA 117.465 -1.694 . . . . 0.0 109.318 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.34 158.06 32.91 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.216 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.94 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.763 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.28 158.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.676 1.235 . . . . 0.0 111.173 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.65 146.59 14.96 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.902 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.28 138.53 38.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.749 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.9 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.863 0.727 . . . . 0.0 111.907 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.07 117.17 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.023 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.89 -163.85 1.01 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.452 0.644 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.21 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.075 1.879 . . . . 0.0 116.075 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.57 4.31 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.33 6.62 48.53 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.57 146.24 34.33 Favored 'General case' 0 N--CA 1.402 -2.839 0 C-N-CA 116.081 -2.248 . . . . 0.0 113.757 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.23 158.3 38.5 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.3 p -137.52 167.93 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.75 76.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.647 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.788 ' C ' HD22 ' A' ' 61' ' ' ASN . 84.5 tttt -163.73 138.6 6.1 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 118.463 -1.295 . . . . 0.0 114.371 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.788 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.51 50.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.323 1.059 . . . . 0.0 110.225 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.1 m -116.91 153.91 31.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.965 0.888 . . . . 0.0 109.069 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.2 157.29 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.817 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.57 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.089 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.0 139.21 42.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.734 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.27 160.6 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.92 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.66 131.67 47.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -1.88 65.63 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.3 128.46 56.28 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.91 136.47 56.16 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.01 169.12 18.31 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.515 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.15 127.39 37.61 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.745 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.04 143.56 51.25 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.065 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.17 120.61 37.84 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.125 -1.609 . . . . 0.0 106.945 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.5 p -78.0 168.36 20.01 Favored 'General case' 0 CA--C 1.469 -2.157 0 CA-C-O 122.374 1.083 . . . . 0.0 111.617 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.671 3.6 mm? -52.36 -44.23 65.1 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.123 -1.853 . . . . 0.0 113.939 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.79 0.39 39.45 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.22 26.17 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.3 156.84 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.609 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.03 22.24 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.9 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.19 117.56 34.82 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.4 m -124.52 154.45 40.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 O-C-N 125.439 1.712 . . . . 0.0 111.736 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.1 143.44 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.44 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.47 22.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.998 1.319 . . . . 0.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.57 177.99 50.43 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.67 -22.44 17.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.85 16.49 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 mt -119.98 128.68 53.79 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -117.79 126.61 52.74 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.56 127.57 54.63 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.916 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.615 1.197 . . . . 0.0 108.771 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.757 -1.577 . . . . 0.0 108.492 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.39 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 11.9 p-10 -64.6 -25.96 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.6 m -138.89 149.65 45.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -100.62 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -32.57 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 -10.41 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.289 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.72 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.57 118.99 24.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.02 121.19 53.89 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.504 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.86 123.26 49.77 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.703 -0.623 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.3 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.75 33.84 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.735 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.18 10.64 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.687 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.63 24.09 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.809 1.318 . . . . 0.0 111.922 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.55 148.82 49.69 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.8 0.81 . . . . 0.0 111.378 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -133.07 130.39 39.28 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.25 61.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 113.998 -1.455 . . . . 0.0 114.336 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -110.09 133.74 52.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.737 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.53 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.089 0.868 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.224 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.6 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.58 63.29 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.615 0.722 . . . . 0.0 112.62 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.41 -10.6 5.07 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.43 28.83 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.736 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.74 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.47 24.91 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.243 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -107.76 135.4 49.25 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.839 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.64 138.14 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.498 0.666 . . . . 0.0 109.699 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -48.65 125.21 9.56 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.576 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.21 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.0 p -159.72 173.99 15.21 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.49 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.617 1.198 . . . . 0.0 111.74 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.37 138.69 53.08 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.24 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.83 9.3 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -78.13 -35.45 49.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.25 -39.08 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.348 1.07 . . . . 0.0 108.123 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.8 -40.74 93.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 119' ' ' ILE . 9.1 t80 -64.2 -45.15 89.58 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 124.03 1.871 . . . . 0.0 109.335 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.4 ptm -60.19 -41.4 92.85 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.885 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.64 -42.68 97.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.02 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.89 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.713 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 23.29 55.94 Favored Glycine 0 C--O 1.213 -1.16 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.425 23.8 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.9 30.4 Favored Glycine 0 CA--C 1.49 -1.493 0 CA-C-O 123.003 1.335 . . . . 0.0 114.299 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.52 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.193 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.17 -34.65 75.27 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.67 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.22 61.94 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -28.94 65.52 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.409 1.005 . . . . 0.0 113.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.82 -10.29 58.16 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.355 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.9 mt -95.65 152.61 18.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.69 80.43 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.615 -2.084 . . . . 0.0 111.004 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.34 158.06 32.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.403 2.735 . . . . 0.0 116.157 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.28 158.56 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 CA-C-O 122.675 1.226 . . . . 0.0 111.182 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.16 138.5 38.11 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.797 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.857 0.723 . . . . 0.0 111.976 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.09 117.15 41.15 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.05 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.43 0.633 . . . . 0.0 111.137 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.6 4.31 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.74 48.2 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.25 34.32 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.751 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.21 167.04 17.4 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.99 138.77 18.88 Favored 'General case' 0 C--N 1.263 -3.153 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.3 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -137.52 167.88 20.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.77 76.38 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.703 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 84.4 tttt -163.69 138.63 6.16 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.424 -1.31 . . . . 0.0 114.351 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.35 9.32 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.64 146.17 21.97 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.92 1.387 . . . . 0.0 111.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.18 42.97 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.6 40.91 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.66 131.69 47.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.48 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.5 56.3 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.695 1.712 . . . . 0.0 110.459 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.47 56.21 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.98 169.14 18.28 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.512 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.713 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.04 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.085 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.61 37.81 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.945 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.616 3.6 mm? -52.34 -44.23 65.05 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.006 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.71 0.29 39.53 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 18.22 26.11 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.976 1.951 . . . . 0.0 117.976 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.89 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -124.57 154.48 40.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.732 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -139.0 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.669 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.5 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.42 22.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.13 89.08 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.54 177.93 50.46 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.55 -22.52 18.16 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.87 16.44 12.62 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.0 128.62 53.71 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.8 118.69 57.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -117.84 126.57 52.66 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.886 1.803 . . . . 0.0 111.914 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.57 54.59 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.883 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -109.28 123.05 48.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.76 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.02 -166.74 1.66 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 117.791 -1.564 . . . . 0.0 108.492 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.45 17.72 Favored Glycine 0 CA--C 1.491 -1.46 0 O-C-N 119.991 -1.693 . . . . 0.0 114.239 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.53 -25.92 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.2 28.84 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.384 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 m -138.88 149.63 45.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.75 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.88 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.8 mt -115.65 122.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.053 0.93 . . . . 0.0 109.966 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.6 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.012 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.54 162.31 41.19 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.54 73.2 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.4 20.04 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.521 -2.472 . . . . 0.0 117.305 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.98 158.74 42.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.2 t -127.56 118.95 24.93 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.3 mt -102.95 121.09 53.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.939 -1.1 . . . . 0.0 111.497 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.79 123.23 49.67 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.69 -0.631 . . . . 0.0 109.804 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.75 122.79 68.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.591 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.74 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.761 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.66 102.79 7.77 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.22 10.8 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.539 -2.267 . . . . 0.0 109.657 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.04 -14.67 24.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.906 0.882 . . . . 0.0 112.1 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.77 29.35 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.785 1.303 . . . . 0.0 111.983 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.45 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.42 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.48 148.8 49.63 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.3 p -131.25 146.78 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.869 0.842 . . . . 0.0 111.323 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.33 61.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.951 -1.477 . . . . 0.0 114.327 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.751 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.283 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.57 56.23 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.196 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.64 63.12 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.671 0.748 . . . . 0.0 112.699 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.56 4.99 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 142.99 58.01 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.704 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.84 69.11 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.84 140.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.664 1.232 . . . . 0.0 108.524 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.46 24.88 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.602 1.668 . . . . 0.0 110.303 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.661 -1.609 . . . . 0.0 106.784 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.65 125.21 9.57 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.957 1.36 . . . . 0.0 112.621 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.15 3.56 Favored 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.7 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.8 173.96 15.2 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.46 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.63 155.85 13.03 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.633 1.208 . . . . 0.0 111.728 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.11 28.8 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -78.09 -35.49 49.3 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.15 82.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.77 93.64 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.8 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.051 1.881 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.406 1.5 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.96 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.315 12.4 pt -90.93 14.18 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -2.007 0 C-N-CA 117.09 -1.844 . . . . 0.0 111.688 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.417 21.9 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.57 74.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -63.88 -49.22 73.58 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.354 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.2 62.0 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.09 65.49 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.72 -10.32 58.22 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.792 0.837 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.83 47.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -95.61 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.39 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.982 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.223 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -119.99 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.317 -2.674 . . . . 0.0 106.703 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 pt -117.25 158.59 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.702 1.251 . . . . 0.0 111.207 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.404 0.621 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.56 4.3 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.66 48.42 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.23 167.03 17.44 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.89 138.86 19.05 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.283 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.03 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.68 16.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.39 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -137.5 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.662 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 53.3 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.05 126.54 51.04 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.297 1.046 . . . . 0.0 110.205 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.29 9.33 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.782 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.6 40.93 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.96 132.98 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.63 131.68 47.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.74 -1.9 65.82 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.43 56.28 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.648 1.69 . . . . 0.0 110.494 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.86 136.45 56.17 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -92.18 127.45 37.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.735 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -127.07 143.56 51.25 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.471 1.605 . . . . 0.0 115.05 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.22 120.65 37.97 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.617 3.5 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.75 0.26 39.88 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.21 25.97 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.909 1.924 . . . . 0.0 117.909 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.88 17.18 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 118.221 -1.392 . . . . 0.0 110.543 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.96 110.06 22.3 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.87 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.18 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -124.6 154.41 40.72 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.736 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.72 28.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.695 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -137.98 143.49 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.28 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.22 89.15 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.94 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.194 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.63 -22.51 17.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.74 16.38 12.73 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.8 126.57 52.67 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.965 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.59 127.58 54.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.942 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -109.25 123.14 48.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.741 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.06 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.502 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.45 17.63 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.345 11.9 p-10 -64.51 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -130.91 75.4 78.69 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 m -138.88 149.63 45.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mt -115.63 122.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.086 0.946 . . . . 0.0 109.905 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.5 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.015 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -124.77 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.91 115.87 31.02 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.54 157.23 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.57 73.25 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.58 1.657 . . . . 0.0 109.411 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.56 119.02 25.06 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.88 116.39 48.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.676 1.227 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 121.13 53.77 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.89 -1.131 . . . . 0.0 111.504 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.6 mp -113.71 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.644 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.69 33.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.794 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.45 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.42 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.79 49.67 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.269 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.692 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.26 132.46 48.19 Favored 'General case' 0 CA--C 1.496 -1.122 0 O-C-N 123.969 0.793 . . . . 0.0 112.245 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.36 1.552 . . . . 0.0 110.713 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 143.05 57.94 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.181 1.55 . . . . 0.0 109.687 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.23 -2.95 68.35 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.78 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.609 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.75 135.42 49.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.784 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.17 49.75 Favored 'General case' 0 C--O 1.265 1.92 0 CA-C-O 121.48 0.657 . . . . 0.0 109.671 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.0 tp -48.64 125.22 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.743 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.82 173.94 15.23 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.184 -1.007 . . . . 0.0 111.43 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -165.58 155.85 13.14 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.763 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.36 138.75 53.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.217 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.1 -35.49 49.19 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.19 -39.15 82.57 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.72 93.47 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.5 t80 -64.23 -45.15 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.409 1.4 ptm -60.19 -41.45 92.97 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.935 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.61 97.22 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.01 81.99 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.33 11.2 pt -90.92 14.11 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.1 -1.84 . . . . 0.0 111.684 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.91 23.28 56.02 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.419 31.1 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.98 30.33 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.47 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.21 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.33 -34.54 74.8 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.645 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.83 -49.26 73.53 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.18 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.04 65.5 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.939 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.7 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.497 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.2 mt -95.65 152.66 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.26 158.05 32.58 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 123.324 2.683 . . . . 0.0 116.263 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 111.358 -2.656 . . . . 0.0 106.733 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 41' ' ' ILE 0.284 12.2 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.62 1.2 . . . . 0.0 111.155 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.27 138.52 38.19 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.91 143.48 50.76 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.863 0.727 . . . . 0.0 111.877 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.493 0.663 . . . . 0.0 111.102 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.3 6.65 48.45 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.58 146.27 34.3 Favored 'General case' 0 N--CA 1.403 -2.807 0 C-N-CA 116.036 -2.266 . . . . 0.0 113.79 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.75 18.93 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.327 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.95 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.43 52.16 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.5 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.7 76.27 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.84 -6.76 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 55.0 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.11 126.55 51.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.283 1.04 . . . . 0.0 110.216 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.1 m -117.0 153.9 31.86 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.17 157.29 9.32 Favored 'General case' 0 CA--C 1.449 -2.913 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.841 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.57 146.24 22.13 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.086 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.65 40.94 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.63 131.63 46.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.86 65.86 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.18 127.37 37.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -126.97 143.52 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.12 120.59 37.77 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.115 -1.615 . . . . 0.0 106.905 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.5 p -78.01 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.631 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.648 3.4 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.13 26.24 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.25 156.9 17.17 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.62 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.87 171.92 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.21 117.61 34.92 Favored 'General case' 0 C--O 1.269 2.131 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -124.58 154.39 40.72 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.464 1.727 . . . . 0.0 111.764 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.254 1.307 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.83 171.45 14.77 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.57 150.46 22.22 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.103 1.361 . . . . 0.0 111.169 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.13 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.94 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.194 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 -22.43 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.216 2.737 . . . . 0.0 119.216 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.79 16.38 12.68 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -119.97 128.69 53.81 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.83 118.56 57.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.252 16.6 t-160 -117.76 126.58 52.71 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.816 1.77 . . . . 0.0 111.988 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.91 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -109.29 123.08 48.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.754 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.4 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.358 11.2 p-10 -64.54 -26.01 68.23 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -130.93 75.36 78.73 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.25 29.13 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.89 1.121 . . . . 0.0 111.42 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 m -138.89 149.64 45.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.3 135.56 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.008 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -124.77 113.94 18.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.23 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.65 -10.43 20.04 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.507 -2.477 . . . . 0.0 117.256 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.5 t -127.57 118.98 24.96 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-O 122.557 1.17 . . . . 0.0 111.181 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.97 121.2 53.84 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.96 -1.088 . . . . 0.0 111.508 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.2 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.437 HG21 ' CE2' ' A' ' 20' ' ' TYR . 15.3 mt -113.69 122.79 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.67 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.75 33.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.735 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.81 29.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.6 148.8 49.73 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.77 52.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.805 0.812 . . . . 0.0 111.408 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.08 130.45 39.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.917 -1.492 . . . . 0.0 114.291 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -110.09 133.69 52.95 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.722 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.29 132.54 48.19 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 124.046 0.841 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.714 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.256 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.647 0.736 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.4 -10.57 5.01 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.52 28.77 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.173 1.545 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.9 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.75 140.34 15.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.705 1.252 . . . . 0.0 108.545 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.644 1.688 . . . . 0.0 110.282 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.74 135.45 49.13 Favored 'General case' 0 N--CA 1.411 -2.394 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.784 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.68 138.15 49.91 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.23 3.55 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.678 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.5 p -159.77 173.95 15.24 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.49 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.8 9.41 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -78.13 -35.49 49.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.7 tt0 -68.18 -39.12 82.6 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.39 1.09 . . . . 0.0 108.084 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -60.79 -40.78 93.9 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 119' ' ' ILE . 26.2 t80 -64.21 -45.13 89.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 124.0 1.857 . . . . 0.0 109.349 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.15 -41.48 92.85 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 113.648 -1.614 . . . . 0.0 110.916 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.68 -42.59 97.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.06 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.331 10.3 pt -90.92 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.982 0 C-N-CA 117.157 -1.817 . . . . 0.0 111.707 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.28 55.94 Favored Glycine 0 C--O 1.215 -1.094 0 N-CA-C 122.379 3.712 . . . . 0.0 122.379 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.416 23.2 t -71.49 131.63 34.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.289 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.69 67.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.5 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.29 -34.62 74.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.25 73.61 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.66 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.258 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.05 65.57 Favored Glycine 0 C--O 1.205 -1.683 0 CA-C-O 122.365 0.981 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.82 47.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.9 mt -95.61 152.65 18.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.27 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.951 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.22 158.04 32.45 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.199 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -120.02 126.22 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.306 -2.679 . . . . 0.0 106.687 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -117.27 158.59 17.83 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 O-C-N 124.62 1.2 . . . . 0.0 111.191 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.23 138.49 38.18 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.788 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.89 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.28 41.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.28 -1.327 . . . . 0.0 107.966 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.51 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.43 6.73 48.21 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.2 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.834 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.57 55.22 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.4 p -128.22 158.34 38.37 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.7 t -141.5 124.64 16.37 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.91 139.43 52.13 Favored 'General case' 0 CA--C 1.474 -1.95 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.8 p -137.54 167.9 20.73 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.87 -6.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 53.8 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.15 126.51 50.89 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.269 1.033 . . . . 0.0 110.176 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.949 1.405 . . . . 0.0 111.119 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -107.96 139.25 42.87 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.689 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.69 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.72 -1.9 65.7 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.47 56.3 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.49 56.21 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -92.2 127.42 37.67 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.703 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.866 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.95 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.632 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.687 3.5 mm? -52.37 -44.22 65.14 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.69 0.21 39.79 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.06 26.27 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 117.926 1.93 . . . . 0.0 117.926 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -101.17 156.86 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.237 -1.385 . . . . 0.0 110.606 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.99 110.08 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.18 117.55 34.78 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.42 40.68 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.75 28.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.659 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -137.98 143.48 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -145.87 171.47 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 54.9 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.162 -3.175 . . . . 0.0 105.162 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.52 -22.53 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.226 2.741 . . . . 0.0 119.226 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.82 16.41 12.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -119.99 128.63 53.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.61 54.65 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.918 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -109.31 123.14 48.81 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.708 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.07 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.533 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.42 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.941 -1.724 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.49 -25.97 68.23 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.892 1.122 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.93 149.62 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.59 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.33 135.53 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 C-N-CA 117.893 -1.523 . . . . 0.0 108.964 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -124.78 113.86 18.5 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.27 16.79 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.53 162.33 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.47 20.02 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.314 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.91 158.76 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.34 48.47 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.1 m -110.88 123.3 49.85 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 109.757 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.414 HG21 ' CE2' ' A' ' 20' ' ' TYR . 11.8 mt -113.76 122.8 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.651 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.53 119.73 33.79 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.786 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -124.62 102.84 7.81 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.6 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.878 0.871 . . . . 0.0 112.108 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.88 124.81 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.887 1.367 . . . . 0.0 111.931 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.7 t -120.41 127.44 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.453 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.77 49.67 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.836 0.826 . . . . 0.0 111.4 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -133.07 130.46 39.38 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.291 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.987 -1.915 . . . . 0.0 111.691 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.55 48.15 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.984 0.802 . . . . 0.0 112.264 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.8 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.256 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.62 -32.58 63.24 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.687 0.756 . . . . 0.0 112.698 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.42 -10.56 5.03 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.35 2.41 28.78 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.042 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.99 57.93 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.162 1.539 . . . . 0.0 109.735 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.73 140.37 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.563 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.682 1.706 . . . . 0.0 110.255 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.72 135.39 49.23 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.664 -1.607 . . . . 0.0 106.804 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.65 138.15 49.87 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.52 0.676 . . . . 0.0 109.674 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -48.57 125.18 9.4 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.584 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 173.97 15.22 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.201 -0.999 . . . . 0.0 111.505 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -165.63 155.82 13.0 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.703 1.252 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.78 9.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.1 -35.55 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.15 -39.11 82.74 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.381 1.086 . . . . 0.0 108.101 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.82 -40.75 93.92 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.5 t80 -64.17 -45.17 89.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 123.987 1.851 . . . . 0.0 109.354 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.35 8.3 ttm -60.12 -41.46 92.66 Favored 'General case' 0 N--CA 1.41 -2.433 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.95 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -60.68 -42.57 97.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.04 82.1 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.299 13.2 pt -90.91 14.14 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.974 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.707 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.27 55.99 Favored Glycine 0 C--O 1.214 -1.124 0 N-CA-C 122.411 3.724 . . . . 0.0 122.411 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.434 12.2 t -71.45 131.64 34.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.264 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.97 30.34 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.71 -47.72 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.96 -33.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.201 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.08 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.2 mtm-85 -63.8 -49.26 73.58 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.07 65.61 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.346 0.97 . . . . 0.0 113.854 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.4 mt -83.73 -10.27 58.25 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.771 0.828 . . . . 0.0 109.433 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.85 47.14 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt -95.64 152.6 18.3 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 117.986 2.587 . . . . 0.0 117.986 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.71 80.4 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.95 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.23 158.03 32.51 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.333 2.689 . . . . 0.0 116.238 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.335 -2.666 . . . . 0.0 106.748 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.278 14.7 pt -117.29 158.59 17.85 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.628 1.204 . . . . 0.0 111.128 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.67 146.56 14.9 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.92 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.25 138.52 38.16 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.761 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.9 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.863 0.727 . . . . 0.0 111.945 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.17 117.23 41.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.961 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.455 0.645 . . . . 0.0 111.119 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.91 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.66 48.41 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.2 167.03 17.42 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.273 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -120.07 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.7 p -128.2 158.31 38.46 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.803 1.287 . . . . 0.0 110.627 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.5 t -141.49 124.68 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.87 139.44 52.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.7 p -137.51 167.86 20.79 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.7 76.24 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.719 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 pp -98.88 -6.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 50.1 tttm -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.5 m -116.96 153.9 31.82 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.3 9.35 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.772 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.6 146.2 22.06 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 124.936 1.397 . . . . 0.0 111.055 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.2 m -107.92 139.22 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.745 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.34 160.62 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.99 133.05 56.29 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.61 131.67 46.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -1.9 65.93 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 115.708 1.043 . . . . 0.0 115.708 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.34 128.43 56.29 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.82 136.45 56.2 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.0 169.17 18.22 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.735 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.16 120.63 37.86 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.151 -1.593 . . . . 0.0 106.888 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -77.97 168.43 19.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.637 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.625 4.1 mm? -52.45 -44.2 65.37 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.153 -1.839 . . . . 0.0 113.963 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.74 0.29 39.68 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.4 m -117.92 171.91 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.9 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -124.61 154.44 40.69 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.99 144.79 28.76 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.659 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.9 mt -138.03 143.4 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.7 p -145.81 171.5 14.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.62 150.43 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.087 1.355 . . . . 0.0 111.189 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.6 177.89 50.4 Favored Glycine 0 N--CA 1.407 -3.29 0 C-N-CA 115.635 -3.174 . . . . 0.0 105.183 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.57 -22.47 18.19 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.265 2.756 . . . . 0.0 119.265 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.81 16.42 12.67 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.03 128.68 53.75 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -117.85 126.56 52.62 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 123.81 1.767 . . . . 0.0 111.947 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.62 54.66 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.91 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.31 123.13 48.78 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.719 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.706 -1.598 . . . . 0.0 108.549 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.38 17.71 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.9 -1.75 . . . . 0.0 114.235 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.36 11.3 p-10 -64.59 -25.95 68.19 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -130.94 75.41 78.65 Favored Pre-proline 0 C--O 1.203 -1.343 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.2 128.27 29.25 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.845 1.102 . . . . 0.0 111.345 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.93 149.64 45.0 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.77 62.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.2 mt -115.62 122.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.59 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 108.988 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -124.8 113.9 18.54 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.89 115.94 31.15 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.69 157.21 16.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.33 41.13 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -32.47 73.16 Favored 'General case' 0 N--CA 1.41 -2.443 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.47 19.96 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 115.503 -2.479 . . . . 0.0 117.274 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.76 42.61 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.93 123.27 49.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.369 0.605 . . . . 0.0 109.747 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.497 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.8 mp -113.73 122.84 68.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.625 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.68 33.65 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.8 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.61 102.79 7.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.61 -117.14 10.53 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.666 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.12 -14.6 24.05 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.871 0.868 . . . . 0.0 112.085 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.86 124.83 29.42 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.832 1.332 . . . . 0.0 111.906 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.8 t -120.43 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.436 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.57 148.77 49.71 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.76 52.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -133.08 130.46 39.37 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.87 119.26 61.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.291 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.13 133.66 52.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.721 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.25 132.54 48.13 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.984 0.802 . . . . 0.0 112.283 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.54 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.371 1.558 . . . . 0.0 110.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 -179.923 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.56 63.28 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.706 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.52 28.66 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.77 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.541 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.51 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.843 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.54 138.17 49.7 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.494 0.664 . . . . 0.0 109.671 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.965 1.364 . . . . 0.0 112.56 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.33 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.693 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.01 15.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.64 155.83 12.99 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.598 1.187 . . . . 0.0 111.759 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.76 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.2 -39.18 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.72 -40.76 93.52 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.494 ' CE2' HG21 ' A' ' 119' ' ' ILE . 8.9 t80 -64.16 -45.15 89.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.349 8.4 ttm -60.23 -41.44 93.1 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.9 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.62 -42.65 97.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.62 -39.93 81.85 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.328 11.3 pt -90.99 14.13 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.149 -1.821 . . . . 0.0 111.66 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.95 23.26 56.01 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.442 12.5 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.001 1.9 . . . . 0.0 110.323 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.97 30.26 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.037 1.354 . . . . 0.0 114.253 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.75 67.04 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -73.0 -33.44 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.156 -1.384 . . . . 0.0 113.235 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.6 75.07 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.89 -49.15 73.81 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.48 -51.11 70.77 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.205 -1.668 0 CA-C-O 122.427 1.015 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.74 -10.32 58.2 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.426 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.75 47.49 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.296 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.67 152.62 18.29 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.84 71.76 80.25 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.951 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.279 14.5 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.666 1.229 . . . . 0.0 111.208 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.56 14.88 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.859 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.758 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.506 0.669 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.29 6.65 48.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.61 55.19 Favored 'General case' 0 C--O 1.278 2.602 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.37 38.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.876 1.322 . . . . 0.0 110.565 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.996 -1.456 . . . . 0.0 107.104 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.51 167.91 20.71 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.6 tttt -163.73 138.62 6.11 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.499 -1.28 . . . . 0.0 114.446 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.13 157.34 9.44 Favored 'General case' 0 CA--C 1.45 -2.883 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.788 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.16 43.03 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.69 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.25 160.6 40.94 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.95 132.97 56.35 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.63 131.72 47.13 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.648 1.69 . . . . 0.0 110.499 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -136.99 169.2 18.18 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.18 127.4 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.764 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -127.05 143.52 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.508 1.623 . . . . 0.0 115.076 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.105 -1.622 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.628 4.1 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.09 26.2 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -101.19 156.87 17.18 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.574 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.09 22.34 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.86 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -124.55 154.43 40.62 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.739 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.659 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.76 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.184 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.23 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.95 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.65 -22.46 17.99 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 N-CA-C 119.153 2.713 . . . . 0.0 119.153 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.82 16.33 12.66 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.1 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.6 t -109.73 118.63 57.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.61 -162.46 17.67 Favored Glycine 0 CA--C 1.491 -1.445 0 O-C-N 119.902 -1.749 . . . . 0.0 114.207 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.346 12.0 p-10 -64.5 -26.01 68.24 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.908 1.128 . . . . 0.0 111.429 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -138.8 149.65 45.2 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.21 119.7 62.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.891 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.55 122.36 69.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.018 0.914 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.57 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.985 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -124.74 113.87 18.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.52 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.54 119.02 25.09 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -102.97 121.13 53.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.97 -1.081 . . . . 0.0 111.504 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.9 123.23 49.73 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.436 0.636 . . . . 0.0 109.733 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' TYR . 2.9 mp -113.65 122.81 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.644 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.0 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.17 10.58 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 tt -80.81 124.84 29.41 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.885 1.366 . . . . 0.0 111.915 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.4 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.79 52.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -133.11 130.43 39.27 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.289 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.27 132.54 48.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.973 0.796 . . . . 0.0 112.255 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.52 56.18 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.256 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.38 2.47 28.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.04 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.95 68.5 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.79 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.701 1.251 . . . . 0.0 108.565 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.49 112.52 24.95 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.59 125.27 9.57 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.621 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.41 138.73 53.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.079 0.862 . . . . 0.0 110.198 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -78.1 -35.47 49.26 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.7 tt0 -68.18 -39.11 82.62 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.35 1.071 . . . . 0.0 108.111 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.7 ttm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.329 11.0 pt -90.87 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.438 11.7 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.69 67.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.058 2.244 . . . . 0.0 117.058 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.5 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.269 0 CA-C-N 114.143 -1.389 . . . . 0.0 113.223 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.11 70.73 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.16 -46.2 61.97 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.04 65.72 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.85 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.34 158.55 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.636 1.21 . . . . 0.0 111.158 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.27 138.48 38.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.761 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.019 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.94 -163.84 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.493 0.663 . . . . 0.0 111.124 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.2 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.62 48.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.51 146.21 34.49 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.115 -2.234 . . . . 0.0 113.808 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.5 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.0 p -137.47 167.96 20.6 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.62 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.7 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.33 160.56 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.01 143.52 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.086 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.3 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.705 4.0 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.3 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.77 28.82 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.06 143.4 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.8 171.51 14.68 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.63 150.41 22.29 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.099 1.36 . . . . 0.0 111.17 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.87 52.45 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -120.06 128.72 53.76 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.04 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.759 -1.576 . . . . 0.0 108.524 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.344 12.0 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.92 75.32 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.15 128.23 29.01 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.913 1.13 . . . . 0.0 111.368 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.4 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.82 113.93 18.56 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.47 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.57 118.95 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.898 -1.127 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.8 mt -113.78 122.82 68.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.575 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.72 33.78 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.758 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -133.1 130.39 39.21 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.254 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.48 -32.7 63.05 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.715 0.769 . . . . 0.0 112.687 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.33 -10.56 4.89 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.45 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 143.02 57.95 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.727 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.3 -2.96 68.7 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.119 1.608 . . . . 0.0 117.119 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.83 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.636 1.218 . . . . 0.0 108.561 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.6 138.11 49.86 Favored 'General case' 0 C--O 1.266 1.957 0 CA-C-O 121.447 0.641 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.9 tp -48.6 125.26 9.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 122.99 1.376 . . . . 0.0 112.59 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.16 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.707 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 124.703 1.252 . . . . 0.0 111.794 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.0 p -127.37 138.69 53.07 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.104 0.878 . . . . 0.0 110.24 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.06 28.79 9.26 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -64.14 -45.18 89.65 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.08 1.895 . . . . 0.0 109.392 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.351 8.9 ttm -60.21 -41.36 92.87 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.934 179.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.65 -42.64 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.345 9.9 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.661 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.441 12.0 t -71.44 131.61 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.295 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.55 161.87 30.45 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.008 1.338 . . . . 0.0 114.216 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.94 -33.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.24 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.688 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 62.3 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.11 70.76 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.444 0.64 . . . . 0.0 111.281 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.12 -46.22 61.82 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.01 65.43 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.79 -10.24 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.742 0.817 . . . . 0.0 109.433 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.79 47.31 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.64 152.55 18.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.81 80.31 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.37 158.06 33.07 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.383 2.722 . . . . 0.0 116.177 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.22 158.59 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.72 146.56 14.83 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.872 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.8 tp -101.19 138.51 38.13 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.87 143.42 50.72 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.994 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.02 117.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.023 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.422 0.63 . . . . 0.0 111.171 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.22 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.61 4.32 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.68 48.35 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.56 146.22 34.37 Favored 'General case' 0 N--CA 1.402 -2.858 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.79 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.25 167.0 17.49 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.293 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.27 158.34 38.42 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.852 1.31 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -141.45 124.62 16.41 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.163 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.37 52.19 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.1 p -137.47 167.97 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.74 76.37 Favored 'General case' 0 C--O 1.192 -1.945 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.624 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.7 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.286 1.041 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 m -116.91 153.95 31.68 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.016 0.913 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.61 146.29 22.12 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.089 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -108.02 139.17 43.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.708 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.58 40.92 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.69 131.67 47.15 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.9 65.6 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -137.01 169.11 18.33 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.1 127.39 37.55 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -127.06 143.51 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.087 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.6 37.85 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.875 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.4 p -77.94 168.32 20.09 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.618 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.686 4.1 mm? -52.31 -44.25 64.98 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 113.999 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.72 0.26 39.72 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.71 18.27 25.88 Favored Glycine 0 CA--C 1.481 -2.039 0 N-CA-C 117.896 1.919 . . . . 0.0 117.896 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.25 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.606 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.9 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.85 171.89 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.15 117.54 34.78 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.53 154.45 40.56 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.476 1.735 . . . . 0.0 111.743 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.01 144.77 28.79 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.644 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.08 143.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.99 50.41 Favored Glycine 0 N--CA 1.407 -3.235 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.53 17.99 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.79 52.52 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.4 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.8 118.64 57.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -117.79 126.65 52.82 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.64 127.53 54.53 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.907 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.22 123.01 48.55 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 124.629 1.206 . . . . 0.0 108.792 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.92 -166.7 1.65 Allowed 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 117.783 -1.567 . . . . 0.0 108.531 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.39 17.74 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.924 -1.735 . . . . 0.0 114.272 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.6 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.1 m -138.84 149.59 45.08 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.16 119.79 63.01 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.18 -1.373 . . . . 0.0 107.875 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.077 0.942 . . . . 0.0 109.942 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.96 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.59 157.22 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.566 1.65 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -10.37 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.338 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.8 t -127.61 119.0 24.95 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.81 116.3 48.36 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.154 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.96 121.13 53.76 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 111.478 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.86 123.24 49.72 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.669 -0.644 . . . . 0.0 109.762 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.6 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.904 0.859 . . . . 0.0 112.599 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.52 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.648 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.66 24.06 Favored 'General case' 0 CA--C 1.47 -2.122 0 C-N-CA 123.938 0.895 . . . . 0.0 112.1 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.87 29.44 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.845 1.341 . . . . 0.0 111.947 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.45 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.4 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.53 148.82 49.67 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.76 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.83 0.824 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -133.05 130.4 39.32 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.84 119.28 61.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 113.968 -1.469 . . . . 0.0 114.314 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -110.15 133.68 52.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 112.956 -1.929 . . . . 0.0 111.743 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.271 3.7 p . . . . . 0 CA--C 1.551 1.019 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.64 -32.59 63.3 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.689 0.757 . . . . 0.0 112.68 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -105.4 2.45 28.71 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 120.073 -0.651 . . . . 0.0 112.042 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.233 1.583 . . . . 0.0 109.704 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.92 68.55 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.72 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.701 1.251 . . . . 0.0 108.59 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.44 112.47 24.9 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 123.597 1.665 . . . . 0.0 110.28 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.73 135.38 49.25 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.844 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.57 138.17 49.74 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.524 0.678 . . . . 0.0 109.659 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp -48.64 125.21 9.55 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.56 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.32 -43.23 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.663 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -159.73 174.0 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.46 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.62 155.84 13.05 Favored 'General case' 0 CA--C 1.486 -1.492 0 O-C-N 124.633 1.208 . . . . 0.0 111.709 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.092 0.87 . . . . 0.0 110.246 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.17 28.77 9.46 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.1 -35.47 49.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' HG2' ' HE ' ' A' ' 31' ' ' ARG . 41.8 tt0 -68.25 -39.13 82.36 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.381 1.086 . . . . 0.0 108.077 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.77 -40.73 93.63 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -64.17 -45.12 89.82 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 124.009 1.862 . . . . 0.0 109.406 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 31' ' ' ARG 0.359 8.3 ttm -60.18 -41.46 92.95 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.901 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.6 -42.65 97.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.318 11.5 pt -90.95 14.13 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.66 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.25 56.05 Favored Glycine 0 C--O 1.214 -1.108 0 N-CA-C 122.427 3.731 . . . . 0.0 122.427 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.409 10.8 t -71.41 131.6 34.34 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.95 30.16 Favored Glycine 0 N--CA 1.478 1.479 0 CA-C-O 123.037 1.354 . . . . 0.0 114.287 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.79 67.01 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.88 -33.52 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.239 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.57 75.01 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.704 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.46 ' HE ' ' HG2' ' A' ' 18' ' ' GLU . 60.5 mtm-85 -63.89 -49.16 73.78 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.39 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.423 0.63 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.17 62.09 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.05 65.51 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.38 0.989 . . . . 0.0 113.914 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -83.76 -10.29 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.829 0.852 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.6 mt -95.65 152.63 18.28 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.74 80.35 Favored Pre-proline 0 C--N 1.348 0.51 0 CA-C-N 112.641 -2.072 . . . . 0.0 110.981 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -60.3 158.0 33.01 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.21 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.9 t -119.98 126.19 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.755 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 pt -117.2 158.55 17.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 O-C-N 124.693 1.245 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.22 138.53 38.12 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.818 0.698 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.25 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.021 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -104.0 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.464 0.65 . . . . 0.0 111.083 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.15 110.18 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.95 -112.65 4.33 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.69 48.33 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.51 146.2 34.48 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.834 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.19 167.0 17.45 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.76 18.94 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.3 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.98 134.64 55.19 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.23 158.33 38.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.849 1.309 . . . . 0.0 110.578 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -141.52 124.68 16.39 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.109 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.86 139.45 52.15 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.6 p -137.5 167.87 20.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.72 76.28 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.689 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.5 tttt -163.72 138.61 6.11 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.473 -1.291 . . . . 0.0 114.386 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.6 51.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.332 1.063 . . . . 0.0 110.146 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.0 m -116.96 153.86 31.87 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.979 0.895 . . . . 0.0 109.053 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.12 157.37 9.48 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.641 -1.223 . . . . 0.0 109.764 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.66 146.24 22.01 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.9 1.375 . . . . 0.0 111.055 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -108.01 139.18 43.04 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.664 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.26 160.59 40.93 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.99 132.97 56.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.6 131.74 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.66 -1.91 65.36 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-O 123.682 1.706 . . . . 0.0 110.479 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.79 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.8 136.48 56.25 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -136.99 169.16 18.24 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.517 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.735 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.01 143.56 51.26 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 123.47 1.605 . . . . 0.0 115.071 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.63 37.91 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.125 -1.609 . . . . 0.0 106.87 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.96 168.33 20.08 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.679 3.7 mm? -52.36 -44.25 65.11 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.187 -1.824 . . . . 0.0 113.999 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -81.72 0.33 39.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.06 22.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.87 171.85 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.79 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.1 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.0 144.78 28.77 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.72 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.3 mt -138.03 143.46 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.9 p -145.9 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.59 150.37 22.31 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.17 89.16 2.58 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.103 -3.199 . . . . 0.0 105.103 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.5 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.8 16.33 12.67 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.82 52.5 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -119.96 128.65 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.76 118.64 57.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.86 126.56 52.62 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.86 1.791 . . . . 0.0 111.936 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.6 127.62 54.65 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.858 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -109.31 123.11 48.76 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.708 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.58 -162.45 17.71 Favored Glycine 0 CA--C 1.49 -1.505 0 O-C-N 119.9 -1.75 . . . . 0.0 114.223 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 12.0 p-10 -64.54 -25.99 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.87 75.32 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.14 128.19 28.86 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.841 1.1 . . . . 0.0 111.416 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.6 45.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 119.77 62.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.88 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.0 mt -115.62 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 122.007 0.908 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.28 135.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.964 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.76 113.87 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.9 115.95 31.15 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.63 157.21 16.84 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.33 41.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.587 1.661 . . . . 0.0 109.447 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.76 42.56 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.55 118.98 24.99 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.8 116.34 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.98 121.14 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.534 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.5 m -110.88 123.27 49.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.369 0.605 . . . . 0.0 109.774 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.68 122.81 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.644 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.58 119.73 33.75 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.732 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.1 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.63 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.548 -2.263 . . . . 0.0 109.666 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.07 -14.61 24.11 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.906 0.882 . . . . 0.0 112.112 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.83 124.82 29.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 124.83 1.331 . . . . 0.0 111.906 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.2 t -120.48 127.42 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.4 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.7 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.14 146.79 52.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -133.12 130.44 39.26 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.88 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.311 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.021 -1.9 . . . . 0.0 111.751 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.54 48.17 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.969 0.793 . . . . 0.0 112.283 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.79 133.46 56.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.349 1.547 . . . . 0.0 110.713 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.199 -179.869 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.6 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.58 -32.59 63.18 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.03 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.39 2.51 28.78 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.033 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 143.01 57.99 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.256 1.597 . . . . 0.0 109.736 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.26 -2.97 68.4 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.38 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.663 1.232 . . . . 0.0 108.58 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.49 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.614 1.673 . . . . 0.0 110.224 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -107.72 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.468 0.652 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -48.64 125.27 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.34 -43.16 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.3 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -165.62 155.85 13.06 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.686 1.241 . . . . 0.0 111.768 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.3 p -127.42 138.71 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.147 0.904 . . . . 0.0 110.181 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.32 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -78.07 -35.46 49.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.26 -39.05 82.34 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.357 1.075 . . . . 0.0 108.122 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.389 1.6 ptm -60.2 -41.36 92.8 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.92 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.66 -42.63 97.39 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.264 13.1 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.9 23.3 55.97 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.365 17.7 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.91 30.58 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.89 -33.54 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.233 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.696 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -63.85 -49.19 73.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.419 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.14 70.65 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.23 61.95 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.02 65.55 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.425 1.014 . . . . 0.0 113.91 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.73 -10.29 58.24 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.764 0.825 . . . . 0.0 109.464 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.73 47.58 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 117.426 -1.71 . . . . 0.0 109.395 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.1 mt -95.68 152.59 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.68 80.5 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.004 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.34 2.693 . . . . 0.0 116.187 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.96 126.29 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.713 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 41' ' ' ILE 0.289 13.8 pt -117.34 158.56 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.146 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.57 14.9 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 tp -101.23 138.52 38.14 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.75 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.46 50.75 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.894 0.746 . . . . 0.0 111.948 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 m -97.08 117.15 41.14 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.053 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.93 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.419 0.628 . . . . 0.0 111.137 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.568 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.38 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.55 146.23 34.38 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.784 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.27 167.0 17.52 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.88 138.78 18.98 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.32 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 t -141.45 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.163 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.4 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.8 p -137.47 167.98 20.56 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.655 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 84.2 tttt -163.7 138.61 6.13 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.52 50.93 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.5 m -116.89 153.92 31.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.062 0.934 . . . . 0.0 109.02 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.26 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.782 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.97 139.16 43.01 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.717 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.29 160.56 40.88 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.63 131.64 46.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.87 65.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.46 56.28 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 123.623 1.677 . . . . 0.0 110.474 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.46 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -137.01 169.14 18.29 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.523 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -92.14 127.34 37.58 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.713 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -127.03 143.53 51.27 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.435 1.588 . . . . 0.0 115.117 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.11 120.61 37.79 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.19 -1.568 . . . . 0.0 106.954 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.4 p -78.0 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.388 1.09 . . . . 0.0 111.59 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.532 3.7 mm? -52.32 -44.23 65.0 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.029 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -81.73 0.29 39.67 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.21 25.97 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.26 156.85 17.2 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.245 -1.382 . . . . 0.0 110.601 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 m -124.57 154.45 40.63 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.743 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -139.02 144.79 28.73 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.656 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.12 143.41 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.81 171.51 14.67 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.18 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.629 -3.177 . . . . 0.0 105.174 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.57 -22.53 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.82 16.45 12.66 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.26 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.03 128.72 53.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.86 118.64 57.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -117.78 126.59 52.71 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.61 127.57 54.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.876 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -109.26 123.05 48.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.792 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.72 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.6 -162.41 17.69 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.949 -1.719 . . . . 0.0 114.254 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.363 11.3 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.1 128.22 28.96 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.4 m -138.88 149.66 45.1 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.8 mt -115.61 122.38 69.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -124.78 113.89 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.89 115.93 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.26 16.82 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.55 162.32 41.17 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.56 73.21 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.4 20.02 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 115.513 -2.475 . . . . 0.0 117.247 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.99 158.74 42.5 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -127.54 118.93 24.91 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 CA-C-O 122.619 1.2 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.95 121.12 53.73 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 O-C-N 120.898 -1.127 . . . . 0.0 111.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 121.635 -0.665 . . . . 0.0 109.747 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.77 122.83 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.565 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.764 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.55 119.74 33.81 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.761 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.2 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.764 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.64 -117.2 10.72 Favored Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 117.55 -2.262 . . . . 0.0 109.624 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tt -80.82 124.78 29.36 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.865 1.353 . . . . 0.0 112.008 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.41 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.52 148.8 49.67 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.79 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -133.1 130.38 39.21 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.357 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -110.1 133.64 53.0 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.996 0.81 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.224 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.65 -32.57 63.31 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.65 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.98 57.93 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.239 1.587 . . . . 0.0 109.767 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.97 68.46 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.74 140.38 15.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.597 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.5 112.55 25.0 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.197 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.267 1.989 0 CA-C-O 121.431 0.634 . . . . 0.0 109.711 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.22 9.58 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.964 1.364 . . . . 0.0 112.606 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.29 -43.18 3.56 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.677 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.74 173.99 15.2 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.479 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.113 0.883 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -78.05 -35.54 49.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.18 -39.11 82.6 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.83 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.403 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.18 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.342 10.8 pt -90.87 14.12 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.127 -1.829 . . . . 0.0 111.714 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.38 55.88 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.452 3.741 . . . . 0.0 122.452 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.0 t -71.45 131.59 34.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.991 1.895 . . . . 0.0 110.298 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.56 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.073 1.374 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.66 -47.78 66.92 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.92 -33.52 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.21 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.19 -34.62 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.704 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.21 73.79 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -57.43 -51.13 70.67 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.247 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.15 62.11 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.49 -29.01 65.78 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.342 0.968 . . . . 0.0 113.846 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.71 -10.27 58.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.66 -10.75 47.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 117.487 -1.685 . . . . 0.0 109.379 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.72 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.76 71.66 80.51 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.3 158.56 17.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-O 122.654 1.216 . . . . 0.0 111.119 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -160.67 146.54 14.89 Favored 'General case' 0 N--CA 1.394 -3.25 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.936 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 tp -101.23 138.48 38.2 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.761 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.51 50.78 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.845 0.716 . . . . 0.0 111.895 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.09 117.16 41.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.238 -1.347 . . . . 0.0 108.053 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.91 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -128.26 167.0 17.51 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.77 18.94 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.3 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.02 134.59 55.2 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.2 158.3 38.47 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.831 1.301 . . . . 0.0 110.566 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.167 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -137.52 167.87 20.78 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.72 76.29 Favored 'General case' 0 N--CA 1.42 -1.969 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.711 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.77 -6.89 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.787 ' C ' HD22 ' A' ' 61' ' ' ASN . 83.7 tttt -163.67 138.65 6.19 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 118.408 -1.317 . . . . 0.0 114.366 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.787 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.16 126.55 50.96 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.9 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.19 157.33 9.3 Favored 'General case' 0 CA--C 1.449 -2.916 0 C-N-CA 118.678 -1.209 . . . . 0.0 109.753 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.5 m -107.95 139.2 42.92 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.34 160.58 40.84 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.93 133.06 56.29 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.67 46.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.82 65.75 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.01 169.13 18.3 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.457 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.733 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.02 143.54 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.475 1.607 . . . . 0.0 115.085 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.13 120.65 37.86 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.151 -1.593 . . . . 0.0 106.936 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -78.03 168.38 19.98 Favored 'General case' 0 CA--C 1.468 -2.192 0 CA-C-O 122.429 1.109 . . . . 0.0 111.603 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.659 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.963 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.14 26.22 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.954 1.941 . . . . 0.0 117.954 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.85 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.626 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.91 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.8 mttt -103.13 117.58 34.87 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.45 40.63 Favored 'General case' 0 N--CA 1.424 -1.746 0 O-C-N 125.436 1.71 . . . . 0.0 111.75 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.42 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.8 171.54 14.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.63 150.47 22.23 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.014 1.326 . . . . 0.0 111.181 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.9 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.55 -22.48 18.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.86 16.45 12.63 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.78 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.85 118.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.62 54.61 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.28 123.03 48.61 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.771 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.914 -1.741 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.341 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.94 75.27 78.86 Favored Pre-proline 0 C--O 1.204 -1.325 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.08 128.22 28.95 Favored 'Trans proline' 0 C--N 1.284 -2.829 0 CA-C-O 122.913 1.13 . . . . 0.0 111.396 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.9 149.68 45.1 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.12 119.73 62.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.35 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.053 0.93 . . . . 0.0 109.994 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.22 135.63 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.862 -1.535 . . . . 0.0 109.013 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.8 113.9 18.53 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.68 157.22 16.85 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.9 p -151.46 162.32 41.16 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.49 73.15 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.549 1.642 . . . . 0.0 109.486 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 -10.39 19.99 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 115.532 -2.467 . . . . 0.0 117.247 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -152.99 158.73 42.48 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -177.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -127.52 118.93 24.92 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.77 116.31 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.568 1.175 . . . . 0.0 111.17 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -110.89 123.27 49.81 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.82 68.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.591 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.52 119.76 33.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.741 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.7 102.74 7.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.62 -117.18 10.65 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.511 -2.281 . . . . 0.0 109.687 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.61 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.89 124.78 29.39 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 124.83 1.331 . . . . 0.0 111.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.42 127.51 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.379 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.75 52.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.09 130.44 39.3 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.349 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.53 48.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.018 0.824 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.78 133.53 56.19 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 123.33 1.538 . . . . 0.0 110.651 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.254 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.274 3.7 p . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.54 -32.6 63.1 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.652 0.739 . . . . 0.0 112.724 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.43 -10.49 4.96 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.45 2.52 28.67 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.038 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.85 143.02 57.99 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.179 1.549 . . . . 0.0 109.704 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.2 -2.86 68.6 Favored Glycine 0 C--O 1.193 -2.426 0 N-CA-C 117.164 1.626 . . . . 0.0 117.164 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.8 140.41 15.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 118.623 1.211 . . . . 0.0 108.529 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.45 112.5 24.94 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 123.617 1.675 . . . . 0.0 110.282 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -107.73 135.4 49.22 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.701 -1.591 . . . . 0.0 106.779 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.61 138.14 49.83 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.18 9.5 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.971 1.367 . . . . 0.0 112.63 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.63 155.83 13.02 Favored 'General case' 0 CA--C 1.487 -1.471 0 O-C-N 124.634 1.209 . . . . 0.0 111.759 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.39 138.69 53.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.095 0.872 . . . . 0.0 110.246 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.18 28.77 9.48 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.1 -35.47 49.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.526 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.28 -39.03 82.25 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.396 1.094 . . . . 0.0 108.098 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.84 -40.7 93.82 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.72 -42.56 97.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.99 82.17 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.34 10.8 pt -90.9 14.16 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.091 -1.844 . . . . 0.0 111.702 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.33 55.88 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.446 3.738 . . . . 0.0 122.446 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.423 24.1 t -71.5 131.64 34.31 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.989 1.894 . . . . 0.0 110.264 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 161.96 30.36 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.052 1.362 . . . . 0.0 114.23 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.79 66.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.91 -33.5 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.278 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.201 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.65 75.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.688 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.8 -49.24 73.67 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.376 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.13 70.69 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.225 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.22 62.01 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.29 -29.08 65.38 Favored Glycine 0 C--O 1.204 -1.768 0 CA-C-O 122.429 1.016 . . . . 0.0 113.918 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.74 -10.32 58.21 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.786 0.834 . . . . 0.0 109.426 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.59 -10.79 47.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.38 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.63 152.54 18.35 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.79 71.76 80.37 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.652 -2.067 . . . . 0.0 110.951 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.25 158.02 32.65 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.396 2.731 . . . . 0.0 116.177 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -119.99 126.22 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.247 -2.706 . . . . 0.0 106.687 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.27 158.6 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.687 1.232 . . . . 0.0 111.18 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -160.68 146.55 14.89 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.872 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.21 138.49 38.17 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.788 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.88 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.16 117.2 41.32 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.016 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.95 -163.84 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.445 0.64 . . . . 0.0 111.119 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.18 110.2 0.52 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.85 -112.52 4.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.4 6.69 48.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -128.25 167.05 17.43 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.82 18.99 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.273 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.03 134.59 55.21 Favored 'General case' 0 C--O 1.28 2.677 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.727 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.9 p -128.24 158.38 38.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.855 1.312 . . . . 0.0 110.58 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.49 124.67 16.41 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.89 139.36 52.17 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.7 p -137.45 167.97 20.58 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.69 76.25 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.662 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.85 -6.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 85.0 tttt -163.74 138.57 6.08 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.431 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.56 51.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.304 1.049 . . . . 0.0 110.203 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -116.96 153.89 31.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.727 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.15 157.29 9.35 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.782 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.58 146.2 22.09 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.897 1.373 . . . . 0.0 111.119 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 m -107.94 139.24 42.86 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.714 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -155.33 160.6 40.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.95 133.02 56.32 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.65 131.68 47.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.9 65.64 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.28 128.46 56.27 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 123.661 1.696 . . . . 0.0 110.474 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.9 136.48 56.18 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.0 169.21 18.16 Favored 'General case' 0 C--O 1.254 1.33 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.19 127.44 37.67 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.714 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -127.07 143.54 51.25 Favored 'General case' 0 CA--C 1.588 2.406 0 CA-C-O 123.418 1.58 . . . . 0.0 115.07 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.64 37.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.19 -1.569 . . . . 0.0 106.866 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p -77.99 168.33 20.06 Favored 'General case' 0 CA--C 1.469 -2.165 0 CA-C-O 122.354 1.073 . . . . 0.0 111.654 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.661 3.6 mm? -52.34 -44.21 65.05 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.233 -1.803 . . . . 0.0 114.023 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.7 0.21 39.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.22 25.91 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.3 mtm105 -101.29 156.87 17.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.539 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.09 22.33 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.91 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.9 m -124.59 154.4 40.74 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.718 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.82 28.72 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.659 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.0 mt -138.07 143.45 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.88 171.48 14.75 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.9 50.41 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 105.194 -3.162 . . . . 0.0 105.194 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.58 -22.55 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.176 2.722 . . . . 0.0 119.176 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.42 12.71 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.3 140.76 52.54 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.1 mt -119.97 128.67 53.79 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.78 118.61 57.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.53 52.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.978 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.55 127.55 54.62 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.947 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.27 123.1 48.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 124.669 1.231 . . . . 0.0 108.735 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.03 -166.67 1.64 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.74 -1.584 . . . . 0.0 108.518 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.56 -162.44 17.73 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.91 -1.744 . . . . 0.0 114.254 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.51 -25.97 68.22 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.95 75.4 78.66 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.17 128.3 29.32 Favored 'Trans proline' 0 C--N 1.285 -2.81 0 CA-C-O 122.913 1.13 . . . . 0.0 111.386 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.92 149.62 45.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.877 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.6 mt -115.59 122.36 69.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 122.056 0.932 . . . . 0.0 109.959 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.24 135.56 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.013 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.74 113.85 18.51 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.87 115.9 31.08 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.64 157.25 16.82 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.54 162.37 41.09 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -32.58 73.24 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.63 -10.48 20.01 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.314 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.9 158.74 42.59 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.5 t -127.53 119.0 25.05 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.481 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -110.9 123.29 49.84 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.412 0.625 . . . . 0.0 109.747 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 mt -113.75 122.88 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.599 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.6 119.69 33.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.732 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.62 102.82 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.21 10.76 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 117.555 -2.26 . . . . 0.0 109.679 -177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.6 24.13 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.79 124.82 29.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 124.887 1.367 . . . . 0.0 111.992 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.48 127.47 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.395 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.51 148.78 49.66 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.15 146.75 52.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.02 130.45 39.45 Favored 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.85 119.3 61.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.922 -1.49 . . . . 0.0 114.269 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -110.19 133.65 53.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 112.98 -1.918 . . . . 0.0 111.691 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.15 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.992 0.807 . . . . 0.0 112.288 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.76 133.5 56.16 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.366 1.555 . . . . 0.0 110.65 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.272 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.51 -32.64 63.07 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.729 0.776 . . . . 0.0 112.699 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.37 -10.55 4.94 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.46 2.5 28.63 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.076 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.82 142.98 57.99 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.711 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.33 15.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.39 112.47 24.92 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.28 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.38 49.22 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.51 138.16 49.69 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.733 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.64 125.26 9.64 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.59 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.701 1.251 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.6 p -127.42 138.73 53.05 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.246 178.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.2 -39.17 82.53 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.424 1.107 . . . . 0.0 108.109 177.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.74 -40.74 93.55 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 119' ' ' ILE . 29.0 t80 -64.16 -45.15 89.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 124.007 1.861 . . . . 0.0 109.391 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.4 1.3 ptm -60.19 -41.42 92.9 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.935 179.343 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.94 82.2 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.304 13.4 pt -90.94 14.17 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.672 -179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.415 23.5 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.88 30.38 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.052 1.362 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.84 66.6 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -177.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.89 -33.47 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.295 -179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.61 75.09 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.688 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.13 70.67 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.2 61.92 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.35 -29.03 65.46 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.928 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.62 -10.79 47.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 117.455 -1.698 . . . . 0.0 109.319 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.9 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.78 71.78 80.38 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.982 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.28 158.03 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.387 2.725 . . . . 0.0 116.202 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.21 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.287 -2.688 . . . . 0.0 106.703 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 pt -117.22 158.6 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.685 1.241 . . . . 0.0 111.208 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.55 14.86 Favored 'General case' 0 N--CA 1.394 -3.257 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.847 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.26 138.53 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.758 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.815 0.697 . . . . 0.0 111.964 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.93 -112.61 4.31 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.22 167.0 17.47 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.85 138.77 19.0 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.32 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.97 134.64 55.18 Favored 'General case' 0 C--O 1.279 2.645 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.27 158.36 38.37 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.48 124.69 16.43 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.104 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.91 139.37 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.2 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 85.0 tttt -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.08 126.59 51.12 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.314 1.054 . . . . 0.0 110.197 177.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.4 m -116.96 153.93 31.76 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -155.6 146.29 22.13 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.109 178.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.99 139.19 42.99 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.29 160.53 40.85 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.91 132.98 56.35 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 177.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.61 131.7 46.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.9 65.51 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.36 128.38 56.28 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 123.644 1.688 . . . . 0.0 110.517 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.78 136.44 56.22 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.14 127.41 37.6 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.735 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -127.03 143.51 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.108 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.18 120.65 37.92 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.849 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.4 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.677 3.6 mm? -52.32 -44.27 65.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.024 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -81.71 0.28 39.59 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.76 18.19 26.0 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.873 1.909 . . . . 0.0 117.873 178.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.15 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.94 50.39 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.76 16.34 12.71 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.83 52.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 mt -119.96 128.63 53.76 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 175.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.9 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -109.22 123.11 48.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.741 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.98 -166.73 1.66 Allowed 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.543 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.59 -162.41 17.7 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.873 -1.767 . . . . 0.0 114.272 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.357 11.3 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.16 128.21 28.98 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.9 m -138.8 149.62 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.902 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.8 113.88 18.51 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.95 115.94 31.12 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.63 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -32.54 73.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.38 20.06 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 115.516 -2.474 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.96 158.8 42.62 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.6 t -127.61 118.98 24.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.17 53.82 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.3 m -110.94 123.23 49.74 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.681 -0.637 . . . . 0.0 109.722 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.6 mt -113.65 122.85 68.57 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.617 -179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.61 119.73 33.72 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.732 179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.51 -117.13 10.48 Favored Glycine 0 N--CA 1.418 -2.506 0 C-N-CA 117.567 -2.254 . . . . 0.0 109.663 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.8 124.83 29.39 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 124.865 1.353 . . . . 0.0 111.931 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.47 127.42 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.4 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.85 49.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.19 146.83 52.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -133.17 130.43 39.15 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.86 119.27 61.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.289 -178.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.49 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.908 0 CA-C-N 114.583 -1.189 . . . . 0.0 113.227 -179.902 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.59 63.16 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.65 0.738 . . . . 0.0 112.676 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.6 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.34 2.39 28.79 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.037 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.01 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.257 1.598 . . . . 0.0 109.719 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.95 68.55 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.76 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-N 118.701 1.251 . . . . 0.0 108.609 178.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.48 112.52 24.96 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.678 1.704 . . . . 0.0 110.202 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -107.74 135.42 49.19 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.653 -1.612 . . . . 0.0 106.843 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp -48.66 125.25 9.65 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.31 -43.19 3.56 Favored 'General case' 0 N--CA 1.413 -2.311 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.728 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -159.75 174.0 15.17 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.6 155.85 13.1 Favored 'General case' 0 CA--C 1.487 -1.468 0 O-C-N 124.686 1.241 . . . . 0.0 111.74 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.901 . . . . 0.0 110.2 178.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.09 28.79 9.31 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 178.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -78.07 -35.53 49.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.19 -39.11 82.58 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mp0 -60.83 -40.72 93.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' CE2' HG21 ' A' ' 119' ' ' ILE . 27.7 t80 -64.18 -45.19 89.44 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 124.028 1.87 . . . . 0.0 109.306 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.404 1.3 ptm -60.13 -41.46 92.69 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.935 179.347 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.01 82.07 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.346 10.1 pt -90.89 14.08 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.117 -1.833 . . . . 0.0 111.691 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.146 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.418 23.8 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.54 161.89 30.37 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.073 1.374 . . . . 0.0 114.216 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.72 -47.68 67.16 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -177.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.1 mt -72.97 -33.52 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.21 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.22 -34.58 75.07 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.693 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.83 -49.23 73.67 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.41 -51.13 70.65 Favored 'General case' 0 C--O 1.202 -1.409 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 179.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.18 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.38 -29.03 65.52 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.357 0.976 . . . . 0.0 113.868 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.77 -10.27 58.22 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.64 -10.81 47.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 117.516 -1.674 . . . . 0.0 109.303 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.66 18.26 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.81 71.66 80.41 Favored Pre-proline 0 C--N 1.349 0.565 0 CA-C-N 112.612 -2.085 . . . . 0.0 111.004 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.3 158.07 32.64 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.321 2.681 . . . . 0.0 116.192 -179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.0 t -119.97 126.23 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.305 -2.679 . . . . 0.0 106.748 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.1 pt -117.3 158.55 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 CA-C-O 122.616 1.198 . . . . 0.0 111.158 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.59 14.91 Favored 'General case' 0 N--CA 1.395 -3.217 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.855 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.25 138.52 38.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.75 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.93 143.46 50.74 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.894 0.746 . . . . 0.0 111.923 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.22 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.019 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.4 mt -103.95 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.698 0 CA-C-O 121.493 0.663 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.34 6.67 48.4 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.881 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.7 mttt -78.58 146.23 34.33 Favored 'General case' 0 N--CA 1.403 -2.794 0 C-N-CA 116.083 -2.247 . . . . 0.0 113.775 -179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.23 167.0 17.48 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.91 138.77 18.95 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.343 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.96 134.55 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.19 158.31 38.45 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.846 1.307 . . . . 0.0 110.578 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.0 t -141.48 124.67 16.42 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.167 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -128.88 139.44 52.14 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -178.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.4 p -137.52 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 177.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.7 76.29 Favored 'General case' 0 C--O 1.192 -1.959 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.632 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.8 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 50.8 tttm -163.74 138.6 6.1 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.403 -1.319 . . . . 0.0 114.395 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.12 126.55 51.0 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.29 1.043 . . . . 0.0 110.23 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -116.92 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.986 0.898 . . . . 0.0 109.053 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.31 9.24 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.801 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.61 146.19 22.03 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.91 1.381 . . . . 0.0 111.096 178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.17 42.97 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 160.61 40.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.89 133.03 56.32 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 177.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -55.63 131.63 46.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.357 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -92.13 127.37 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -127.05 143.48 51.27 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.487 1.613 . . . . 0.0 115.076 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.09 120.61 37.77 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.115 -1.615 . . . . 0.0 106.954 177.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.663 3.6 mm? -52.4 -44.2 65.22 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.963 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.73 0.31 39.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.74 18.15 26.17 Favored Glycine 0 CA--C 1.482 -1.99 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 178.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.87 171.89 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.13 117.59 34.88 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.448 1.717 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -138.97 144.76 28.85 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.669 177.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.8 mt -138.05 143.43 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.1 p -145.83 171.48 14.72 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.281 55.0 tt0 -99.55 150.46 22.21 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 125.108 1.363 . . . . 0.0 111.203 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.24 89.11 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 177.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.58 177.95 50.42 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.605 -3.188 . . . . 0.0 105.174 -178.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.63 -22.46 18.03 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.224 2.74 . . . . 0.0 119.224 -178.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.83 16.41 12.65 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.29 140.82 52.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt -120.0 128.63 53.73 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 175.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.77 118.6 57.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.841 1.781 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.65 127.6 54.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.871 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -109.26 123.07 48.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.777 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 117.731 -1.588 . . . . 0.0 108.533 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.63 -162.38 17.66 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.898 -1.751 . . . . 0.0 114.235 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.92 68.18 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -130.93 75.31 78.81 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.19 128.21 29.0 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 CA-C-O 122.91 1.129 . . . . 0.0 111.429 -178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.7 m -138.85 149.68 45.17 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.76 62.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.902 178.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.2 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.076 0.941 . . . . 0.0 109.971 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -124.81 113.94 18.58 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 5.0 tt0 -104.93 115.94 31.13 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.64 157.25 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.51 162.33 41.15 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 105.366 -2.086 . . . . 0.0 105.366 177.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.57 73.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 123.537 1.636 . . . . 0.0 109.46 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 -10.39 20.03 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.536 -2.466 . . . . 0.0 117.247 -179.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.344 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -177.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.59 118.94 24.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 175.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -104.76 116.32 48.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.577 1.18 . . . . 0.0 111.181 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 O-C-N 120.939 -1.1 . . . . 0.0 111.478 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 20' ' ' TYR . 12.8 mt -113.73 122.77 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.594 -179.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.8 33.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.321 -1.309 . . . . 0.0 112.728 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.68 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.59 -117.14 10.51 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.577 -2.249 . . . . 0.0 109.674 -177.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.8 29.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.9 t -120.39 127.48 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.54 148.8 49.68 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.74 52.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.805 0.812 . . . . 0.0 111.378 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp85 -133.1 130.39 39.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.81 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.349 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.09 133.65 52.99 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.781 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.24 132.49 48.14 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 124.064 0.852 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.71 133.5 56.16 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 123.313 1.53 . . . . 0.0 110.732 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.944 0 CA-C-N 114.558 -1.201 . . . . 0.0 113.254 -179.925 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.52 -32.6 63.06 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.674 0.75 . . . . 0.0 112.724 178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.38 -10.56 4.96 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.46 2.51 28.65 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.038 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 143.02 57.97 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 125.249 1.593 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.24 -2.94 68.45 Favored Glycine 0 C--O 1.194 -2.39 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.9 mt -87.79 140.36 15.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 118.663 1.232 . . . . 0.0 108.548 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.38 112.51 24.98 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 123.641 1.686 . . . . 0.0 110.259 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.72 135.36 49.28 Favored 'General case' 0 N--CA 1.41 -2.463 0 CA-C-N 113.705 -1.589 . . . . 0.0 106.838 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.57 138.14 49.78 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.49 0.662 . . . . 0.0 109.687 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 tp -48.63 125.18 9.48 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 122.979 1.371 . . . . 0.0 112.569 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -112.3 -43.16 3.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.707 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.2 p -159.75 173.99 15.19 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.6 155.86 13.12 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.634 1.209 . . . . 0.0 111.758 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -127.38 138.66 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.145 0.903 . . . . 0.0 110.285 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.15 28.79 9.45 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 178.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -78.07 -35.49 49.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.6 tt0 -68.23 -39.07 82.43 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.431 1.11 . . . . 0.0 108.147 177.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -60.81 -40.72 93.8 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -64.17 -45.18 89.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 123.985 1.85 . . . . 0.0 109.34 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.22 -41.38 92.96 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.621 -1.627 . . . . 0.0 110.9 179.399 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -60.65 -42.68 97.48 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.99 81.94 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.93 14.14 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.937 0 C-N-CA 117.175 -1.81 . . . . 0.0 111.69 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.3 55.9 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.396 3.718 . . . . 0.0 122.396 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.49 131.59 34.37 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-N 120.017 1.909 . . . . 0.0 110.323 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.52 161.88 30.31 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 123.037 1.354 . . . . 0.0 114.239 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.6 -47.82 66.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.95 -33.44 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.309 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.235 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.24 -34.64 75.11 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.696 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -63.81 -49.2 73.81 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.46 -51.15 70.6 Favored 'General case' 0 C--O 1.203 -1.373 0 CA-C-O 121.437 0.637 . . . . 0.0 111.225 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.2 62.02 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -28.97 65.38 Favored Glycine 0 C--O 1.204 -1.722 0 CA-C-O 122.428 1.016 . . . . 0.0 113.924 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.8 -10.32 58.15 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 123.801 0.84 . . . . 0.0 109.426 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.61 -10.76 47.54 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 117.46 -1.696 . . . . 0.0 109.358 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 mt -95.66 152.55 18.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.8 71.77 80.34 Favored Pre-proline 0 C--N 1.349 0.561 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.28 158.06 32.62 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.415 2.743 . . . . 0.0 116.172 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -120.02 126.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.276 -2.693 . . . . 0.0 106.687 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.24 158.61 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-O 122.654 1.216 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.69 146.54 14.86 Favored 'General case' 0 N--CA 1.395 -3.22 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.875 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.25 138.49 38.2 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.317 -1.31 . . . . 0.0 108.788 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.88 143.41 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.863 0.727 . . . . 0.0 111.976 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.08 117.19 41.21 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.055 179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.96 -163.87 1.01 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.89 -112.56 4.29 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.37 6.7 48.31 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -179.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.22 34.42 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.095 -2.242 . . . . 0.0 113.81 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -128.24 167.03 17.45 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.78 18.95 Favored 'General case' 0 C--N 1.264 -3.152 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.273 178.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.01 134.61 55.2 Favored 'General case' 0 C--O 1.278 2.604 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.8 p -128.26 158.37 38.34 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.862 1.315 . . . . 0.0 110.553 179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 t -141.49 124.69 16.42 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.104 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.92 139.36 52.16 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.6 p -137.51 167.92 20.68 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 177.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.72 76.29 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.689 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.78 -6.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 46.0 tttm -163.7 138.64 6.15 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.45 -1.3 . . . . 0.0 114.411 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.18 126.56 50.97 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.304 1.049 . . . . 0.0 110.168 177.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.3 m -116.92 153.9 31.76 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.032 0.92 . . . . 0.0 109.053 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.16 157.31 9.35 Favored 'General case' 0 CA--C 1.449 -2.911 0 C-N-CA 118.685 -1.206 . . . . 0.0 109.763 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.64 146.24 22.04 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.961 1.413 . . . . 0.0 111.119 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.98 139.18 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.717 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.32 160.53 40.82 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.879 2.177 . . . . 0.0 116.879 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -117.9 133.02 56.33 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 177.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -55.65 131.73 47.18 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.65 -1.9 65.33 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.31 128.41 56.27 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-O 123.657 1.694 . . . . 0.0 110.497 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.84 136.5 56.25 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -136.98 169.18 18.22 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.512 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.41 37.65 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.744 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -127.09 143.49 51.26 Favored 'General case' 0 CA--C 1.587 2.397 0 CA-C-O 123.434 1.588 . . . . 0.0 115.074 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.15 120.64 37.87 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.191 -1.568 . . . . 0.0 106.866 177.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.2 p -78.0 168.32 20.08 Favored 'General case' 0 CA--C 1.469 -2.15 0 CA-C-O 122.345 1.069 . . . . 0.0 111.59 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.27 -44.33 64.88 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.168 -1.833 . . . . 0.0 113.992 -179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -81.65 0.24 39.5 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -178.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.12 26.12 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 117.888 1.915 . . . . 0.0 117.888 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.2 mtm105 -101.24 156.86 17.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 118.275 -1.37 . . . . 0.0 110.57 178.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.93 110.08 22.32 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 171.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.789 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.7 mttt -103.2 117.58 34.86 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -124.57 154.41 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.436 1.71 . . . . 0.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.95 144.79 28.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.448 -1.705 . . . . 0.0 108.669 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.1 143.46 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.0 p -145.86 171.51 14.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.64 150.45 22.25 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.026 1.33 . . . . 0.0 111.162 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.19 89.1 2.57 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.61 177.9 50.38 Favored Glycine 0 N--CA 1.408 -3.207 0 N-CA-C 105.135 -3.186 . . . . 0.0 105.135 -178.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.56 -22.52 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 N-CA-C 119.172 2.72 . . . . 0.0 119.172 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -119.84 16.36 12.64 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.824 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.25 140.79 52.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -119.97 128.66 53.78 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 175.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.78 118.68 57.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.85 126.52 52.55 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 123.87 1.795 . . . . 0.0 111.949 -177.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.57 127.56 54.62 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.907 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -109.31 123.07 48.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.702 179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -89.99 -166.69 1.65 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.794 -1.563 . . . . 0.0 108.573 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.53 -162.45 17.75 Favored Glycine 0 CA--C 1.491 -1.434 0 O-C-N 119.967 -1.708 . . . . 0.0 114.287 178.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.343 11.9 p-10 -64.5 -25.94 68.21 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.94 75.29 78.84 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.16 128.26 29.17 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.933 1.139 . . . . 0.0 111.395 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.61 45.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.16 119.73 62.84 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.144 -1.389 . . . . 0.0 107.902 178.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.58 122.37 69.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 122.076 0.941 . . . . 0.0 109.991 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.23 135.57 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 117.944 -1.502 . . . . 0.0 109.033 179.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -124.77 113.84 18.47 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.824 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.86 115.94 31.14 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.69 157.27 16.81 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.0 p -151.57 162.3 41.2 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -32.58 73.22 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 123.537 1.636 . . . . 0.0 109.45 -179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -10.4 20.05 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 115.492 -2.483 . . . . 0.0 117.305 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.343 0.0 OUTLIER -152.95 158.79 42.6 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.8 t -127.57 118.97 24.95 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 175.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.84 116.32 48.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 CA-C-O 122.585 1.183 . . . . 0.0 111.207 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.94 121.11 53.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 O-C-N 120.97 -1.081 . . . . 0.0 111.523 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.5 m -110.85 123.19 49.62 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 121.709 -0.619 . . . . 0.0 109.762 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 mt -113.7 122.84 68.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 121.891 0.853 . . . . 0.0 112.625 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.57 119.73 33.77 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.732 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -124.67 102.86 7.8 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.53 -117.21 10.72 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 117.528 -2.272 . . . . 0.0 109.676 -177.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.06 -14.61 24.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.883 0.873 . . . . 0.0 112.135 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.76 124.78 29.34 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.885 1.366 . . . . 0.0 111.992 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.3 t -120.44 127.41 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.4 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.47 148.84 49.61 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.2 146.78 52.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.828 0.823 . . . . 0.0 111.364 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -133.08 130.44 39.33 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.91 119.32 61.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 113.928 -1.487 . . . . 0.0 114.267 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -110.14 133.64 53.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.751 179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.23 132.54 48.1 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 123.996 0.81 . . . . 0.0 112.255 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.81 133.53 56.19 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 123.325 1.536 . . . . 0.0 110.663 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.292 -1.901 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.227 -179.928 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.279 2.0 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.36 -10.6 4.99 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -105.4 2.5 28.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.071 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.83 142.98 58.01 Favored 'General case' 0 C--N 1.359 0.98 0 O-C-N 125.277 1.611 . . . . 0.0 109.736 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.32 -2.93 69.01 Favored Glycine 0 C--O 1.194 -2.388 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.8 mt -87.85 140.37 15.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 CA-C-N 118.68 1.24 . . . . 0.0 108.561 178.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.46 112.46 24.87 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.599 1.666 . . . . 0.0 110.245 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.665 -1.607 . . . . 0.0 106.843 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.37 -43.19 3.55 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 119.271 -0.971 . . . . 0.0 111.693 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.76 174.02 15.14 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.46 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -165.62 155.86 13.08 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.684 1.24 . . . . 0.0 111.737 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.5 p -127.41 138.72 53.06 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.109 0.881 . . . . 0.0 110.2 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.13 28.72 9.31 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.701 2.111 . . . . 0.0 116.701 178.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -78.06 -35.44 49.58 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 42.0 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -64.18 -45.14 89.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 124.051 1.881 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.402 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.341 10.7 pt -90.9 14.15 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.108 -1.837 . . . . 0.0 111.694 -179.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.92 23.25 56.08 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 122.463 3.745 . . . . 0.0 122.463 178.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.422 24.0 t -71.41 131.59 34.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.162 0 CA-C-N 119.972 1.886 . . . . 0.0 110.298 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.6 161.92 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 123.063 1.368 . . . . 0.0 114.242 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.8 66.83 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.8 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.0 mtm-85 -63.88 -49.18 73.71 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.405 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.44 -51.11 70.75 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-O 121.396 0.617 . . . . 0.0 111.252 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.17 62.02 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.43 -29.0 65.6 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.391 0.995 . . . . 0.0 113.91 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.77 -10.29 58.2 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 123.748 0.819 . . . . 0.0 109.433 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -95.65 152.58 18.32 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 -178.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.626 -2.079 . . . . 0.0 111.035 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.32 158.09 32.7 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.4 t -119.99 126.25 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 111.286 -2.688 . . . . 0.0 106.703 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.8 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.19 138.54 38.09 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.747 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.92 143.42 50.71 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.846 0.716 . . . . 0.0 111.964 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.03 117.2 41.17 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.019 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.008 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.19 0.51 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.9 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.66 48.41 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.53 146.21 34.44 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.056 -2.258 . . . . 0.0 113.808 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -128.22 167.04 17.41 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.008 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.92 138.76 18.93 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.347 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.98 134.6 55.2 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -141.44 124.63 16.42 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.163 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.87 139.41 52.16 Favored 'General case' 0 CA--C 1.473 -1.991 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -178.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.8 -6.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 51.0 tttm -163.7 138.61 6.14 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.426 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.55 51.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.318 1.056 . . . . 0.0 110.224 177.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.3 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.726 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.32 9.25 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -155.61 146.21 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 124.868 1.355 . . . . 0.0 111.119 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 m -107.95 139.16 42.98 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.688 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.1 tt0 -65.83 136.44 56.18 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -137.03 169.16 18.25 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.493 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -92.13 127.33 37.56 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.733 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -126.99 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.119 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.1 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.665 3.6 mm? -52.36 -44.21 65.09 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.155 -1.838 . . . . 0.0 114.023 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -81.74 0.28 39.73 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.75 18.18 26.06 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 117.935 1.934 . . . . 0.0 117.935 178.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -101.22 156.86 17.19 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.606 178.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.92 110.05 22.27 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.83 171.91 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.6 mttt -103.17 117.59 34.87 Favored 'General case' 0 C--O 1.271 2.194 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -124.58 154.43 40.67 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 125.49 1.743 . . . . 0.0 111.761 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.98 144.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.253 1.272 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.705 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -138.05 143.47 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.3 p -145.87 171.51 14.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -99.59 150.41 22.27 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.063 1.345 . . . . 0.0 111.184 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -73.62 -22.52 18.0 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 N-CA-C 119.185 2.725 . . . . 0.0 119.185 -178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.31 140.83 52.48 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.3 mt -120.0 128.61 53.7 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 175.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.5 t -109.75 118.6 57.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -117.79 126.63 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.66 127.56 54.54 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 113.708 -1.587 . . . . 0.0 111.902 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.2 123.09 48.66 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.798 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.0 mttt -90.03 -166.74 1.66 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.502 179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.65 -162.41 17.64 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.898 -1.751 . . . . 0.0 114.238 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.342 11.9 p-10 -64.58 -25.96 68.2 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.88 75.28 78.9 Favored Pre-proline 0 C--O 1.205 -1.276 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.5 m -138.84 149.67 45.16 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.72 62.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.877 178.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.8 mt -115.61 122.39 69.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 122.102 0.953 . . . . 0.0 109.971 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.27 135.61 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.988 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -124.81 113.9 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.94 115.93 31.11 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 -10.38 20.05 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.544 -2.462 . . . . 0.0 117.305 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.728 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.1 t -127.57 118.98 24.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 175.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 tp -124.67 102.82 7.79 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.56 -117.15 10.54 Favored Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 117.594 -2.241 . . . . 0.0 109.644 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.1 -14.63 24.04 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.938 0.895 . . . . 0.0 112.112 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.46 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.5 148.82 49.64 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.79 119.28 61.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.327 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -110.11 133.67 52.97 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.751 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.49 48.19 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 123.973 0.796 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.308 1.528 . . . . 0.0 110.725 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.273 3.7 p . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -55.57 -32.63 63.18 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.669 0.747 . . . . 0.0 112.651 178.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -60.39 -10.58 5.02 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.41 2.51 28.75 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.971 -0.691 . . . . 0.0 112.076 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.02 57.96 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 125.201 1.563 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.27 -2.93 68.65 Favored Glycine 0 C--O 1.194 -2.353 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 73.7 mt -87.8 140.35 15.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-N 118.736 1.268 . . . . 0.0 108.592 178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -108.42 112.44 24.86 Favored 'General case' 0 C--O 1.258 1.519 0 CA-C-O 123.592 1.663 . . . . 0.0 110.243 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.7 135.42 49.15 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.843 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -112.58 138.16 49.76 Favored 'General case' 0 C--O 1.266 1.966 0 CA-C-O 121.472 0.653 . . . . 0.0 109.696 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -48.66 125.29 9.73 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-O 122.95 1.357 . . . . 0.0 112.598 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -112.42 -43.09 3.55 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.698 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -159.83 173.97 15.17 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.479 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -165.57 155.83 13.14 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.702 1.251 . . . . 0.0 111.737 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.5 p -127.37 138.73 53.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.126 0.891 . . . . 0.0 110.198 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 54.07 28.79 9.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 178.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -78.09 -35.4 49.39 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 41.8 tt0 -68.22 -39.15 82.44 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mp0 -60.75 -40.74 93.56 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -64.18 -45.14 89.69 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 124.068 1.89 . . . . 0.0 109.358 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HA ' ' A' ' 18' ' ' GLU 0.401 1.3 ptm -60.2 -41.42 92.94 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.92 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -60.62 -42.64 97.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.97 82.28 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 12.8 pt -90.89 14.11 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.962 0 C-N-CA 117.126 -1.83 . . . . 0.0 111.684 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.94 23.23 56.09 Favored Glycine 0 C--O 1.215 -1.078 0 N-CA-C 122.448 3.739 . . . . 0.0 122.448 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.413 23.6 t -71.43 131.62 34.32 Favored 'Isoleucine or valine' 0 C--O 1.252 1.205 0 CA-C-N 119.994 1.897 . . . . 0.0 110.291 179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 161.91 30.57 Favored Glycine 0 N--CA 1.478 1.495 0 CA-C-O 122.99 1.328 . . . . 0.0 114.271 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.8 66.8 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -177.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.86 -33.55 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.314 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.271 -179.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.18 -34.61 75.2 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.688 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -63.9 -49.16 73.79 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.426 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -57.45 -51.06 70.98 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-O 121.425 0.631 . . . . 0.0 111.281 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.2 -46.2 62.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.36 -29.09 65.59 Favored Glycine 0 C--O 1.204 -1.729 0 CA-C-O 122.396 0.998 . . . . 0.0 113.918 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.71 -10.29 58.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.77 0.828 . . . . 0.0 109.464 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.67 -10.72 47.53 Favored 'General case' 0 N--CA 1.419 -1.99 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.333 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.69 152.62 18.3 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 m -131.75 71.68 80.54 Favored Pre-proline 0 C--N 1.349 0.546 0 CA-C-N 112.601 -2.09 . . . . 0.0 111.035 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.32 158.06 32.84 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.312 2.675 . . . . 0.0 116.216 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.94 126.26 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 111.316 -2.674 . . . . 0.0 106.729 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 pt -117.32 158.55 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 O-C-N 124.709 1.255 . . . . 0.0 111.173 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -160.68 146.56 14.89 Favored 'General case' 0 N--CA 1.394 -3.253 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.844 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.7 tp -101.22 138.5 38.16 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.758 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.86 143.45 50.74 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 123.828 0.705 . . . . 0.0 111.948 179.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.3 m -97.08 117.2 41.24 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.019 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.007 HD11 ' HB2' ' A' ' 52' ' ' LYS . 7.5 mt -103.98 -163.88 1.01 Allowed 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.16 110.24 0.52 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 178.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.86 -112.6 4.32 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -95.32 6.65 48.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.829 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 29.8 mttt -78.52 146.21 34.46 Favored 'General case' 0 N--CA 1.403 -2.813 0 C-N-CA 116.048 -2.261 . . . . 0.0 113.808 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.25 166.98 17.55 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 1.007 ' HB2' HD11 ' A' ' 46' ' ' LEU . 1.4 ttmt -151.86 138.78 19.0 Favored 'General case' 0 C--N 1.263 -3.171 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.347 178.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.0 mt -119.99 134.56 55.21 Favored 'General case' 0 C--O 1.28 2.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 63' ' ' GLU . 26.6 p -128.24 158.34 38.41 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.807 1.289 . . . . 0.0 110.581 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -141.43 124.64 16.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.142 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -128.85 139.39 52.18 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 74.0 p -137.47 167.96 20.59 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 177.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.71 76.3 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.655 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 pp -98.83 -6.77 9.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.786 ' C ' HD22 ' A' ' 61' ' ' ASN . 51.1 tttm -163.72 138.55 6.09 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.454 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.786 HD22 ' C ' ' A' ' 60' ' ' LYS . 1.6 m120 -120.09 126.51 50.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.351 1.072 . . . . 0.0 110.219 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 m -116.93 153.93 31.72 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.016 0.913 . . . . 0.0 109.02 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.725 ' HB3' HG22 ' A' ' 54' ' ' THR . 12.5 pt-20 -168.22 157.29 9.22 Favored 'General case' 0 CA--C 1.449 -2.941 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.782 178.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -155.56 146.25 22.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.856 1.348 . . . . 0.0 111.109 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.9 m -107.97 139.2 42.95 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.714 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.26 160.56 40.9 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 49' ' ' ASP . 2.0 mttt -117.9 132.99 56.36 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.62 131.64 46.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -1.86 65.77 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.35 128.43 56.29 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-O 123.609 1.671 . . . . 0.0 110.494 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.788 ' OE1' ' HD3' ' A' ' 83' ' ' LYS . 40.2 tt0 -65.87 136.45 56.16 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.03 169.17 18.23 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.485 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.18 127.39 37.64 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.745 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -127.02 143.55 51.26 Favored 'General case' 0 CA--C 1.586 2.365 0 CA-C-O 123.488 1.614 . . . . 0.0 115.098 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -97.19 120.67 37.97 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 120.124 -1.61 . . . . 0.0 106.897 177.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.8 p -77.97 168.34 20.06 Favored 'General case' 0 CA--C 1.468 -2.184 0 CA-C-O 122.4 1.095 . . . . 0.0 111.604 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.662 3.6 mm? -52.33 -44.25 65.03 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 113.155 -1.838 . . . . 0.0 113.999 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -81.81 0.41 39.46 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.64 18.26 26.07 Favored Glycine 0 CA--C 1.481 -2.047 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 178.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.0 mtm105 -101.29 156.86 17.2 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.249 -1.381 . . . . 0.0 110.614 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -104.94 110.03 22.25 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.85 171.91 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.788 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 34.5 mttt -103.2 117.63 34.96 Favored 'General case' 0 C--O 1.27 2.176 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.6 m -124.6 154.39 40.74 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 125.409 1.693 . . . . 0.0 111.764 -179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -138.97 144.77 28.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 113.516 -1.674 . . . . 0.0 108.67 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.4 mt -138.1 143.42 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.2 p -145.83 171.44 14.79 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.28 55.0 tt0 -99.55 150.41 22.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 125.048 1.339 . . . . 0.0 111.184 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -133.21 89.13 2.57 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 177.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.59 177.95 50.4 Favored Glycine 0 N--CA 1.408 -3.227 0 C-N-CA 115.64 -3.171 . . . . 0.0 105.174 -178.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.64 -22.5 17.99 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 N-CA-C 119.19 2.727 . . . . 0.0 119.19 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -119.8 16.41 12.68 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.825 ' HE2' ' CD ' ' A' ' 109' ' ' GLU . 10.6 mttt -125.27 140.86 52.47 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -120.02 128.69 53.76 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.82 118.6 57.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -117.79 126.58 52.7 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 123.831 1.777 . . . . 0.0 111.93 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -116.58 127.6 54.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.91 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -109.24 123.09 48.68 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.798 179.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' HE3' ' OE2' ' A' ' 71' ' ' GLU . 20.1 mttt -90.01 -166.71 1.65 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 117.765 -1.574 . . . . 0.0 108.491 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.62 -162.4 17.67 Favored Glycine 0 CA--C 1.49 -1.479 0 O-C-N 119.949 -1.719 . . . . 0.0 114.238 178.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.356 11.2 p-10 -64.6 -25.93 68.18 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -178.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -130.92 75.28 78.86 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.09 128.18 28.77 Favored 'Trans proline' 0 C--N 1.284 -2.845 0 CA-C-O 122.89 1.121 . . . . 0.0 111.43 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 m -138.85 149.64 45.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -178.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.13 119.76 62.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 114.154 -1.384 . . . . 0.0 107.849 178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mt -115.65 122.4 69.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 122.103 0.954 . . . . 0.0 109.942 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.21 135.58 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 117.955 -1.498 . . . . 0.0 109.037 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -124.78 113.88 18.52 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.825 ' CD ' ' HE2' ' A' ' 93' ' ' LYS . 4.9 tt0 -104.92 115.94 31.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -100.62 157.23 16.83 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 p -151.56 162.32 41.18 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.56 73.23 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-O 123.58 1.657 . . . . 0.0 109.42 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -10.47 20.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 115.582 -2.447 . . . . 0.0 117.314 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . 0.345 0.0 OUTLIER -153.0 158.76 42.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 44.4 t -127.59 119.02 25.02 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.85 116.36 48.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 CA-C-O 122.659 1.219 . . . . 0.0 111.105 179.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -102.98 121.13 53.78 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 111.478 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.4 m -110.89 123.29 49.84 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.662 -0.649 . . . . 0.0 109.747 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.72 122.8 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.583 -179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.765 ' HE2' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -120.56 119.74 33.79 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.761 179.877 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.0 tp -124.67 102.79 7.77 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.765 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . 60.58 -117.17 10.6 Favored Glycine 0 N--CA 1.418 -2.522 0 C-N-CA 117.588 -2.244 . . . . 0.0 109.615 -177.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.08 -14.63 24.07 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.85 124.82 29.41 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.865 1.353 . . . . 0.0 111.947 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.715 ' CG2' ' HE3' ' A' ' 120' ' ' LYS . 74.5 t -120.43 127.5 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.404 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -126.56 148.8 49.69 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 p -131.22 146.8 52.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.836 0.826 . . . . 0.0 111.37 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -133.14 130.39 39.14 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.8 119.23 61.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.901 -1.499 . . . . 0.0 114.357 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.06 133.72 52.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.0 -1.909 . . . . 0.0 111.715 179.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -102.28 132.46 48.23 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.991 0.807 . . . . 0.0 112.265 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.77 133.5 56.15 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 123.319 1.533 . . . . 0.0 110.725 179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 C--N 1.291 -1.951 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.224 -179.897 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' OLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_